# EDGAR Filing Document

**Accession Number:** 0001849253
**File Stem:** 0001849253-26-000013
**Filing Date:** 2026-3
**Character Count:** 280799
**Document Hash:** 6aef48a260c303f54eef6144e49e89e1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001849253-26-000013.hdr.sgml**: 20260317

**ACCESSION NUMBER**: 0001849253-26-000013

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 44

**CONFORMED PERIOD OF REPORT**: 20260317

**FILED AS OF DATE**: 20260317

**DATE AS OF CHANGE**: 20260317

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RYAN SPECIALTY HOLDINGS, INC.
- **CENTRAL INDEX KEY:** 0001849253
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSURANCE AGENTS BROKERS & SERVICES [6411]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40645
- **FILM NUMBER:** 26762323

**BUSINESS ADDRESS:**
- **STREET 1:** 155 NORTH WACKER DRIVE, SUITE 4000
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606
- **BUSINESS PHONE:** 312-784-6001

**MAIL ADDRESS:**
- **STREET 1:** 155 NORTH WACKER DRIVE, SUITE 4000
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** RYAN SPECIALTY GROUP HOLDINGS, INC.
- **DATE OF NAME CHANGE:** 20210511

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MAVERICK SPECIALTY, INC.
- **DATE OF NAME CHANGE:** 20210304

?xml version='1.0' encoding='ASCII'? ryan-20260317

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

______________________

**SCHEDULE 14A** 

**Proxy Statement Pursuant to Section 14(a) of the** 

**Securities Exchange Act of 1934 (Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)**

______________________

---

| | | |
|:---|:---|:---|
| Filed by the Registrant ⌧ | Filed by the Registrant ⌧ | Filed by a Party other than the Registrant □ |
| Check the appropriate box:  | Check the appropriate box:  | Check the appropriate box:  |
| □ | Preliminary Proxy Statement | Preliminary Proxy Statement |
| □ | **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** | **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** |
| ⌧ | Definitive Proxy Statement | Definitive Proxy Statement |
| □ | Definitive Additional Materials | Definitive Additional Materials |
| □ | Soliciting Material under § 240.14a-12 | Soliciting Material under § 240.14a-12 |

---

![img150566244_0.jpg](ryan-20260317_g1.jpg)

**RYAN SPECIALTY HOLDINGS, INC.** 

**(Name of Registrant as Specified in Its Charter)** 

**(Name of Person(s) Filing Proxy Statement, if other than the Registrant)** 

---

| | |
|:---|:---|
| Payment of filing fee (Check all boxes that apply):  | Payment of filing fee (Check all boxes that apply):  |
| ⌧ | No fee required. |
| □ | Fee paid previously with preliminary materials. |
| □ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |

---

![RyanSpecialty_Proxy-02192026-Front Cover.jpg](ryan-20260317_g2.jpg)

![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg)

March 17, 2026

Dear fellow stockholders:

![Ryan-2026 Proxy.jpg](ryan-20260317_g4.jpg)

It is my privilege to present Ryan Specialty's 2026 Proxy

Statement.

On behalf of the entire Board of Directors of Ryan Specialty,

we invite you to attend Ryan Specialty's 2026 Annual

Meeting of Stockholders to be held on April 28, 2026 at 2:30

p.m. Eastern Time.

Overall, 2025 was a strong year for Ryan Specialty,

particularly considering the significant headwinds the

industry faced. We surpassed revenues of $3 billion, up 21%

year-over-year, and delivered our 15th consecutive year of

double-digit organic revenue growth and our seventh

consecutive year of growing total revenue by over 20%.

Achieving these results at a time of challenging market

conditions is an incredible testament to the resilience of our

platform, the quality of our people, and the intentional

diversification we've built over the past 15 years.

We built Ryan Specialty to excel through transitioning markets, not just for the easier years. Diversified

specialties, diversified products, and diversified earnings, all backed by world-class talent, all by design. This

intentional diversification has opened the door to additional opportunities across all of our specialties, and we

believe positions us well for a wide range of market outcomes.

Over the last two years, we've invested nearly $2.7 billion in 12 acquisitions, significantly diversifying our

platform with new products, geographies, and capabilities. This transformation has been exciting, and with scale

comes complexity. Earlier this year, we launched EMPOWER, a three-year restructuring program designed to

streamline our broking, binding, and underwriting operations, optimize our scale, accelerate our data,

technology, and AI strategies, and enhance efficiencies across all of our specialties. These anticipated

efficiencies will create headroom for continued strategic investment in growth, top-tier talent, de novo

formations, and innovation, which should enable us to maintain industry-leading growth in the years to come.

In 2025, we also continued to strengthen the leadership team that will guide Ryan Specialty into the future. We

were pleased to announce the appointments of Brendan Mulshine and Steve Keogh as Co-Presidents of the

firm, complementing our outstanding leadership team.

As we entered 2026, we took several important steps to further enhance stockholder value. Our Board of

Directors authorized Ryan Specialty's inaugural share repurchase program of $300 million, reflecting the

confidence we have in both our near- and long-term outlook. The Board also approved an 8% increase to our

regular quarterly dividend. The addition of share repurchases, alongside continued disciplined M&A, organic

investment, and a growing dividend, gives us greater flexibility in how we return value to you, our stockholders.

I am incredibly proud of the depth, expertise, and determination of our entire team. Through their unwavering

commitment to excellence, we will strive to continue to deliver differentiated value for our brokers, agents, and

insurance carrier trading partners, which we expect will drive significant additional value for our stockholders.

Following with our strong 2025 performance, our management and Board remained actively engaged with

stockholders throughout the year. The Board appreciates this regular feedback, which will continue to be taken

into consideration and inform our corporate governance practices moving forward.

We thank you for your investment and continued support of Ryan Specialty.

Respectfully yours,

![PGR Sig.jpg](ryan-20260317_g5.jpg)

Patrick G. Ryan

Founder and Executive Chairman of the Board

**NOTICE OF 2026 ANNUAL MEETING**

**OF STOCKHOLDERS AND PROXY STATEMENT** 

Dear stockholder:

You are cordially invited to attend the Annual Meeting of Stockholders (the "Annual Meeting") of Ryan Specialty Holdings,

Inc. (the "Company") on:

---

| | | |
|:---|:---|:---|
| ![Calendar IMG.jpg](ryan-20260317_g6.jpg) | **DATE:** | Tuesday, April 28, 2026. |
| ![Clock IMG.jpg](ryan-20260317_g7.jpg) | **TIME:** | 2:30 p.m. Eastern Time. |
| ![Place IMG.jpg](ryan-20260317_g8.jpg) | **PLACE:** | The meeting will be a virtual-only meeting, conducted exclusively via webcast at <br>www.proxydocs.com/RYAN. There will not be a physical location for the meeting, and you will not <br>be able to attend the meeting in person. Stockholders will be able to attend and vote (both before <br>and during a portion of the meeting) and submit questions, virtually.<br>|
| ![Record Date IMG.jpg](ryan-20260317_g9.jpg) | **RECORD** <br>**DATE:**<br>| March 2, 2026 ("Record Date"). |
| **WHO CAN VOTE:** | **WHO CAN VOTE:** | Holders of the Class A common stock and Class B common stock of the Company as of the close <br>of business on the Record Date.<br>|
| **WHO CAN ATTEND:** | **WHO CAN ATTEND:** | All stockholders are invited to attend the virtual Annual Meeting. To attend the meeting at <br>www.proxydocs.com/RYAN, you must enter the control number on your Notice of Internet <br>Availability of Proxy Materials, Proxy Card, or voting instruction form. The virtual meeting room <br>will open at 2:15 p.m. Eastern Time.<br>|
| **DATE OF MAILING:** | **DATE OF MAILING:** | A Notice of how to access the Proxy Statement and 2025 Annual Report to stockholders and a <br>form of proxy are first being sent to stockholders on or about March 17, 2026.<br>|

---

**Items of Business to be Conducted:** 

1. To elect five director nominees presented in the accompanying Proxy Statement to serve for a one-year term until <br>the 2027 annual meeting of stockholders and until their successors are duly elected and qualified; <br>2.To ratify the selection of Deloitte & Touche LLP ("Deloitte") as our independent registered public accounting firm for <br>the year ending December 31, 2026; <br>3.To approve, by a non-binding advisory vote, the compensation of our named executive officers (i.e., "say-on-pay <br>proposal"); and<br>4.To conduct any other business that may properly come before the meeting or any adjournment thereof. <br>

Please note that there is no in-person Annual Meeting for you to attend. Stockholders will be able to listen, vote, and submit

questions during the virtual Annual Meeting from any remote location with Internet connectivity. Information on how to

participate in the virtual Annual Meeting can be found on page [3](#i9c3f589d4c534be3881406dabba08ed6_26970) of this Proxy Statement.

**Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting** 

**of Stockholders to be held on April 28, 2026** 

The Proxy Statement and our 2025 Annual Report are available directly at the following website: www.proxydocs.com/RYAN

**YOUR VOTE IS VERY IMPORTANT** 

If you were a stockholder at the close of business on the Record Date (i.e., March 2, 2026), you are eligible to vote at this

year's Annual Meeting. Regardless of whether you plan to attend the virtual Annual Meeting, your vote is very important. We

urge you to participate in the election of our directors and in deciding the other items on the agenda for the Annual Meeting.

Stockholders are strongly encouraged to vote their shares by proxy in advance of the Annual Meeting. Stockholders who

wish to attend the Annual Meeting virtually may do so via webcast at www.proxydocs.com/RYAN. Please note that attending

the Annual Meeting virtually will not necessarily allow you to vote at the Annual Meeting. Accordingly, we strongly advise you

to vote in advance by one of the methods described on page [3](#i9c3f589d4c534be3881406dabba08ed6_26971) of the Proxy Statement.

Our Board recommends that you vote:

---

| | | |
|:---|:---|:---|
| **Proposals** | **Board**<br>**Recommendation**<br>| **Page**<br>**Reference**<br>|
| **1.**Election of five directors | **FOR each nominee** | **[16](#i21c78727e72e4a19a16dcfdbe3a1abce_31)** |
| **2.**Ratification of Deloitte & Touche LLP as our independent registered public <br>accounting firm for the year ending December 31, 2026<br>| **FOR** | **[26](#i21c78727e72e4a19a16dcfdbe3a1abce_70)** |
| **3.**Advisory (non-binding) vote to approve executive compensation | **FOR** | **[29](#i21c78727e72e4a19a16dcfdbe3a1abce_76)** |

---

The matters to be acted upon at the Annual Meeting are more fully described in the Proxy Statement and related materials.

Please read the materials carefully.

All holders of Class A common stock, $0.001 par value per share, and Class B common stock, $0.001 par value per share,

at the close of business on the Record Date can vote. A stockholder of record entitled to attend and vote at the Annual

Meeting may appoint one or more proxies to attend, speak, and vote on their behalf by any of the procedures set out on

page [3](#i9c3f589d4c534be3881406dabba08ed6_26970) of the Proxy Statement. A proxy holder need not be a stockholder of record.

We will provide access to our proxy materials via the Internet at www.proxydocs.com/RYAN rather than in hard copy. We will

mail a notice containing instructions on how to access this Proxy Statement and our Annual Report on or about March 17,

2026, to all stockholders entitled to vote at the Annual Meeting. Stockholders who prefer a paper copy of the proxy materials

may request one, at no cost, by following the instructions provided in the notice we will send.

Only stockholders that owned Class A common stock or Class B common stock at the close of business on the Record Date

are entitled to notice. A list of our stockholders of record will be available at our principal executive offices, 155 North Wacker

Drive, Suite 4000, Chicago, Illinois 60606 for examination by any stockholder for any purpose relevant to the meeting during

ordinary business hours for at least ten days prior to April 28, 2026. Your vote is important. Regardless of whether you plan

to attend the Annual Meeting, we urge you to vote. You may vote by proxy over the Internet, by telephone, or by mail by

following the instructions on your Notice of Internet Availability of Proxy Materials, Proxy Card, or voting instruction form.

Voting by proxy will ensure your representation at the Annual Meeting regardless of whether you attend online.

By Order of the Board of Directors,

![MSK Sig.jpg](ryan-20260317_g10.jpg)

**Mark S. Katz** 

Corporate Secretary

Chicago, Illinois

March 17, 2026

**TABLE OF CONTENTS** 

---

| | | |
|:---|:---|:---|
| [Important Notice](#i21c78727e72e4a19a16dcfdbe3a1abce_22) |  | **[1](#i21c78727e72e4a19a16dcfdbe3a1abce_22)** |
|  | [Proxy Materials for the Stockholder Meeting](#i21c78727e72e4a19a16dcfdbe3a1abce_22) | [1](#i21c78727e72e4a19a16dcfdbe3a1abce_22) |
| [Questions and Answers](#i21c78727e72e4a19a16dcfdbe3a1abce_25) |  | **[2](#i21c78727e72e4a19a16dcfdbe3a1abce_25)** |
|  | [Proxy Material and Voting](#i21c78727e72e4a19a16dcfdbe3a1abce_25) | [2](#i21c78727e72e4a19a16dcfdbe3a1abce_25) |
| [Board of Directors](#i21c78727e72e4a19a16dcfdbe3a1abce_28) |  | **[7](#i21c78727e72e4a19a16dcfdbe3a1abce_28)** |
|  | [Corporate Governance](#i21c78727e72e4a19a16dcfdbe3a1abce_28) | [7](#i21c78727e72e4a19a16dcfdbe3a1abce_28) |
| [Proposal No. 1](#i21c78727e72e4a19a16dcfdbe3a1abce_31) |  | **[16](#i21c78727e72e4a19a16dcfdbe3a1abce_31)** |
|  | [Election of Directors](#i21c78727e72e4a19a16dcfdbe3a1abce_31) | [16](#i21c78727e72e4a19a16dcfdbe3a1abce_31) |
|  | [Director Compensation](#i21c78727e72e4a19a16dcfdbe3a1abce_34) | [22](#i21c78727e72e4a19a16dcfdbe3a1abce_34) |
|  | [Executive Officers](#i21c78727e72e4a19a16dcfdbe3a1abce_37) | [24](#i21c78727e72e4a19a16dcfdbe3a1abce_37) |
| [Proposal No.](#i21c78727e72e4a19a16dcfdbe3a1abce_70)2 |  | **[26](#i21c78727e72e4a19a16dcfdbe3a1abce_70)** |
|  | [Ratification of Appointment of Independent Registered Public Accounting Firm](#i21c78727e72e4a19a16dcfdbe3a1abce_70) | [26](#i21c78727e72e4a19a16dcfdbe3a1abce_70) |
|  | [Audit Committee Report](#i21c78727e72e4a19a16dcfdbe3a1abce_73) | [28](#i21c78727e72e4a19a16dcfdbe3a1abce_73) |
| [Proposal No.](#i21c78727e72e4a19a16dcfdbe3a1abce_76)3 |  | **[29](#i21c78727e72e4a19a16dcfdbe3a1abce_76)** |
|  | [Advisory (Non-Binding) Vote on Named Executive Officer Compensation](#i21c78727e72e4a19a16dcfdbe3a1abce_76) | [29](#i21c78727e72e4a19a16dcfdbe3a1abce_76) |
|  | [Executive Compensation: Compensation Discussion and Analysis](#i21c78727e72e4a19a16dcfdbe3a1abce_79) | [30](#i21c78727e72e4a19a16dcfdbe3a1abce_79) |
|  | [Executive Compensation: Compensation Tables and Disclosure](#i21c78727e72e4a19a16dcfdbe3a1abce_82) | [43](#i21c78727e72e4a19a16dcfdbe3a1abce_82) |
| [Security Ownership](#i21c78727e72e4a19a16dcfdbe3a1abce_85) |  | **[56](#i21c78727e72e4a19a16dcfdbe3a1abce_85)** |
|  | [Certain Beneficial Owners and Management](#i21c78727e72e4a19a16dcfdbe3a1abce_88) | [56](#i21c78727e72e4a19a16dcfdbe3a1abce_85) |
| [Certain Relationships](#i21c78727e72e4a19a16dcfdbe3a1abce_88) |  | **[59](#i21c78727e72e4a19a16dcfdbe3a1abce_88)** |
|  | [Related Party Transactions](#i21c78727e72e4a19a16dcfdbe3a1abce_88) | [59](#i21c78727e72e4a19a16dcfdbe3a1abce_88) |
| [Other Matters](#i21c78727e72e4a19a16dcfdbe3a1abce_91) |  | **[63](#i21c78727e72e4a19a16dcfdbe3a1abce_91)** |
|  | [Incorporation By Reference](#i21c78727e72e4a19a16dcfdbe3a1abce_94) | [63](#i21c78727e72e4a19a16dcfdbe3a1abce_94) |
|  | [Proposals of Stockholders and Communications with Our Board](#i21c78727e72e4a19a16dcfdbe3a1abce_97) | [63](#i21c78727e72e4a19a16dcfdbe3a1abce_97) |
|  | [Availability of SEC Filings and Where to Find Additional Information](#i21c78727e72e4a19a16dcfdbe3a1abce_100) | [63](#i21c78727e72e4a19a16dcfdbe3a1abce_100) |
|  | [Cost of Proxy Solicitation](#i21c78727e72e4a19a16dcfdbe3a1abce_103) | [64](#i21c78727e72e4a19a16dcfdbe3a1abce_103) |

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **1** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **1** |

---

**IMPORTANT NOTICE REGARDING THE AVAILABILITY OF** 

**PROXY MATERIALS FOR THE STOCKHOLDER MEETING** 

**The Board of Directors (the "Board") of Ryan Specialty Holdings, Inc. is soliciting your proxy to vote at our 2026** 

**Annual Meeting of Stockholders to be held on April 28, 2026, at 2:30 p.m. Eastern Time in a virtual-only meeting** 

**online at www.proxydocs.com/RYAN, and any adjournment or postponement of that meeting (the "Annual** 

**Meeting").** This Proxy Statement is dated as of March 17, 2026. As used in this Proxy Statement henceforward, unless

otherwise stated or the context clearly indicates otherwise, the terms the "Company," the "Registrant," "Ryan Specialty,"

"we," "us," and "our" refer to Ryan Specialty Holdings, Inc., a Delaware corporation.

In addition to solicitations by mail, our directors, officers, and regular employees, without additional remuneration, may solicit

proxies in person, by telephone, or by other means of communication. All costs of solicitation of proxies will be borne by us.

Brokers, custodians, and fiduciaries will be requested to forward proxy soliciting material to the owners of our common stock

held in their names as of the close of business on March 2, 2026 (the "Record Date"), and we will reimburse them for their

reasonable out-of-pocket expenses incurred in connection with the distribution of proxy materials.

We have elected to provide access to our proxy materials on the Internet. Accordingly, we are sending a Notice of Internet

Availability of Proxy Materials to our stockholders of record as of the Record Date, while brokers and other nominees who

hold shares on behalf of beneficial owners will be sending their own similar notice. All stockholders will have the ability to

access the proxy materials on the website referred to in the Notice of Internet Availability of Proxy Materials or to request a

printed set of the proxy materials. Instructions on how to request a printed set of proxy materials by mail or e-mail may be

found in the Notice of Internet Availability of Proxy Materials and on the website referred to in the Notice of Internet

Availability of Proxy Materials, including an option to request paper copies, at no cost, on an ongoing basis. We are making

this Proxy Statement available on the Internet on or about March 17, 2026, and are mailing the Notice of Internet Availability

of Proxy Materials to all stockholders entitled to vote at the Annual Meeting on or about March 17, 2026. We intend to mail or

e-mail this Proxy Statement, together with a Proxy Card, to those stockholders entitled to vote at the Annual Meeting who

have properly requested copies of such materials by mail or e-mail, within three business days of such request.

The Company has two classes of voting securities, Class A common stock, $0.001 par value per share ("Class A common

stock"), and Class B common stock, $0.001 par value per share ("Class B common stock," and, collectively with the Class A

common stock the "common stock"). Holders of Class A common stock are entitled to one vote per share on all matters

submitted to a vote of the Company's stockholders and the holders of Class B common stock are entitled to ten votes per

share on all matters submitted to a vote of the Company's stockholders. As of the Record Date, there were 263,179,571

shares of common stock outstanding consisting of 128,670,686 shares of Class A common stock and 134,508,885 shares of

Class B common stock. We need the holders of a majority in voting power of the outstanding capital stock entitled to vote at

the Annual Meeting, present in person (including virtually), or represented by proxy, to hold the Annual Meeting.

**The Company's Annual Report, which contains financial statements for the year ended December 31, 2025 (the** 

**"Annual Report"), accompanies this Proxy Statement. Stockholders that receive the Notice of Internet Availability** 

**of Proxy Materials can access this Proxy Statement and the Annual Report at the website referred to in the Notice** 

**of Internet Availability of Proxy Materials. The Annual Report and this Proxy Statement are also available on the** 

**"SEC Filings" section of our investor relations website at https//ir.ryanspecialty.com and at the website of the** 

**Securities and Exchange Commission (the "SEC") at www.sec.gov.** You also may obtain a copy of Ryan Specialty's

Proxy Statement and Annual Report, without charge, by writing to our Investor Relations department at

ir@ryanspecialty.com. Please note that the information on our website is not part of or incorporated into this Proxy

Statement.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **2** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **2** |

---

**QUESTIONS AND ANSWERS ABOUT THE PROXY** 

**MATERIALS AND VOTING** 

Q: Why did I receive these materials?

The Board of Ryan Specialty is soliciting your proxy to vote at our Annual Meeting (or at any postponement or adjournment

of the meeting). Stockholders who own shares of our common stock as of the Record Date are entitled to vote at the Annual

Meeting. You should review these proxy materials carefully as they provide important information about the proposals that

will be voted on at the Annual Meeting, as well as other important information about Ryan Specialty.

*Notice of Internet Availability of Proxy Statement and Annual Report.* As permitted by SEC rules, we are making this Proxy

Statement and our Annual Report available to our stockholders electronically via the Internet. The Notice of Internet

Availability of Proxy Materials contains instructions on how to access this Proxy Statement and our Annual Report and vote

online. If you received the Notice of Internet Availability of Proxy Materials by mail, you will not receive a printed copy of the

proxy materials in the mail. Instead, the Notice of Internet Availability of Proxy Materials instructs you on how to access and

review all of the important information contained in this Proxy Statement and Annual Report. The Notice of Internet

Availability of Proxy Materials also instructs you on how you may submit your proxy over the Internet or by telephone. If you

received a Notice of Internet Availability of Proxy Materials by mail and would like to receive a printed copy of our proxy

materials, at no cost, you should follow the instructions for requesting such materials contained in the notice.

*Householding.* The SEC's rules permit us to print an individual's multiple accounts on a single notice or set of Annual

Meeting materials. To take advantage of this opportunity, we have summarized on one notice or set of Annual Meeting

materials all of the accounts registered with the same tax identification number or duplicate name and address, unless we

received contrary instructions from the impacted stockholder prior to the mailing date. We agree to deliver promptly, upon

written or oral request, a separate copy of the notice or Annual Meeting materials, as requested, to any stockholder to which

a single copy of those documents was delivered. If a single copy of the notice or Annual Meeting materials was delivered

and you prefer to receive separate copies, or if multiple copies were delivered and you prefer to receive a single copy of the

materials in the future, contact our Investor Relations department at ir@ryanspecialty.com. A number of brokerage firms

have instituted householding. They will have their own procedures for stockholders who wish to receive individual copies of

the proxy materials.

Q: Who can vote at the Annual Meeting?

Only stockholders of record at the close of business on the Record Date will be entitled to vote at the Annual Meeting. At the

close of business on the Record Date, there were 263,179,571 shares of common stock outstanding consisting of

128,670,686 shares of Class A common stock and 134,508,885 shares of Class B common stock.

***Stockholder of Record: Shares Registered in Your Name***

If, on the Record Date, your shares of Class A common stock were registered directly in your name with our transfer agent,

Equiniti Trust Company, LLC, or if you hold shares of Class B common stock, then you are a stockholder of record. As a

stockholder of record, you may: vote virtually at the Annual Meeting; vote by proxy on the Internet or by telephone; or vote

by proxy by signing and returning a Proxy Card, if you request and receive one. Regardless of whether you plan to attend

the virtual Annual Meeting, to ensure your vote is counted, we urge you to vote by proxy on the Internet as instructed in the

Notice of Internet Availability of Proxy Materials, by telephone as instructed on the website referred to in the Notice of

Internet Availability of Proxy Materials, or (if you request and receive a Proxy Card by mail or e-mail) by signing, dating, and

returning the Proxy Card sent to you or by following the instructions on such Proxy Card to vote on the Internet or by

telephone.

***Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent***

If, on the Record Date, your shares were held in an account at a brokerage, bank, or other agent, then you are the beneficial

owner of shares held in "street name" and these proxy materials are being forwarded to you by that organization. The

organization holding your account is considered the stockholder of record for purposes of voting at the Annual Meeting. As a

beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account. You are

also invited to attend the virtual Annual Meeting. However, since you are not the stockholder of record, you may not vote

your shares at the virtual Annual Meeting, unless you request and obtain a legal proxy from your broker or other agent who

is the record holder of the shares, authorizing you to vote at the Annual Meeting.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **3** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **3** |

---

Q: What am I being asked to vote on?

You are being asked to vote on the following three management proposals:

**Proposal No. 1:** the election of five director nominees for a one-year term to hold office until the 2027 annual meeting of

stockholders and until their successors are duly elected and qualified ("Proposal 1");

**Proposal No. 2:** the ratification of the selection, by the Audit Committee of our Board, of Deloitte & Touche LLP as the

Company's independent registered public accounting firm for the year ending December 31, 2026 ("Proposal 2"); and

**Proposal No. 3:** the non-binding advisory approval of the compensation of our named executive officers ("Proposal 3").

In addition, you are entitled to vote on any other matters that are properly brought before the Annual Meeting.

Q: How does the Board recommend I vote on the proposals?

The Board recommends that you vote:

• **FOR** each of the five director nominees in Proposal 1;

• **FOR** Proposal 2; and

• **FOR** Proposal 3.

Q: Who can attend the Annual Meeting?

The Annual Meeting is being held as a virtual-only meeting. If you are a stockholder of record as of the Record Date, you

may attend, vote, and ask questions virtually at the meeting by logging in at www.proxydocs.com/RYAN and registering by

providing your control number.

If you are a stockholder holding your shares in "street name" as of the Record Date, you may gain access to the meeting by

following the instructions in the voting instruction card provided by your broker, bank, or other nominee holder. You may not

vote your shares at the Annual Meeting unless you receive a valid proxy from your brokerage, bank, or other nominee

holder. You may attend and ask questions virtually at the meeting by logging in at www.proxydocs.com/RYAN and registering

by providing your control number.

The control number is included in the notice or on your Proxy Card. Upon completing your registration, you will receive

further instructions via email, including your unique link that will allow you to access the Annual Meeting and to submit

questions during the meeting and, if you are either the (i) record holder or (ii) a beneficial holder with a valid proxy, vote

during the meeting. Please be sure to follow the instructions found on your Proxy Card and/or voting instruction form and

subsequent instructions that will be delivered to you via email after you register.

If you have registered for the meeting and have questions during the meeting, you may type them into the dialog box

provided at any point during the Annual Meeting (until the floor is closed to questions). Recording of the Annual Meeting will

not be permitted.

Q: Why is the Annual Meeting virtual only?

Our Annual Meeting will be a virtual meeting format only in which stockholders will participate by accessing a website using

the Internet. There will not be a physical meeting location. We believe that hosting a virtual meeting will facilitate

stockholders' attendance and participation at our Annual Meeting by enabling stockholders to participate remotely from any

location around the world. We have designed the virtual Annual Meeting to provide stockholders the same rights and

opportunities to participate as they would have at an in-person meeting, including the right to vote and ask questions through

the virtual meeting platform. A virtual meeting also provides an additional opportunity for stockholders to communicate with

the Board by submitting questions before the meeting when registering for the meeting and during the meeting through the

virtual meeting platform. A virtual meeting also eliminates many of the costs associated with hosting a physical meeting.

Q: What are my voting options?

• For Proposal 1, you may either vote "For" or "Against" each of the nominees to the Board or "Abstain" from voting

for each of the nominees to the Board.

• For Proposals 2 and 3, you may either vote "For" or "Against" the proposal or "Abstain" from voting.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **4** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **4** |

---

Please note that by casting your vote by proxy you are authorizing the individuals listed on the proxy card to vote your

shares in accordance with your instructions and in their discretion with respect to any other matter that properly comes

before the Annual Meeting or any adjournments or postponements thereof. The procedures for voting, depending on

whether you are a stockholder of record or a beneficial owner, are as follows:

***Stockholder of Record: Shares Registered in Your Name***

If you are a stockholder of record, you may vote in any of the following manners:

• To personally vote during the Annual Meeting, you must register to attend the Annual Meeting and then prior to the

close of the polls, log into the virtual Annual Meeting and follow the instructions on how to vote at the Annual

Meeting.

• To vote over the Internet prior to the Annual Meeting, follow the instructions provided on the Notice of Internet

Availability of Proxy Materials or on the Proxy Card that you request and receive by mail or e-mail. We provide

Internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the authenticity

and correctness of your proxy vote instructions.

• To vote by telephone, call the toll-free number found on the Proxy Card you request and receive by mail or e-mail

or the toll-free number that you can find on the website referred to on the Notice of Internet Availability of Proxy

Materials.

• To vote by mail, complete, sign, and date the Proxy Card you request and receive by mail or e-mail and return it

promptly. As long as your signed Proxy Card is received prior to the Annual Meeting, the proxy holder will vote your

shares as you direct.

Regardless of whether you plan to attend the virtual Annual Meeting, we urge you to vote by proxy by mail, Internet, or

telephone to ensure your vote is counted. Even if you have submitted your vote before the Annual Meeting, you may still

attend the virtual Annual Meeting and vote during the Annual Meeting. In such case, your previously submitted vote will be

disregarded.

***Beneficial Owner: Shares Registered in the Name of Broker, Bank, or Other Agent***

If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received

a voting instruction card and voting instructions with these proxy materials from that organization, rather than from us.

Simply complete and mail the voting instruction card to ensure that your vote is counted or follow the instructions to submit

your vote by the Internet or telephone, if those instructions provide for Internet and telephone voting. To vote during the

Annual Meeting, you must obtain a valid proxy from your broker, bank, or other agent. Follow the instructions from your

broker, bank, or other agent included with these proxy materials, or contact your broker, bank, or other agent to request a

proxy form.

Q: Who counts the votes?

Mediant, a BetaNXT Inc. business, has been engaged as our independent agent to tabulate stockholder votes, also known

as the Inspector of Election. If you are a stockholder of record, and you choose to vote over the Internet prior to the Annual

Meeting or by telephone, Mediant will access and tabulate your vote electronically, and if you request and receive proxy

materials via mail or e-mail and choose to sign and mail your Proxy Card, your executed Proxy Card is returned directly to

Mediant for tabulation. As noted above, if you hold your shares through a broker, bank, or other nominee, they (or its agent

for tabulating votes of shares held in "street name") return one Proxy Card to Mediant on behalf of all of its clients.

Q: How are votes counted?

Votes will be counted by the Inspector of Election appointed for the Annual Meeting. For Proposal 1, the Inspector of

Election will separately count "For" and "Against" votes, abstentions, and broker non-votes for each nominee. For Proposals

2 and 3, the Inspector of Election will separately count "For" and "Against" votes, abstentions, and broker non-votes, as

applicable. If you do not give instructions to your broker, bank, or other nominee, they can vote your shares with respect to

"routine" items, but not with respect to "non-routine" items. See below for more information regarding: "*What are 'broker non-*

*votes'"?* and "*Which ballot measures are considered 'routine' and 'non-routine'"?* 

Q: What are "broker non-votes"?

Broker non-votes occur when a beneficial owner of shares held in "street name" does not give instructions to the broker,

bank, or other nominee holding the shares as to how to vote on matters deemed "non-routine." Generally, if shares are held

in "street name", the beneficial owner of the shares is entitled to give voting instructions to the broker, bank, or other

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **5** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **5** |

---

nominee holding the shares. If the beneficial owner does not provide voting instructions, the broker, bank, or other nominee

holder can still vote the shares with respect to matters that are considered to be "routine," but not with respect to "non-

routine" matters. In the event that a broker, bank, or other nominee holder indicates on a proxy that it does not have

discretionary authority to vote certain shares on a particular proposal, then those shares will be treated as broker non-votes

with respect to that proposal. Accordingly, if you own shares through a broker, bank, or other nominee, please be sure to

instruct your nominee how to vote to ensure that your vote is counted on each of the proposals. Under the listing rules of the

New York Stock Exchange ("NYSE"), abstentions will be treated in accordance with our Bylaws and Delaware state law.

Q: Which ballot measures are considered "routine" or "non-routine"?

The ratification of the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year

ending December 31, 2026 (Proposal 2) is considered routine under the NYSE rules. A broker, bank, or other nominee

holder may generally vote on routine matters, and therefore, no broker non-votes are expected in connection with Proposal

2. The election of director nominees (Proposal 1) and the non-binding approval of the compensation of our named executive

officers (Proposal 3) are considered non-routine under the NYSE rules. A broker, bank, or other nominee cannot vote without

instructions on non-routine matters, and therefore, broker non-votes are expected on Proposals 1 and 3.

Q: How many votes are needed to approve each proposal?

With respect to Proposal 1, to be elected in an uncontested election, such as this one, a director nominee must receive more

"For" votes than "Against" votes. Because we did not receive proper advance notice in accordance with our Bylaws of any

shareholder nominees for director, this election of directors is an uncontested election. Abstentions and broker non-votes will

have no effect on the election of directors.

With respect to Proposal 2, the affirmative vote of the majority of voting power of the capital stock present or represented by

proxy at the virtual Annual Meeting and entitled to vote thereon is required for ratification. Votes to "Abstain" are treated as

cast "Against" this proposal. We do not expect there to be any broker non-votes with respect to this proposal.

With respect to Proposal 3, the affirmative vote of the majority of voting power of the capital stock present or represented by

proxy at the virtual Annual Meeting and entitled to vote thereon is required for approval. Votes to "Abstain" are treated as

cast "Against" this proposal and broker non-votes will have no effect on the vote for this proposal.

Q: What if a director nominee does not receive the required vote?

Ryan Specialty is a Delaware corporation and, under Delaware law, if an incumbent director is not elected, that director

remains in office until the director's successor is duly elected and qualified or until the director's earlier resignation or

removal. To address this potential outcome, each director nominee has submitted an irrevocable resignation that is

contingent on (i) such nominee's failure to receive the required vote at the Annual Meeting and (ii) acceptance of such

resignation by the Board. If an incumbent director does not receive the required vote at the Annual Meeting, then the

Compensation and Governance Committee will consider the resignation and recommend to the Board whether to accept it.

Thereafter, the Board will publicly disclose, within ninety days following certification of the election results, its decision

regarding the resignation and, if such resignation is rejected, the rationale behind the decision.

Q: How many votes do I have?

On each matter to be voted upon, each share of Class A common stock that you own as of the Record Date has one vote

and each share of Class B common stock that you own as of the Record Date has ten votes.

Q: What if I return a Proxy Card but do not make specific choices?

If we receive a signed and dated Proxy Card that does not specify how your shares are to be voted, your shares will be

voted "**For**" the election of each of the five nominees for director in Proposal 1 and "**For**" the ratification or approval, as

applicable, of each of Proposals 2 and 3. If any other matter is properly presented at the Annual Meeting or any adjournment

thereof, your proxy (one of the individuals named on your Proxy Card) is authorized to vote your shares using their best

judgment.

Q: Who is paying for this proxy solicitation?

We will pay for the entire cost of soliciting proxies. In addition to those proxy materials received by mail or on the Internet,

our directors, officers, and employees may also solicit proxies in person, by telephone, or by other means of communication.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **6** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **6** |

---

Directors, officers, and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse

brokerage firms, banks, and other agents for the cost of forwarding proxy materials to beneficial owners.

Q: What does it mean if I receive more than one Notice of Internet Availability of Proxy

Materials or more than one set of printed materials?

If you receive more than one Notice of Internet Availability of Proxy Materials or more than one set of printed materials, your

shares are registered in more than one name or are registered in different accounts. In order to vote all the shares you own,

you must follow the instructions for voting on each Notice of Internet Availability of Proxy Materials or Proxy Card you

receive via mail or e-mail upon your request, which include voting over the Internet, telephone, or by signing and returning

any of the Proxy Cards you request and receive.

Q: Can I change or revoke my proxy after submitting my proxy vote?

Yes, you can revoke your proxy vote at any time before the Annual Meeting by:

• submitting a new vote on the Internet or by telephone or submitting a properly completed Proxy Card with a later

date; or

• sending a written notice that you are revoking your proxy, which is received prior to the Annual Meeting, to Ryan

Specialty's Corporate Secretary at 155 North Wacker Drive, Suite 4000, Chicago, IL 60606.

If you are the record holder of your shares, you may also revoke your proxy vote by:

• attending the virtual Annual Meeting and personally voting during the Annual Meeting prior to the close of the polls.

Simply attending the virtual Annual Meeting without voting during the meeting will not, by itself, revoke your proxy.

Q: How will voting on any business not described in this Proxy Statement be

conducted?

We are not aware of any business to be considered at the Annual Meeting other than the items described in this Proxy

Statement. If any other matter is properly presented at the Annual Meeting, your proxy will vote your shares using their best

judgment.

Q: What is the quorum requirement?

A quorum of stockholders is necessary to hold a valid meeting of stockholders. A quorum will be present if the holders of a

majority in voting power of the outstanding capital stock entitled to vote at the Annual Meeting are present in person

(including virtually) or are represented by proxy at the virtual Annual Meeting. On the Record Date, there were 128,670,686

shares of Class A common stock, with one vote each, and 134,508,885 shares of Class B common stock, with 10 votes

each. Accordingly, shares representing 736,879,769 votes must be represented by stockholders present in person or by

proxy at the virtual Annual Meeting to have a quorum.

If you are a stockholder of record, your shares will be counted towards the quorum only if you submit a valid proxy vote or

vote at the virtual Annual Meeting. If you are a beneficial owner of shares held in "street name," your shares will be counted

towards the quorum if your broker or nominee submits a proxy for your shares at the Annual Meeting, even a proxy which

result in a broker non-vote due to the absence of voting instructions from you. Abstentions and broker non-votes will be

counted towards the quorum requirement. If a quorum is not present, either the chairperson of the Annual Meeting or a

majority in voting power of the voting stock present in person (including virtually) or represented by proxy at the Annual

Meeting and entitled to vote thereon, may adjourn the Annual Meeting to another time or place.

Q: How can I find out the results of the voting at the Annual Meeting?

The preliminary voting results will be announced at the Annual Meeting. Final voting results will be announced by the filing of

a Current Report on Form 8-K within four business days after the Annual Meeting. If final voting results are unavailable at

that time, we will file an amended Current Report on Form 8-K within four business days of the day the final results are

available.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **7** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **7** |

---

**BOARD OF DIRECTORS AND CORPORATE** 

**GOVERNANCE** 

Our business and affairs are managed under the direction of our Board. Our current Amended and Restated Certificate of

Incorporation (the "Certificate") provides that the authorized number of directors may be changed only by resolution of our

Board. The Board is currently classified into three classes, each comprising as nearly as possible one-third of the total

number of directors, each serving a three-year term. At our 2025 annual meeting of stockholders, a proposal to declassify

the Board and phase-in annual director elections was approved by our stockholders. Therefore, beginning with this Annual

Meeting, as the term of each class of directors expires, directors will stand for reelection, if nominated by the Board, for a

term of one year and will no longer be assigned to a new class. Specifically, the director nominees standing for election at

this Annual Meeting will be elected to hold office until the 2027 annual meeting of stockholders and until their successors are

duly elected and qualified. As a result, at our annual meeting of stockholders to be held in 2028, when the term of our

current Class I directors expires, all directors will stand for election annually, and our Board will no longer be classified.

Board Composition

Pursuant to the Company's Certificate, the Board adopted resolutions to set the size of the Board at thirteen members. The

Board currently consists of twelve members. Four directors are Class I directors, whose term expires at the 2028 annual

meeting of stockholders, three directors are Class III directors, whose term expires at the 2027 annual meeting of

stockholders, and five directors (four of which were previously assigned to Class II), whose terms expire at this Annual

Meeting, if elected, will hold office until the 2027 annual meeting of stockholders and until their successors are duly elected

and qualified.

The table below sets forth for each director nominee, and all continuing directors, their respective ages as of the Record

Date, the positions currently held with the Company (if any), the year each was first elected or appointed as a director of the

Company, the year their current term will expire, and the class to which they were last elected.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Nominee/Director Name** | **Age** | **Position** | **Director**<br>**Since**<sup>(1)</sup><br>| **Current**<br>**Term**<br>**Expires**<br>| **Director**<br>**Class**<br>|
| ***Nominees for Director*** | ***Nominees for Director*** | ***Nominees for Director*** | ***Nominees for Director*** | ***Nominees for Director*** | ***Nominees for Director*** |
| David P. Bolger | 68 | Director | 2012 | 2026 | II |
| Michael G. Bungert | 71 | Director | 2025 | 2026 | N/A |
| Francesca Cornelli | 63 | Director | 2023 | 2026 | II |
| Nicholas D. Cortezi | 59 | Director | 2021 | 2026 | II |
| Anthony J. Kuczinski | 67 | Director | 2023 | 2026 | II |
| ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** |
| Patrick G. Ryan | 88 | Executive Chairman of the Board | 2010 | 2027 | III |
| Timothy W. Turner | 65 | Chief Executive Officer and Director | 2012 | 2028 | I |
| Henry S. Bienen | 86 | Director | 2012 | 2028 | I |
| Michelle L. Collins | 65 | Director | 2021 | 2027 | III |
| Michael D. O'Halleran | 75 | Director | 2018 | 2028 | I |
| John W. Rogers, Jr. | 67 | Lead Director | 2014 | 2027 | III |
| Patrick G. Ryan, Jr. | 58 | Director | 2024 | 2028 | I |

---

(1)For all directors other than Ms. Collins, Dr. Cornelli, and Messrs. Bungert, Cortezi, Kuczinski, and Ryan, Jr., this column reflects the

date that the director joined the Board of Ryan Specialty, LLC prior to the Company's initial public offering on July 21, 2021, when the

Board of Ryan Specialty Holdings, Inc. was formed.

*Director Nomination Agreement* 

In connection with the Company's initial public offering in July 2021 (the "IPO"), the Company entered into a Director

Nomination Agreement with Patrick G. Ryan, our founder and Executive Chairman, and certain members of his family and

various entities and trusts over which Patrick G. Ryan and his family exercise control (collectively, the "Ryan Parties") and

Onex RSG Holdings LP, a Delaware limited partnership ("Onex"), an affiliate of Onex Corporation.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **8** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **8** |

---

The Director Nomination Agreement currently provides the Ryan Parties the right to nominate certain members of our Board

based on the number of shares of the Company's common stock held by the Ryan Parties. The Director Nomination

Agreement provides the Ryan Parties the right to designate (in each instance, rounded up to the nearest whole number if

necessary): (i) all of the nominees for election to our Board for so long as the Ryan Parties control, in the aggregate, 50% or

more of the total number of shares of our common stock beneficially owned by the Ryan Parties upon completion of the IPO,

as adjusted for any reorganization, recapitalization, stock dividend, stock split, reverse stock split, or similar changes in our

capitalization (the "Original Amount"); (ii) 50% of the nominees for election to our Board for so long as the Ryan Parties

control, in the aggregate, more than 40%, but less than 50% of the Original Amount; (iii) 40% of the nominees for election to

our Board for so long as the Ryan Parties control, in the aggregate, more than 30%, but less than 40% of the Original

Amount; (iv) 30% of the nominees for election to our Board for so long as the Ryan Parties control, in the aggregate, more

than 20%, but less than 30% of the Original Amount; and (v) 20% of the nominees for election to our Board for so long as

the Ryan Parties control, in the aggregate, more than 10%, but less than 20% of the Original Amount, which could result in

representation on our Board that is disproportionate to the Ryan Parties' beneficial ownership. Upon the death or disability of

Patrick G. Ryan, or at such time that he is no longer on the Board or actively involved in the operations of the Company, the

Ryan Parties will no longer hold the nomination rights specified in clauses (i) through (v) above; however, the Ryan Parties

will have the right to designate one nominee for so long as the Ryan Parties control, in the aggregate, 10% or more of the

Original Amount. Onex's right to designate one nominee for election to our Board fell away upon its sale of shares of our

Class A common stock in April 2023. See "*Certain Relationships and Related Party Transactions — Director Nomination* 

*Agreement*" for more details with respect to the Director Nomination Agreement.

Board Leadership and Structure

The following section describes our Board leadership structure, the reasons why the structure is in place at this time, the

roles of various positions, and related key governance practices. We believe the mix of experienced independent and

management directors that make up our Board, along with the independent role of our Lead Director and our independent

board-committee composition, benefits us and our stockholders.

*Director Independence; Board Mix* 

Our Board has an effective mix of independent and non-independent directors. It is composed of seven independent

directors and five non-independent directors including our Executive Chairman, Patrick G. Ryan; our Chief Executive Officer,

Timothy W. Turner; the retired Chairman of Ryan Specialty Underwriting Managers, Nicholas D. Cortezi; the Executive

Chairman of Geneva Re, Michael D. O'Halleran; and Patrick G. Ryan, Jr. We believe each of our independent and non-

independent directors adds value to our Board and benefits us and our stockholders.

The NYSE Listed Company Manual requires directors to satisfy certain criteria to be deemed "independent." The Board

applies these standards in determining whether any director has a material relationship with the Company that would impair

their independence, as discussed below. As required by the NYSE Listed Company Manual, the Board considers all material

relevant facts and circumstances known to it in making an independence determination, from the standpoints of both the

director and persons or organizations with which the director has an affiliation.

Our Board has affirmatively determined that Drs. Bienen and Cornelli, Ms. Collins, and Messrs. Bolger, Bungert, Kuczinski,

and Rogers meet the requirements to be independent directors. In making this determination, our Board considered the

relationships that each such non-employee director has with the Company and all other facts and circumstances that our

Board deemed relevant in determining their independence. Specifically, the Board considered Dr. Cornelli's affiliation with

Northwestern University's Kellogg School of Management and the Ryan family's charitable donations to Northwestern

University. The Board concluded that the Ryan family's charitable donations to Northwestern University do not give rise to a

material relationship with the Company or its management that would impair Dr. Cornelli's independence.

*Lead Director and Executive Session* 

Our Board designates one of our non-employee independent directors as Lead Director of our Board (the "Lead Director").

Mr. John W. Rogers, Jr., has served in the position of Lead Director since July 2025 and was appointed based on his

significant public company board and corporate governance experience. The Board believes that it is beneficial for us and

our stockholders to have a Lead Director who serves a variety of roles, including presiding at the executive sessions of

independent directors, and at all other meetings of the Board at which the chairperson of the Board is not present, and

calling an executive session of independent directors at any time, consistent with our Corporate Governance Guidelines.

Independent directors of the Board meet outside the presence of other directors in executive sessions, held in conjunction

with our regular Board meetings four times a year, and our Lead Director presides at all such executive sessions.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **9** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **9** |

---

*Chairperson and CEO* 

With respect to the roles of chairperson and CEO, the Corporate Governance Guidelines provide that the roles may be

separated or combined, and the Board will exercise its discretion in combining or separating these positions as it deems

appropriate in light of prevailing circumstances. Mr. Ryan, the founder of our Company, served as our chairperson and CEO

from our IPO until October 1, 2024, and has been at the helm of our business since its formation in 2010. On October 1,

2024, Mr. Ryan became our Executive Chairman, retaining his position as Chairman of the Board, and Mr. Turner assumed

the role of CEO, effectively separating the role of CEO and chairperson. The Board believes that separating the roles of

chairperson and CEO, while maintaining the separate, independent role of our Lead Director, is currently the most effective

leadership structure as it best utilizes the respective knowledge and experience of Mr. Ryan and Mr. Turner. Mr. Ryan has

extensive knowledge and industry leading experience in the area of insurance as the founder of our Company and through

his leadership at Aon Corporation. Mr. Turner, as our current leader, has a strong understanding of our business and is

highly in tune with the industry and current market dynamics along with day-to-day operations.

*Self-Evaluation* 

Pursuant to its charter, our Compensation and Governance Committee developed and oversees a process for an annual

evaluation of the Board, its committees, and individual directors. The Compensation and Governance Committee completed

the most recent annual evaluation in October 2025.

As part of the annual Board self-evaluation, the Board evaluates whether the size, composition, and responsibilities of our

Board and its committees and our Corporate Governance Guidelines continue to be appropriate for us and our stockholders.

Our Corporate Governance Guidelines provide flexibility for our Board to modify our leadership structure in the future as

appropriate.

Meetings and Attendance

During 2025, our Board held four regularly scheduled meetings. Each director attended at least 75% of the aggregate

number of Board meetings and committee meetings of which such director is a member. The Board expects, but does not

require, directors to attend the annual meeting of stockholders. Each of our directors attended the 2025 annual meeting of

stockholders.

Board Committees

Our Board has a standing Audit Committee, Compensation and Governance Committee, and Executive Committee. The

composition, duties, and responsibilities of these committees are as set forth below. In the future, our Board may establish

other committees, as it deems appropriate, to assist it with its responsibilities.

---

| | | | |
|:---|:---|:---|:---|
| **Board Member** | **Audit Committee** | **Compensation**<br>**and**<br>**Governance**<br>**Committee**<br>| **Executive**<br>**Committee**<br>|
| Patrick G. Ryan |  |  | Chair |
| Timothy W. Turner |  |  | X |
| Henry S. Bienen | X | Chair |  |
| David P. Bolger | Chair |  |  |
| Michael G. Bungert |  | X |  |
| Michelle L. Collins | X |  |  |
| Francesca Cornelli | X |  |  |
| Nicholas D. Cortezi |  |  | X |
| Anthony J. Kuczinski | X | X |  |
| Michael D. O'Halleran |  |  |  |
| John W. Rogers, Jr. |  | X | X |
| Patrick G. Ryan, Jr. |  |  |  |

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **10** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **10** |

---

*Audit Committee* 

Our Audit Committee is composed of Dr. Bienen, Mr. Bolger, Ms. Collins, Dr. Cornelli, and Mr. Kuczinski, with Mr. Bolger

serving as chairperson of the committee. The Board has determined that all of the members of the Audit Committee are

independent directors and meet the independence requirements of Rule 10A-3 under the Securities Exchange Act of 1934,

as amended, (the "Exchange Act") and the applicable listing standards of the NYSE. Our Board has determined that all

members of our Audit Committee are "financially literate" under the applicable listing standards of the NYSE and that Mr.

Bolger is an "audit committee financial expert" within the meaning of SEC regulations and applicable listing standards of the

NYSE. The Audit Committee held four regularly scheduled meetings in 2025. The Audit Committee's responsibilities include:

• appointing, approving the compensation of, and assessing the qualifications, performance, and independence of

our independent registered public accounting firm, including an evaluation of the lead audit partner;

• pre-approving audit and permissible non-audit services, and the terms of such services, to be provided by our

independent registered public accounting firm;

• reviewing and discussing, on a periodic basis or as appropriate, with management, our policies, programs and

controls with respect to risk assessment and risk management;

• reviewing and discussing with management procedures and internal controls relating to cybersecurity and the

enterprise risk function;

• reviewing and discussing with management and the independent registered public accounting firm our annual and

quarterly financial statements and related disclosures, as well as critical accounting policies and practices used by

us;

• reviewing our Management's Discussion and Analysis of Financial Condition and Results of Operations to be

included in our annual and quarterly reports to be filed with the SEC;

• reviewing and discussing with management our earnings releases;

• monitoring the rotation of partners of the independent registered public accounting firm on our engagement team in

accordance with requirements established by the SEC;

• monitoring and assessing the performance of the Company's internal audit function and reviewing the scope and

results of the internal audit;

• reviewing management's report on its assessment of the effectiveness of internal controls over financial reporting

and any changes thereto;

• reviewing the adequacy and effectiveness of our internal controls over financial reporting and disclosure controls

and procedures;

• establishing policies and procedures for the receipt, retention, follow-up, and resolution of accounting, internal

controls, or auditing matters, complaints, and concerns;

• recommending, based upon the Audit Committee's review and discussions with management and the independent

registered public accounting firm, whether our audited financial statements shall be included in our Annual Report

on Form 10-K;

• reviewing our compliance with legal and regulatory requirements as they relate to our financial statements,

applicable laws and regulations, and climate disclosure obligations;

• preparing the Audit Committee report required by the rules of the SEC to be included in our annual Proxy

Statement;

• reviewing and assessing annually tax and treasury functions, including cash management processes;

• investigating any alleged breaches or violations of the Company's Code of Ethics, and reporting to the Board

periodically, with respect to ethics issues, complaints, and associated investigations;

• reviewing the Audit Committee charter and the committee's performance at least annually; and

• reviewing all related party transactions for potential conflict of interest situations and disapproving, approving, or

ratifying all such transactions.

Our Audit Committee charter is available on our website at www.ryanspecialty.com. To access the charter, go to our website,

click on the "Investors" tab, and then click on "Governance/Governance Documents" to download or view the charter.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **11** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **11** |

---

*Compensation and Governance Committee* 

Our Compensation and Governance Committee is composed of Dr. Bienen, Mr. Bungert, Mr. Kuczinski, and Mr. Rogers, with

Mr. Bienen serving as chairperson of the committee. The Board has determined that all the members of the Compensation

and Governance Committee are independent directors and meet the independence requirements of Rule 10C-1 under the

Exchange Act and the applicable listing standards of the NYSE. The Compensation and Governance Committee held five

regularly scheduled meetings in 2025. The Compensation and Governance Committee's responsibilities include:

• recommending to our Board best practices relative to corporate governance principles;

• developing and recommending to our Board, and reviewing periodically, our set of corporate governance

guidelines;

• reviewing and discussing with management the Company's Environmental, Social and Governance strategy,

initiatives, and policies;

• reviewing and recommending to our Board the functions, duties, and compositions of our Board committees;

• developing and recommending to our Board criteria for Board and committee membership;

• identifying and recommending to our Board the persons to be nominated for election as directors and appointed to

each of our Board's committees;

• assisting our Board with orientation and continuing education of directors;

• overseeing the annual evaluations of our Board and our Board committees;

• establishing and overseeing the Company's succession, leadership, and talent development planning and process;

• reviewing and approving periodically a group of peer companies against which to benchmark the compensation of

the Company's executive officers;

• reviewing and approving corporate goals and objectives relevant to the compensation of our Chief Executive

Officer;

• evaluating the performance of our Chief Executive Officer in light of such corporate goals and objectives and

determining and approving the compensation of our Chief Executive Officer;

• reviewing and approving the compensation of our other executive officers;

• appointing, compensating, and overseeing the work of any compensation consultant, legal counsel, or other

advisors retained by the Compensation and Governance Committee;

• conducting the independence assessment outlined in the NYSE's rules with respect to any compensation

consultant, legal counsel, or other advisor retained by the Compensation and Governance Committee;

• reviewing the Company's incentive compensation arrangements to determine whether they encourage excessive

risk-taking;

• reviewing the Company's human capital programs, policies, and practices to determine their effectiveness;

• reviewing and reassessing the adequacy of the committee charter in its compliance with the listing standards of the

NYSE;

• reviewing and establishing our overall management compensation philosophy and policies;

• overseeing our compensation and benefits programs and policies, including any equity incentive plans;

• reviewing and making recommendations to our Board with respect to director compensation;

• reviewing and discussing with management the Company's corporate governance practices to be included in our

annual Proxy Statement or Annual Report on Form 10-K; and

• reviewing and discussing with management the Compensation Discussion and Analysis to be included in our

annual Proxy Statement or Annual Report on Form 10-K.

Our Compensation and Governance Committee charter is available on our website at www.ryanspecialty.com. To access the

charter, go to our website, click on the "Investors" tab, and then click on "Governance/Governance Documents" to download

or view the charter.

*Executive Committee* 

Our Executive Committee is composed of Mr. Ryan, Mr. Turner, Mr. Cortezi, and Mr. Rogers, with Mr. Ryan serving as

chairperson of the committee. During intervals between meetings of the Board, the Executive Committee has and may

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **12** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **12** |

---

exercise the power and authority of the Board in directing the management of the business and affairs of the Company,

including but not limited to the power and authority to declare dividends, except as may be limited by applicable law, our

Certificate, Bylaws, or by resolution of the Board.

*Risk Oversight* 

The Board is responsible for reviewing the major risks facing the Company and helping develop and oversee strategies to

address these risks. The Board has delegated to the Audit Committee the role of overseeing our enterprise risk assessment

and risk management policies. Pursuant to its charter, our Audit Committee is responsible for reviewing and discussing with

management our enterprise risk management framework. Taking into consideration the allocation of responsibility for risk

oversight to the other committees of the Board, the Audit Committee is responsible for reviewing and discussing with

management, on a periodic basis or as appropriate, the risks faced by us and policies, guidelines, and processes by which

management assesses and manages our risks, including our major financial risk exposures and the steps management has

taken to monitor and control such exposures.

The Audit Committee is also responsible for reviewing and discussing with management the Company's procedures and

internal controls relating to cybersecurity. The Board and Audit Committee set the tone at the top by providing oversight and

establishing expectations for the overall effectiveness and efficiency of the information security program.

Pursuant to its charter, the Compensation and Governance Committee is responsible for reviewing our incentive

compensation arrangements to determine whether they encourage excessive risk-taking, analyzing the relationship between

risk management policies and practices and compensation, and evaluating compensation policies and practices that could

mitigate any such risk. For more information, please see "*Executive Compensation: Compensation Discussion and Analysis* 

*— Compensation Decision Process and Methodology.*"

Board Skills Matrix

Each director possesses certain personal qualities and attributes that we believe are essential for the proper functioning of

the Board to fulfill its duties to our stockholders. The following matrix provides information regarding each nominee for

election as a director and each continuing director, including certain types of experiences and skills that the Board has

determined are important. The matrix does not encompass all the experiences and skills of our directors, and the fact that a

particular experience or skill is not listed does not mean that a director does not possess it. In addition, the director

biographies below include a non-exhaustive list of other key experiences and qualifications that further qualify the individual

to serve on our Board. These collective qualities, skills, experiences, and attributes are essential to our Board's ability to

exercise its oversight function for us and our stockholders and guide our long-term sustainable, dependable performance.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Director Name** | **Leadership**<br>**Experience**<br>| **Financial or**<br>**Accounting**<br>**Acumen**<br>| **Enterprise**<br>**Risk**<br>**Management**<br>| **Industry**<br>**Experience**<br>| **Operational**<br>**Experience**<br>| **Public**<br>**Company**<br>**Experience**<br>| **Cyber-**<br>**security** <br>**Experience**<br>|
| Patrick G. Ryan | ✔ | ✔ |  | ✔ | ✔ | ✔ |  |
| Timothy W. Turner | ✔ |  |  | ✔ | ✔ | ✔ |  |
| Henry S. Bienen | ✔ | ✔ | ✔ |  | ✔ | ✔ | ✔ |
| David P. Bolger | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |  |
| Michael G. Bungert | ✔ | ✔ |  | ✔ | ✔ | ✔ |  |
| Michelle L. Collins | ✔ | ✔ |  |  | ✔ | ✔ |  |
| Francesca Cornelli | ✔ | ✔ |  | ✔ |  | ✔ |  |
| Nicholas D. Cortezi | ✔ |  |  | ✔ | ✔ | ✔ |  |
| Anthony J. Kuczinski | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| Michael D. O'Halleran | ✔ | ✔ |  | ✔ | ✔ | ✔ |  |
| John W. Rogers, Jr. | ✔ |  |  |  | ✔ | ✔ |  |
| Patrick G. Ryan, Jr. | ✔ | ✔ |  |  | ✔ | ✔ |  |

---

Stockholder Nominations and Recommendations for Director Nominees

The Compensation and Governance Committee will consider stockholder nominations for membership on the Board that

conform to the requirements of our Bylaws. For the 2027 annual meeting, nominations may be submitted to Ryan Specialty

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **13** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **13** |

---

Holdings, Inc., 155 North Wacker Drive, Suite 4000, Chicago, IL 60606, Attn: Corporate Secretary, and such nominations will

then be forwarded to the chairperson of the Compensation and Governance Committee. The candidates are then evaluated

based on the process outlined in our Corporate Governance Guidelines and the Compensation and Governance Committee

charter. The same process is used for all candidates, including candidates recommended by stockholders. Nominations

must be in writing, and we must receive the nomination no later than the close of business on January 28, 2027, and not

earlier than December 29, 2026, assuming we do not change the date of the 2027 annual meeting of the stockholders by

more than 30 days before or after the anniversary of this Annual Meeting. Nominations must also satisfy certain other

procedural requirements as specified in our Bylaws. For more information, see the section entitled "Proposal of Stockholders

and Communications with our Board."

When filling a vacancy on the Board, the Compensation and Governance Committee identifies the desired skills and

experience of a new director and nominates individuals who it believes can strengthen the Board's capabilities and further

diversify the collective experience represented by the then-current directors. The Compensation and Governance

Committee may engage third parties to assist in the search and provide recommendations. Also, directors are generally

asked to recommend candidates for the position. The same process is used for all candidates, including candidates

recommended by stockholders.

Compensation Committee Interlocks and Insider Participation

Patrick G. Ryan, our Executive Chairman, serves as a member of the Board and as a member of the compensation

committee of Geneva Re, a joint venture. The Executive Chairman of Geneva Re, Michael D. O'Halleran, serves on our

Board. For more information relating to Geneva Re, please see the section entitled "*Certain Relationships and Related Party* 

*Transactions — Related Party Transactions — Ryan Investment Holdings, Geneva Re and Ryan Re.*"

Governance Policies

*Corporate Governance Guidelines* 

We have adopted a set of Corporate Governance Guidelines, which are available on our website at www.ryanspecialty.com.

To access the Corporate Governance Guidelines, go to our website, click on the "Investors" tab and then click on

"Governance/Governance Documents" to download or view the Corporate Governance Guidelines.

*Code of Conduct* 

We have adopted a Code of Conduct that applies to all of our employees, contractors, officers, and directors, including those

officers responsible for financial reporting. The Code of Conduct is available on our website at www.ryanspecialty.com. To

access our Code of Conduct, go to our website, click on the "Investors" tab and then click on "Governance/Governance

Documents" to download or view the code.

We intend to disclose any amendments to the code, or any waivers of its requirements, on our website. Since our IPO, we

have not amended the code or waived any of its provisions.

*Insider Trading Policy* 

We have adopted an Insider Trading Policy governing all transactions in our securities, including our shares of common

stock, options to purchase our shares of common stock, or any other type of securities that we may issue, including (but not

limited to) preferred stock, convertible debentures, and warrants, as well as derivative securities that are not issued by us,

such as exchange-traded put or call options or swaps relating to our securities. Our Insider Trading Policy applies to our

directors, officers, employees and those of our subsidiaries, as well as other persons as we may determine, such as

contractors or consultants. A person covered by our Insider Trading Policy is prohibited from engaging in transactions of our

securities while aware of material nonpublic information, recommending the purchase or sale of any of our securities, and

disclosing such information to persons outside of the Company or whose jobs do not require them to have that information.

We believe our Insider Trading Policy is reasonably designed to promote compliance with insider trading laws, rules and

regulations, and NYSE listing rules. A copy of our Insider Trading Policy was filed as Exhibit 19.1 to our Annual Report on

Form 10-K for the year ended December 31, 2024.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **14** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **14** |

---

*Anti-Hedging and Anti-Pledging Policies* 

The Company prohibits directors and employees from pledging any Company shares and prohibits directors and employees

from engaging in hedging transactions with respect to ownership in the Company's securities except as explicitly approved

in accordance with our Insider Trading Policy.

*Clawback Policy* 

The Company has adopted a Clawback Policy that complies with Section 10D of the Exchange Act and the listing standards

of the NYSE. The Clawback Policy applies to the Company's current and former executive officers subject to Section 16 of

the Exchange Act ("Section 16 Officers"). Under this policy, the Company must recover erroneously awarded incentive

compensation (as defined in the Clawback Policy) on a pre-tax basis within a specified lookback period, subject to limited

impracticability exceptions, in the event the Company is required to prepare certain accounting restatements. The Clawback

Policy requires recovery of erroneously awarded incentive compensation regardless of whether a Section 16 Officer

engaged in any misconduct or is otherwise at fault.

*2025 Amendments to our Certificate and Bylaws* 

The Board, upon advice and recommendation from the Compensation and Governance Committee, reviews the corporate

governance practices and standards under which the Company operates and assesses trends, stockholder input, and best

practices on a regular basis. After careful consideration of our governance structure prior to our 2025 annual meeting of

stockholders, our Board determined to recommend a number of amendments to our then effective certificate of

incorporation, each of which required stockholder approval. In making these recommendations, our Board reviewed,

considered, and discussed corporate governance trends, communications from our stockholders, and best practices

followed by other public companies perceived to be market leaders in the area of corporate governance and supported by

institutional and retail investors.

As a result, at the 2025 annual meeting of stockholders, we submitted, and the Board unanimously recommended a vote for,

nine separate proposals to amend our then effective certificate of incorporation:

• a proposal to declassify our Board and phase-in annual director elections;

• a proposal to implement a majority voting standard in uncontested director elections;

• a proposal to eliminate the springing supermajority voting standard with respect to the removal of a director from

our Board;

• a proposal to provide for a specific outside date, September 30, 2029, by which the ten-to-one vote disparity of the

Class B common stock to the Class A common stock would sunset;

• a proposal to provide stockholders with the ability to take action by written consent;

• a proposal to provide stockholders with the ability to call special meetings of stockholders;

• a proposal to eliminate the springing supermajority voting standard with respect to the amendment of our Bylaws

and certain provisions of the then effective certificate of incorporation;

• a proposal to provide for the exculpation of certain officers of the Company to the fullest extent provided under

Delaware law; and

• a proposal to approve certain other non-substantive amendments.

Additionally, the Board approved an amendment and restatement of our then effective Bylaws to adopt provisions related to

the amendments to our then effective certificate of incorporation, including:

• adoption of qualifications and procedures specifying the ownership percentage and information requirements that a

stockholder or stockholders must provide to exercise their right to call a special meeting;

• implementation of a majority voting standard for the election of directors in uncontested director elections, with a

plurality voting standard applying to contested director elections;

• adoption of a market standard resignation policy with respect to director nominees consistent with the majority

voting standard, so that an incumbent director who does not receive the requisite affirmative majority of the votes

cast for his or her re-election is required to promptly tender his or her resignation to the Board, subject to

acceptance by the Board; and

• certain conforming and administrative changes.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **15** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **15** |

---

The proposals submitted to our stockholders were overwhelmingly approved at the 2025 annual meeting, and thereafter, we

amended our Certificate and the amended and restated Bylaws went into effect. These actions demonstrate our commitment

to best-in-class corporate governance.

Our Culture

Since the inception of the Company, meritocracy, inclusion, empowerment, and all of our other core values have been in

place and are essential as the foundation of our culture. Our core values are paramount to our workplace and enable our

teammates to innovate the best solutions for our clients and trading partners. Our commitment is to continue to foster an

environment wherein each person can be their authentic self and perform up to their highest potential, to self-optimize.

Together, we continually work towards a culture where everyone can thrive and achieve their best work and is rewarded

based on that achievement. Our core values reflect a culture of meritocracy that is inclusive and treats people equally. Every

employee is recognized and assessed based on their performance and contributions, which serves to fulfill our mission of

hiring and retaining the top talent in our industry. We strive to protect the invaluable attributes of meritocracy and are

committed to purposefully reinforcing and refining our culture and values through various initiatives to enable our firm to reap

the benefits that are inherent in a diverse and inclusive environment. Our values set the foundation for a workplace where

people can be their best self and do their best work. The Company strives to reward top performers and harness our

differences and similarities to better serve our clients, trading partners, teammates, and communities. We are committed to

continuing to build a culture where meritocracy is the standard, equality is championed for all, and inclusion is a fundamental

part of who we are.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **16** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **16** |

---

**PROPOSAL NO. 1: ELECTION OF DIRECTORS** 

The Board has nominated David P. Bolger, Michael G. Bungert, Francesca Cornelli, Nicholas D. Cortezi, and Anthony J.

Kuczinski for election at the Annual Meeting to serve until the 2027 annual meeting of stockholders and until their

successors are duly elected and qualified. Each of the nominees, other than Mr. Bungert, who was appointed to the Board in

September 2025 to fill a vacancy upon the death of a director, has been previously elected by our stockholders. Mr. Bungert

was initially recommended to the Compensation and Governance Committee by our Executive Chairman, Patrick G. Ryan.

Dr. Cornelli and Messrs. Bolger, Bungert, Cortezi, and Kuczinski have each consented to be named in this Proxy Statement

and indicated their willingness to serve if elected.

Nomination of Directors

The Compensation and Governance Committee of our Board identifies, evaluates, and recommends to the Board potential

nominees for election to the Board. In reviewing potential nominees, the Compensation and Governance Committee

considers the qualifications of each potential nominee with the qualification standards set forth in its committee charter and

in our Corporate Governance Guidelines. Specifically, the Compensation and Governance Committee considers, among

other things, (i) each potential nominee's past attendance and performance at Board meetings and committee meetings, if

applicable, (ii) the nominee's ability to represent all stockholders without a conflict of interest, (iii) the nominee's ability to

work in and promote a productive environment, (iv) whether the nominee has sufficient time and willingness to fulfill the

substantial duties and responsibilities of a director, (v) whether the nominee has demonstrated the high level of character,

ethics, and integrity expected by the Company, (vi) whether the nominee possesses the broad professional and leadership

experience and skills necessary to effectively respond to the complex issues encountered by a publicly-traded company, (vii)

the nominee's ability to apply sound and independent business judgment, and (viii) the viewpoint and background of the

nominee. The Board membership criteria are set forth in our Corporate Governance Guidelines and Compensation and

Governance Committee charter, copies of which are available under the tabs "Investors > Governance > Governance

Documents" on our website at www.ryanspecialty.com. After reviewing the qualifications of potential Board candidates, the

Compensation and Governance Committee presents its recommendations to the Board, which selects the final director

nominees.

The Company did not pay any fees to any third parties to identify or assist in identifying or evaluating nominees for the

Annual Meeting. The Compensation and Governance Committee considers stockholder nominees using the same criteria

set forth above. Stockholders who wish to present a potential nominee to the Compensation and Governance Committee for

consideration for election at a future annual meeting of stockholders must provide the Compensation and Governance

Committee with notice of the nomination and certain information regarding the candidate as described in our Bylaws and

within the time periods set forth under the caption "Proposals of Stockholders and Communications with our Board."

Pursuant to our Corporate Governance Guidelines, the Company endeavors to have a Board consisting of directors who

possess the highest personal and professional ethics, integrity and values and who are committed to representing the long-

term interests of the Company and its stockholders.

Nominees and Incumbent Directors

The Compensation and Governance Committee has recommended, and the Board has nominated, Dr. Cornelli and Messrs.

Bolger, Bungert, Cortezi, and Kuczinski for election as directors at the Annual Meeting to serve until the 2027 annual

meeting of stockholders and until their successors are duly elected and qualified.

Director Nominees

![Bolger-2026 Proxy.jpg](ryan-20260317_g11.jpg)

**DAVID P. BOLGER**

David P. Bolger has served on our Board since 2012 and is the chairperson of the Audit

Committee. Mr. Bolger served as Chief Operating Officer of Chicago 2016, the effort to

bring the 2016 Olympic and Paralympic Games to Chicago. From 2004 to 2019, Mr.

Bolger served on the board of directors of MB Financial, Inc. From 2003 to 2008, he

served as Executive Vice President and Chief Financial Officer of Aon Corporation. Prior

to joining Aon, Mr. Bolger served in multiple executive positions at Bank One Corporation

and its predecessor companies. He earned a Bachelor of Science in Accounting and

Finance from Marquette University and a Master of Management from Northwestern

University Kellogg School of Management. We believe Mr. Bolger is qualified to serve on

our Board due to his extensive insurance industry, accounting, and finance experience.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **17** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **17** |

---

![Bungert-2026 Proxy.jpg](ryan-20260317_g12.jpg)

**MICHAEL G. BUNGERT**

Michael G. Bungert has served on our Board since September 2025 and is a member of

the Compensation and Governance Committee. He served as Chairman of Aon Re

Global from 2013 to 2024. Prior to that, Mr. Bungert was the Chief Executive Officer of

Aon Re Global starting in 1998. Mr. Bungert started his career in reinsurance in 1977 as

an underwriter trainee at Continental Casualty Company. He then joined CNA Re in 1979

as a London-based North American underwriter. In 1984, Mr. Bungert joined reinsurance

intermediary Thomas A. Greene Inc. Intermediaries in Chicago and subsequently joined

Aon Re in 1989. Mr. Bungert received his Bachelor of Arts from Illinois State University.

We believe Mr. Bungert is well qualified to serve on our Board due to his extensive

insurance and reinsurance industry experience.

![Cornelli-2026 Proxy.jpg](ryan-20260317_g13.jpg)

**FRANCESCA CORNELLI**

Francesca Cornelli has served as a member of our Board since July 2023 and is a

member of the Audit Committee. Dr. Cornelli is the dean of Northwestern University's

Kellogg School of Management, a position she has held since August of 2019. She is

also a professor of finance and holds the Donald P. Jacobs Chair in Finance. Prior to that,

she was a professor of finance and deputy dean at London Business School from 1994 to

2019. Dr. Cornelli's research interests include corporate governance, private equity,

privatization, bankruptcy, IPOs, and innovation policy. She has been an editor of the

Review of Financial Studies and previously served on the board of editors of the Review

of Economic Studies and as an associate editor at the Journal of Finance. She is a

research fellow at the Center for Economic and Policy Research and previously served

as a director of the American Finance Association. Dr. Cornelli has previously taught at

the Wharton School of the University of Pennsylvania, the Fuqua School of Business at

Duke University, The London School of Economics, the Indian School of Business in Hyderabad and the New Economic

School in Moscow. Dr. Cornelli currently serves as a member of the board of directors of GCM Grosvenor Inc., a public

company engaged in global alternative asset management. She has also served as an independent board member of

several global corporations, including GCP Capital Partners Limited, an investment company, from 2023 to 2024, which was

recently acquired, Banca Intesa San Paolo from 2016 to 2019, Telecom Italia from 2014 to 2018, American Finance

Association from 2013 to 2016, and Swiss Re International and Swiss Re Holdings from 2013 to 2019. In January 2016, she

helped create and became a board member of AFFECT, a committee of the American Finance Association designed to

promote the advancement of women academics in the field of finance. We believe Dr. Cornelli is well qualified to serve on

our Board due to her experience as an academic in finance and governance, and her experience on boards of directors of

other for-profit companies.

![Cortezi-2026 Proxy.jpg](ryan-20260317_g14.jpg)

**NICHOLAS D. CORTEZI**

Nicholas D. Cortezi has served on our Board since our IPO in July 2021 and is a member

of the Executive Committee. He served as the Chairman of Ryan Specialty Underwriting

Managers from September 2020 through June 2023. In 1987, Mr. Cortezi joined All Risks,

Ltd. ("All Risks") and was promoted to CEO in 1999, which he served as until its

acquisition by Ryan Specialty in September 2020. Mr. Cortezi has served on the boards

of the Independent Insurance Agents of Baltimore, Independent Insurance Agents of

Maryland, the National Association of Surplus Lines Offices ("NAPSLO") (now known as

the Wholesale & Specialty Insurance Association ("WSIA")) and was President of

NAPSLO between 2002 and 2003. Mr. Cortezi earned a Bachelor of Arts in International

Relations and a Masters in International Public Policy from Johns Hopkins University. We

believe that Mr. Cortezi's extensive and industry-leading experience in the area of

insurance and his insight into our business as prior Chairman of Ryan Specialty

Underwriting Managers qualifies him to serve on our Board.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **18** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **18** |

---

![Kuczinski-2026 Proxy.jpg](ryan-20260317_g15.jpg)

**ANTHONY J. KUCZINSKI**

Anthony J. Kuczinski has served on our Board since October 2023 and is a member of

both the Audit Committee and the Compensation and Governance Committee. Mr.

Kuczinski is Founder and CEO of LST Risk Concepts, LLC, a consulting and advisory

firm to the P&C Insurance Industry. He formerly served as executive advisor to the

Munich Re Board of Management for Munich Reinsurance US Holding, the North

American property and casualty operations of Munich Re, a role he served during

transition after retirement. He was the President and Chief Executive Officer of Munich

Reinsurance US Holdings from 2008 through 2023. Prior to that, he held numerous

senior roles with Munich Re starting in 1989. Prior to Munich Re, Mr. Kuczinski was Chief

Operating Officer of NY Marine and General Insurance Company, a publicly traded

insurance group now part of Pro-Sight Insurance Group, and he worked in the audit

practice for the public accounting firm of Coopers & Lybrand (now

PricewaterhouseCoopers). Mr. Kuczinski is a lead independent director of Skyward Specialty Insurance Group and a

director of Hagerty, Inc. and also serves on the Penn Medicine Healthcare System (Penn Medicine) board and on its

executive committee. He is also a board member and executive committee chair for Penn Medicine Princeton Health, a

subsidiary of Penn Medicine. Mr. Kuczinski holds a Bachelor of Arts in Public Accounting from Pace University, Magna Cum

Laude, and holds a Certificate in Advanced Executive Education from the Wharton School. Mr. Kuczinski is a Certified Public

Accountant and a Chartered Property Casualty Underwriter. We believe Mr. Kuczinski is well qualified to serve on our Board

due to his extensive insurance industry and financial experience.

Class III Directors: Continuing in Office Until 2027

![Ryan-2026 Proxy.jpg](ryan-20260317_g4.jpg)

**PATRICK G. RYAN**

Patrick G. Ryan is a widely respected entrepreneur and global insurance leader who

founded Ryan Specialty in 2010. Mr. Ryan became our Executive Chairman on October

1, 2024. Prior to that, he served as the Chairman and Chief Executive Officer of Ryan

Specialty since its inception. Mr. Ryan is also a member and the chairperson of the

Executive Committee. Prior to launching Ryan Specialty, Mr. Ryan founded Aon

Corporation and served as its Chairman and/or CEO for 41 years. At the time of Mr.

Ryan's retirement, Aon had more than 500 offices in 120 countries, generating revenues

then in excess of $7 billion. Mr. Ryan has received a number of accolades throughout his

career. In 1987, Mr. Ryan received the esteemed Horatio Alger Award, which honors

those who are dedicated to the principles of integrity, hard work, perseverance, and

compassion for others. In 2008, Mr. Ryan was inducted into the American Academy of

Arts and Sciences, one of the nation's oldest and most prestigious honorary societies and

independent research centers, founded in 1780. Also in 2008, he was elected to the International Insurance Society Hall of

Fame and received the Ernst and Young Entrepreneur of the Year Lifetime Achievement Award. He was named by Brigham

Young University International Executive of the Year for Corporate Integrity. Other career tributes include the College of

Insurance's Insurance Leader of the Year and the Insurance Federation of New York's Free Enterprise Award. Most recently,

in July 2019, Mr. Ryan was inducted into the Automotive Hall of Fame for his contribution to the Finance and Insurance

Specialists sector of the automotive industry. Mr. Ryan has been a member of Northwestern University's board of trustees

for 42 years, 14 years of which he served as Chairman. Mr. Ryan served on the boards of directors of 1st National Bank of

Chicago and its successors and the Tribune Company. Mr. Ryan earned a Bachelor of Business Administration from

Northwestern in 1959 and, in 2009, Northwestern awarded Mr. Ryan a Doctor of Humane Letters degree. Also in 2009, Mr.

Ryan was inducted into the Northwestern Athletic Hall of Fame. Four years later, in 2013, Mr. Ryan received the

Northwestern Alumni Association Medal of Honor. This award is the highest award granted by the Northwestern Alumni

Association to an alumnus who combines superior professional distinction and/or exemplary volunteer service to society,

with an outstanding record of service to Northwestern. Mr. Ryan also served as Chairman of Chicago 2016, the effort to

bring the 2016 Olympic and Paralympic Games to Chicago. We believe that Mr. Ryan's extensive and industry-leading

experience in the area of insurance, his experience as the founder, Chairman and CEO of Aon, and his insight into our

business as our Founder and Chief Executive Officer qualifies him to serve on our Board.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **19** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **19** |

---

![Collins-2026 Proxy.jpg](ryan-20260317_g16.jpg)

**MICHELLE L. COLLINS**

Michelle L. Collins has served on our Board since our IPO in July 2021 and is a member

of the Audit Committee. Since 2007, she has served as the president of Cambium LLC, a

consulting firm. Ms. Collins was co-founder of Svoboda Capital Partners, LLC and served

as Managing Director from 1998 to 2006. Prior to that, Ms. Collins was a principal in the

Corporate Finance Department at William Blair & Company, LLC. Since 2014, Ms. Collins

has served on the board of Ulta Beauty, Inc. She has also served on the boards of

Canadian Imperial Bank of Commerce ("CIBC") and CIBC Bancorp USA/CIBC Bank U.S.

since 2017. Previously, she was a member of the mutual fund boards of Columbia Acorn

and Wanger Advisors Trusts and the boards of directors of the following public and

private companies: PrivateBankcorp, Inc., Integrys Energy Group, Inc., Molex, Inc.,

Bucyrus International, CDW Corporation, Coldwater Creek, Inc., McWhorter

Technologies, Inc., and Health Care Service Corporation, a mutual reserve company. She

earned a Bachelor of Arts from Yale University and a Master of Business Administration from Harvard Business School. We

believe Ms. Collins is qualified to serve on our Board due to her extensive finance industry experience and experience as a

director on the boards of other for-profit companies.

![Rogers-2026 Proxy.jpg](ryan-20260317_g17.jpg)

**JOHN W. ROGERS, JR.**

John W. Rogers, Jr., has served on our Board since 2014, has been our Lead Director

since July 2025, and is a member of both the Compensation and Governance Committee

and the Executive Committee. He is the Founder, Chairman, Co-CEO (since 2019; from

1983-2019 he served as Chief Executive Officer), and Chief Investment Officer of Ariel

Investments. Mr. Rogers is a member of the mutual fund board of Ariel Investments Trust,

serves as vice chair of the board of trustees of the University of Chicago, and as a

member of the boards of directors of NIKE, Inc. and The New York Times Company.

From 2000 to 2019, he served on the board of directors of Exelon Corp. and from 2003 to

2023 he served on the board of directors of McDonalds Corporation. Following the

election of President Barack Obama, Mr. Rogers served as co-chair for the Presidential

Inaugural Committee 2009, and in 2016 he joined the Barack Obama Foundation's board

of directors. He earned his Bachelor of Arts from Princeton University and in 2008 was

awarded Princeton University's highest honor, the Woodrow Wilson Award, presented each year to the alumnus or alumna

whose career embodies a commitment to national service. We believe Mr. Rogers is qualified to serve on our Board due to

his extensive finance industry experience and experience as a director on the boards of other for-profit companies.

Class I Directors: Continuing in Office Until 2028

![Turner-2026 Proxy.jpg](ryan-20260317_g18.jpg)

**TIMOTHY W. TURNER** 

Timothy W. Turner became our Chief Executive Officer on October 1, 2024. Prior to that,

he served as our President from March 2021 until October 1, 2024 and as the Chairman

and CEO of RT Specialty from RT's founding in 2010 until October 1, 2024. Mr. Turner

has been a member of our Board of Directors since 2012 and is a member of the

Executive Committee. Prior to co-founding RT Specialty, Mr. Turner was with CRC

Insurance Services, Inc. ("CRC") for 10 years and was President of CRC at the time of

his departure. Prior to CRC, Mr. Turner worked for the Crump Group and was named

President of its Chicago Office. Mr. Turner began his insurance career as a casualty

broker with A.J. Renner & Associates in 1987. He has received a number of awards, and

in 2020, one of the insurance industry's most respected media outlets, the Insurance

Insider, named Mr. Turner the Distribution Leader of the Year, honoring him as the year's

most influential and outstanding individual in insurance distribution. In 2019, Mr. Turner

received the prestigious Insurance Industry "Good Scout" Award from the Boy Scouts of America, Greater New York

Councils. Additionally, Mr. Turner received the 2021 Spirit of Life Award from the City of Hope, National Insurance Industry

Counsel. Before joining the insurance industry, Mr. Turner graduated from the Detroit Police Academy, served on the Wayne

County SWAT Team, and was an undercover narcotics officer with the Narcotics Cocaine Task Force with the Michigan State

Police. Mr. Turner earned a Bachelor of Science in Criminal Justice from Madonna University. We believe that Mr. Turner's

extensive and industry-leading experience in the area of insurance and his insight into our business as our President and

the Chairman and CEO of RT Specialty qualifies him to serve on our Board.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **20** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **20** |

---

![Bienen-Ryan-ext-251204-01-fave-final-2_Client Ryan -final-L.jpg](ryan-20260317_g19.jpg)

**HENRY S. BIENEN, PH.D**

Henry S. Bienen has served on our Board since 2012, is the Chairperson of the

Compensation and Governance Committee, and is a member of the Audit Committee. Dr.

Bienen served as Northwestern University's president from 1995 through 2009 and

currently serves as president emeritus and interim president of Northwestern University.

He was the James S. McDonnell Distinguished University Professor and Dean of the

Woodrow Wilson School of Public and International Affairs at Princeton University prior to

his appointment at Northwestern. Dr. Bienen is Emeritus Trustee of the Chicago Council

on Global Affairs. Additionally, Dr. Bienen is on the boards of directors of Hedge Fund

Guided Portfolio Solutions and Grosvenor Multi Strategy Funds, chairs the Advisory

Committee of The Vistria Group's Education Investments, and is a lifetime member of the

board of MetroSquash, an urban squash and education program in Chicago.

Furthermore, Dr. Bienen is a member of the board of the Lucas Museum of Narrative Art,

was the chairman of the board of the Crown Center on Middle East Studies at Brandeis University, and was both a member

and a past chairman of the board, and was both a member and a past chairman of the board of directors for Rasmussen

University. Dr. Bienen is also a consultant for Academic Partnerships, an online project manager for regional public

universities. Dr. Bienen served on the board of the Council on Foreign Relations from 2001 to 2011 and Bear Stearns

Companies, Inc. from 2004 to 2008. He earned a Bachelor of Arts from Cornell University with honors, as well as a Master of

Political Science and a PhD in Political Science from the University of Chicago. We believe Dr. Bienen is qualified to serve

on our Board due to his extensive experience as a director on the boards of other for-profit companies.

![O_halleran-2026 Proxy.jpg](ryan-20260317_g20.jpg)

**MICHAEL D. O'HALLERAN**

Michael D. O'Halleran has served on our Board since 2018. Mr. O'Halleran has been

Executive Chairman of Geneva Re Ltd. since 2019 and previously served as a senior

advisor at Ryan Specialty. Mr. O'Halleran was the founder, and for twenty-four years

served as Executive Chairman, of Aon Re, a reinsurance brokerage and capital advisory

firm. Additionally, Mr. O'Halleran was previously President and COO of Aon Corporation

from 1999 to 2005. He also served on the following boards of directors: NuVasive, Inc.,

CareFusion, Inc., Cardinal Health, Inc., and Allegiance Corp. Mr. O'Halleran earned his

Bachelor of Science from the University of Wisconsin - Whitewater. We believe Mr.

O'Halleran is qualified to serve on our Board due to his extensive insurance industry

experience.

![Ryan-Pat Jr-2024-EXT-final-2.jpg](ryan-20260317_g21.jpg)

**PATRICK G. RYAN, JR.**

Patrick G. Ryan, Jr., has served on our Board since January 2024 and is a technology

entrepreneur and investor. He is the Founder and CEO of Incisent Labs Group, a holding

company and incubator for creating new technology companies. Mr. Ryan also founded

two high growth software as a service (SaaS) companies, each of which was ranked by

Inc. Magazine as one of the four fastest growing software companies in the United States

and cofounded venture capital firm Chicago Ventures. Mr. Ryan served on the board of

directors of Penske Corporation, a $50 billion diversified transportation services

company, for 25 years. He is a Trustee of Northwestern University and serves on its

executive committee. He earned a Bachelor of Arts from Georgetown University and a

Master of Business Administration from Northwestern University's Kellogg School, as well

as a Juris Doctorate cum laude from Northwestern School of Law. We believe Mr. Ryan is

qualified to serve on our Board due to his experience as a founder of two successful

technology companies and his financial experience as a CEO.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **21** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **21** |

---

Vote Required

Each of the five nominees who receive more "FOR" votes than "AGAINST" votes at the virtual Annual Meeting by

stockholders entitled to vote thereon will be elected as a director to hold office until the 2027 annual meeting of stockholders

and until their successors are elected and qualified, unless they resign, or their seats become vacant due to removal or

death. Abstentions and broker non-votes will not affect the election of directors.

Holders of proxies solicited by this Proxy Statement will vote the proxies received by them as directed on the Proxy Card or,

if no direction is given, then FOR the election of each of the nominees named in this Proxy Statement.

---

| | |
|:---|:---|
| ![14.jpg](ryan-20260317_g22.jpg) | **The Board recommends a vote "FOR" each of the five director nominees identified above.** |

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **22** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **22** |

---

**DIRECTOR COMPENSATION** 

The following table presents the total compensation for each person who served as a non-employee director on our Board

during 2025. Other than as set forth in the table and described more fully below, we did not pay any compensation, make

any equity or non-equity awards, or pay any other compensation to any of the non-employee directors on the Board. Patrick

G. Ryan and Timothy W. Turner, each of whom are employed by the Company, did not receive any additional compensation

for their service on the Board. Robert M. Le Blanc, who retired from the Board effective February 11, 2026, agreed to forgo

any cash or equity compensation for his service on the Board. Michael D. O'Halleran is eligible to receive the annual equity

grant in accordance with the Company's Non-Employee Director Compensation Policy, discussed below, but does not

receive any additional cash payments for his service to the Board in light of his role as Executive Chairman of Geneva Re.

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Fees Earned**<br>**or Paid in**<br>**Cash ($)**<br>| **Stock**<br>**Awards**<br>**($)**<sup>(1)</sup><br>| **Total**<br>**($)**<br>|
| Henry S. Bienen <sup>(2)</sup> | 131481 | 162500 | 293981 |
| David P. Bolger | 155000 | 162500 | 317500 |
| Michael G. Bungert <sup>(3)</sup> | 36196 |  | 36196 |
| Michelle L. Collins | 120000 | 162500 | 282500 |
| Francesca Cornelli | 120000 | 162500 | 282500 |
| Nicholas D. Cortezi | 120000 | 162500 | 282500 |
| D. Cameron Findlay <sup>(4)</sup> | 95380 | 162500 | 257880 |
| Anthony J. Kuczinski | 120000 | 162500 | 282500 |
| Robert M. Le Blanc |  |  |  |
| Michael D. O'Halleran |  | 162500 | 162500 |
| John W. Rogers, Jr. <sup>(5)</sup> | 136073 | 162500 | 298573 |
| Patrick G. Ryan, Jr. | 120000 | 162500 | 282500 |

---

(1)On May 30, 2025, each of the non-employee directors, other than Mr. Bungert who was not elected to the Board until September

2025, received a grant of 2,323 Restricted Stock Units ("RSUs"), rounded down to the nearest whole share, with a grant date fair

value of approximately $162,500, as compensation for their full year of service to the Company ending at the 2025 annual meeting

of stockholders. RSUs were fully vested as of the grant date and each RSU represents a right to receive one fully vested share of

Class A common stock within 30 days of grant (or, if elected by the director, upon the earlier of the director's "separation from

service" or a "change in control," each as defined in the applicable award agreement).

(2)Henry S. Bienen was appointed as chair of the Compensation and Governance Committee on July 16, 2025, and received a

prorated fee for his services as chair of the Compensation and Governance Committee for the third quarter of 2025.

(3)Michael G. Bungert began his services to the Board on September 12, 2025, and received a prorated fee for his services to the

Board for the third quarter of 2025.

(4)D. Cameron Findlay passed away on July 11, 2025, and received a prorated fee for his services to the Board as both a director and

the Lead Director for the third quarter of 2025.

(5)John W. Rogers, Jr., was appointed Lead Director on July 16, 2025, and received a prorated fee for his services as Lead Director for

the third quarter of 2025.

In October 2024, after a detailed review of director compensation provided by our peers, the Board amended the Non-

Employee Director Compensation Policy to provide its non-employee members the following compensation to be effective

January 1, 2025: (i) an annual cash retainer of $120,000, (ii) an annual grant of equity with a grant date fair value of

$200,000, (iii) an annual fee for the Chair of the Audit Committee of $35,000, (iv) an annual fee for the Chair of the

Compensation and Governance Committee of $25,000, and (v) an annual fee for the Lead Director of the Board of $35,000.

Other than the chairperson of the respective Board committees, no participating committee members receive additional

compensation for their participation on such committees.

Mr. O'Halleran will continue to forgo any cash compensation as a director and Mr. Le Blanc agreed to forgo any cash or

equity compensation for his service as a director. The annual cash retainer, as well as the Lead Director fee and committee

chairperson fee, are all paid quarterly.

Our Non-Employee Director Compensation Policy provides that each of our non-employee directors will receive an annual

grant of equity. With the exception of Mr. Le Blanc, who elected not to receive any compensation for his service on the

Board, we make an annual equity grant to our non-employee directors each year on the date of the Company's annual

meeting of stockholders. The grants are compensation for a year of service comprising the third and fourth quarters of the

prior year and the first and second quarters of the current year. Should any director not serve for the full year covered by the

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **23** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **23** |

---

grant (from annual meeting to annual meeting), the grant will be prorated. Each director that served for the entire year

through the 2025 annual meeting of stockholders received a grant of equity on May 30, 2025 in the form of RSUs with a

grant date fair value equal to approximately $162,500, rounded down to the nearest whole share (which reflects two quarters

prorated at $125,000 and two quarters prorated at $200,000). The RSUs were fully vested as of the grant date and each

represents a right to receive one fully vested share of Class A common stock within 30 days of the grant date (or, at the

election of the director, upon the earlier of the director's "separation from service" or a "change in control," each as defined in

the applicable award agreement).

In October 2025, after a detailed review of director compensation provided by our peers, the Board did not make any

changes to the Non-Employee Director Compensation Policy.

Stock Ownership Guidelines

The Company has stock ownership guidelines which apply to the Company's non-employee directors. Pursuant to the

guidelines, the Company's non-employee directors are expected to accumulate Company common stock or equivalents with

a value equivalent to five times their annual cash retainer, within five years of the adoption of the requirement or within five

years of a director joining the Board. If a non-employee director does not hold sufficient shares of the Company's common

stock or equivalents to meet the guideline requirements, they will then be required to hold 100% of their current Company

common stock or equivalents plus any future grants until they have met the requirement. Compliance with the stock

ownership requirements is measured annually and calculated on the last trading day of each calendar year, based on the

closing price of the Company's stock on such trading day.

The guidelines were adopted on April 21, 2021, such that each non-employee director serving at that time has until April 21,

2026 to meet the guidelines. The table below sets forth the date by which each of our current non-employee directors is

required to meet the guidelines.

---

| | |
|:---|:---|
| **Director Name** | **Date** <br>**Compliance is** <br>**Required**<br>|
| Henry S. Bienen | April 21, 2026 |
| David P. Bolger | April 21, 2026 |
| Michael G. Bungert | September 12, 2030 |
| Michelle L. Collins | July 21, 2026 |
| Francesca Cornelli | July 31, 2028 |
| Nicholas D. Cortezi | June 1, 2028 |
| Anthony J. Kuczinski | October 30, 2028 |
| Michael D. O'Halleran | April 21, 2026 |
| John W. Rogers, Jr. | April 21, 2026 |
| Patrick G. Ryan, Jr. | January 1, 2029 |

---

Each non-employee director has achieved holdings in excess of the applicable requirement as of December 31, 2025, or is

within the five-year compliance period.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **24** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **24** |

---

**EXECUTIVE OFFICERS** 

Below is a list of the names, ages as of the Record Date, positions, and brief accounts of the business experience of our

current Executive Officers.

---

| | | |
|:---|:---|:---|
| **Name** | **Age** | **Position** |
| Patrick G. Ryan | 88 | Executive Chairman of the Board of Directors |
| Timothy W. Turner | 65 | Chief Executive Officer and Director |
| Brendan M. Mulshine | 60 | Co-President and Chief Revenue Officer |
| Stephen P. Keogh | 59 | Co-President and Chief Operating Officer |
| Michael L. Conklin | 57 | Executive Vice President and Chief Human Resources Officer |
| Janice M. Hamilton | 44 | Chief Financial Officer |
| Mark S. Katz | 57 | Executive Vice President, General Counsel, and Corporate Secretary |
| Benjamin M. Wuller | 50 | CEO Ryan Specialty Underwriting Managers |

---

**Patrick G. Ryan** — See biography under "*Proposal No. 1 Election of Directors — Class III Directors: Continuing in Office* 

*Until 2027."* 

**Timothy W. Turner** — See biography under "*Proposal No. 1 Election of Directors – Class I Directors: Continuing in Office* 

*Until 2028*."

**Brendan M. Mulshine** has served as our Co-President and Chief Revenue Officer since October 2025. Mr. Mulshine served

as our Executive Vice President and Chief Revenue Officer from 2020 through October 2025 and previously served as our

Executive Vice President and Managing Director from 2012 through 2020. From 1995 to 2012, Mr. Mulshine held various

leadership positions at Aon Re, working with domestic and global insurance company clients on their reinsurance capital

needs. Mr. Mulshine began his career practicing law in New York City. He earned a Bachelor of Arts from Yale College, a

Juris Doctor from the University of Notre Dame School of Law, and a Master of Business Administration from Northwestern

University's Kellogg School of Management.

**Stephen P. Keogh** has served as our Co-President and Chief Operating Officer since October 2025. Prior to that, from May

2025, Mr. Keogh served as the Company's Chief Operating Officer. Previously, Mr. Keogh was the Senior Advisor to the

Office of President, Aon plc, a position he held from October 2021 until his retirement in September 2022. Prior to that,

commencing June 2019, Mr. Keogh was President of Aon plc's Commercial Risk Solutions, the global risk management

business of Aon. Mr. Keogh has more than thirty-two years of experience at Aon, where he held positions in operations,

finance and accounting, technology, human resources, and executive management. Mr. Keogh earned a Bachelor of Arts

degree from the University of Illinois.

**Michael L. Conklin** has served as our Executive Vice President and Chief Human Resource Officer since August 2023.

From July 2020 through August 2023, Mr. Conklin served as the Executive Vice President and Chief Human Resource

Officer for WSFS Financial Corporation. From 2013 to 2020, Mr. Conklin served in numerous HR Leadership roles at US

Bank, supporting strategy and corporate affairs, communications, marketing, HR, consumer and business banking, legal,

and global payments. In Mr. Conklin's last assignment at US Bank, he served as Senior Vice President for Global Human

Resources, Global Payment Services and Strategy & Corporate Affairs. Mr. Conklin has served on several nonprofit boards,

including most recently the Community Education Building Board of Directors, chairing the Human Resources and

Leadership Committee, as well as serving as a board advisor to Drexel University's Solutions Institute. Mr. Conklin served in

the Marine Corps Reserve and is a veteran of the Gulf War. He holds a Masters of Business Administration from Regis

University with a concentration on general management and a Bachelor of Science in Political Science and Psychology from

Augsburg University.

**Janice M. Hamilton** has served as our Chief Financial Officer since October 2024. From March 2021 to October 2024, she

served as Ryan Specialty's Chief Accounting Officer. Prior to that, Ms. Hamilton served as our Controller from May 2018 to

March 2021. Prior to joining Ryan Specialty, Ms. Hamilton was based in London serving as the CFO for AmTrust

International, the non-US and Lloyds operations of AmTrust Financial Services Inc. Prior to her role with AmTrust, Ms.

Hamilton held positions as CFO of ANV Holdings BV, which was acquired by Am Trust, and prior to that was the Controller

and then Finance Director for Jubilee Group Holdings, a prior subsidiary of Ryan Specialty. Ms. Hamilton began her career

with EY in Chicago, Illinois providing audit services to insurance sector companies such as Aon Corporation. Ms. Hamilton

received her Bachelor of Science in Finance from Miami University in Ohio and a Master of Science in Accounting at the

University of Virginia. She is a licensed CPA in the State of Illinois.

**Mark S. Katz** has served as our Executive Vice President, General Counsel, and Corporate Secretary since March 2020,

after first joining Ryan Specialty in 2019 as Counsel for Insurance Services. Prior to joining Ryan Specialty, Mr. Katz

practiced law with boutique Manhattan-based insurance litigation firm Mound Cotton Wollan & Greengrass LLP from 1993

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **25** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **25** |

---

through 2018, litigating complex insurance coverage disputes throughout the United States. He was a partner with the firm

from 2002 through 2018 and served as the firm's Administrative Partner and on its hiring and compensation committees for

numerous years. Mr. Katz earned his Bachelor of Arts from Syracuse University, Maxwell School of Citizenship and Public

Affairs and his Juris Doctor from Hofstra University School of Law, where he was an editor of the Hofstra Law Review.

**Benjamin M. Wuller** has served as the CEO of Ryan Specialty Underwriting Managers ("RSUM") since October 2021 and

concurrently served as RSUM's President from March 2021 to February 2025. Prior to that, he served as Executive Vice

President of RSUM from October 2020 to March 2021 and its Chief Operating Officer from June 2015 to October 2020. Mr.

Wuller joined Ryan Specialty in 2010, originally as Treasurer, leading capital activity and executing Ryan Specialty's M&A

strategy across the specialty industry. Prior to joining Ryan Specialty, Mr. Wuller severed in various positions for Aon

Corporation over a ten-year period in corporate finance, financial risk management, and derivatives trading culminating as

Assistant Treasurer – Investments & Corporate Development. Mr. Wuller received his Bachelor of Architecture at the

University of Kansas and his Master of Business Administration at the University of Chicago, Graduate School of Business.

Family Relationships

There are no family relationships between any of our directors or executive officers, except as described below:

• Brendan M. Mulshine's spouse is the niece of Patrick G. Ryan and a cousin of Patrick G. Ryan, Jr.

• Patrick G. Ryan, Jr., a director, is the son of Patrick G. Ryan.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **26** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **26** |

---

**PROPOSAL NO. 2: RATIFICATION OF APPOINTMENT OF** 

**INDEPENDENT REGISTERED PUBLIC ACCOUNTING** 

**FIRM** 

The Audit Committee of our Board has appointed Deloitte & Touche LLP as our independent registered public accounting

firm for the year ending December 31, 2026, and is seeking ratification of this selection by our stockholders at the Annual

Meeting. Deloitte & Touche LLP has audited our financial statements since the year ended December 31, 2011. Services

provided to the Company and its subsidiaries by Deloitte & Touche LLP for the years ended December 31, 2025 and 2024

are described below and under "Audit Committee Report." Representatives of Deloitte & Touche LLP are expected to be

present at the Annual Meeting. They will have an opportunity to make a statement if they so desire, and we expect that they

will be available to respond to appropriate questions.

Neither our Bylaws nor other governing documents or law require stockholder ratification of the selection of Deloitte &

Touche LLP as our independent registered public accounting firm. The Audit Committee, however, is submitting the selection

of Deloitte & Touche LLP to our stockholders for ratification as a matter of good corporate practice. If our stockholders fail to

ratify the selection, the Audit Committee will reconsider whether to retain Deloitte & Touche LLP. Even if the selection is

ratified, the Audit Committee, in its discretion, may direct the appointment of a different independent registered public

accounting firm at any time during the year if it determines that a change would be in the best interests of the Company and

our stockholders.

Audit and Non-Audit Fees and Services

The following table provides information regarding the fees incurred to Deloitte & Touche LLP during the years ended

December 31, 2025 and 2024. All fees described below were pre-approved by the Audit Committee.

---

| | | |
|:---|:---|:---|
|  | **Year Ended December 31,** | **Year Ended December 31,** |
|  | **2025** | **2024** |
| Audit Fees<sup>(1)</sup> | $2318847 | $2292640 |
| Audit Related Fees<sup>(2)</sup> | 12500 | 12000 |
| Tax Fees<sup>(3)</sup> |  |  |
| All Other Fees<sup>(4)</sup> | 4890 | 4890 |
| Total Fees | $2336237 | $2309530 |

---

(1)Audit Fees paid to Deloitte & Touche LLP for 2025 and 2024 were for professional services associated with the annual audit of our

consolidated financial statements, the reviews of our quarterly consolidated financial statements, and the issuance of consents and

comfort letters in connection with registration statement filings with the SEC or for debt issuances.

(2)Audit-Related Fees consist of fees billed for assurance and related services that are reasonably related to the performance of the

audit or review of our consolidated financial statements and are not reported under "Audit Fees." Fees include review of a

subsidiary's financial statements for regulatory reporting purposes.

(3)Tax Fees consist of fees for tax compliance, tax advice, and tax planning. No such services were provided by Deloitte & Touche LLP

in either period.

(4)All Other Fees include any fees billed that are not audit, audit-related, or tax fees, which for 2025 and 2024 were for accounting

research subscription fees.

Audit Committee Pre-Approval Policies and Procedures

Before Deloitte & Touche LLP is engaged by the Company to render audit or non-audit services, our Audit Committee must

review the terms of the proposed engagement and pre-approve the engagement. It is also the policy of the Audit Committee

to pre-approve fees for all audit and permitted non-audit and tax services to be provided by the independent registered

accountant, to review pre-approved fees quarterly, and establish other necessary procedures. Audit Committee pre-approval

of non-audit services (other than review and attest services) are not required if those services fall within available exceptions

established by the SEC. The Audit Committee may delegate authority to one or more of the members of the Audit

Committee to provide these pre-approvals for audit or non-audit services, provided that the person or persons to whom

authority is delegated must report the pre-approvals to the full Audit Committee at its next scheduled meeting.

The Audit Committee pre-approved all audit, audit-related, tax, and other services provided by Deloitte & Touche LLP for the

years 2025 and 2024.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **27** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **27** |

---

Vote Required

The affirmative vote of the majority of the voting power of the capital stock present or represented by proxy at the virtual

Annual Meeting and entitled to vote thereon is required for ratification. Votes to "Abstain" are treated as cast "Against"

Proposal 2.

Holders of proxies solicited by this Proxy Statement will vote the proxies received by them as directed on the Proxy Card or,

if no direction is given, then FOR the ratification of the appointment of Deloitte & Touche LLP as the Company's independent

registered public accounting firm.

---

| | |
|:---|:---|
| ![14.jpg](ryan-20260317_g22.jpg) | **The Audit Committee and the Board recommend a vote "FOR" the ratification of Deloitte & Touche LLP** <br>**as the Company's independent registered public accounting firm.**<br>|

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **28** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **28** |

---

**AUDIT COMMITTEE REPORT** 

The Audit Committee is composed of five independent directors (as defined by the NYSE listing standards). Our Audit

Committee operates under a written charter, which is posted on our website at ir.ryanspecialty.com. As provided in the

charter, the Audit Committee's oversight responsibilities include monitoring the integrity of our financial statements (including

reviewing financial information, the systems of internal controls, the audit process, and the independence and performance

of our internal audit function and independent registered public accounting firm) and our compliance with legal and

regulatory requirements. However, management has the primary responsibility for the financial statements and the reporting

process, including our systems of internal controls. In fulfilling its oversight responsibilities, the Audit Committee:

• reviewed and discussed the audited financial statements for the year ended December 31, 2025, with our

management;

• discussed with our independent auditors, Deloitte & Touche LLP, the matters required to be discussed by the

applicable requirements of the Public Company Accounting Oversight Board ("PCAOB") and the SEC; and

• received the written disclosures and the letter from Deloitte & Touche LLP required by applicable requirements of

the PCAOB regarding Deloitte & Touche LLP's communications with the Audit Committee concerning

independence and has discussed with Deloitte & Touche LLP its independence.

Based on the Audit Committee's review and discussions noted above, the Audit Committee recommended to the Board that

the audited financial statements be included in our Annual Report on Form 10-K for the year ended December 31, 2025.

Respectfully submitted by:

David P. Bolger (Chair)

Henry S. Bienen

Michelle L. Collins

Francesca Cornelli

Anthony J. Kuczinski

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **29** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **29** |

---

**PROPOSAL NO. 3: ADVISORY (NON-BINDING) VOTE ON** 

**NAMED EXECUTIVE OFFICER COMPENSATION** 

Recognizing that executive compensation is an important matter for our stockholders, and in accordance with SEC rules, we

are asking our stockholders to approve an advisory resolution on the compensation of our named executive officers

("NEOs") as disclosed in this Proxy Statement. At our 2022 annual meeting, a majority of stockholders voted, consistent with

the recommendation of the Board, to hold a stockholder vote annually on an advisory resolution to approve the

compensation of our NEOs. The annual vote will continue until the next required vote on the frequency of stockholder votes

on the compensation of our NEOs as required pursuant to Section 14(A) of the Exchange Act and the rules and regulations

promulgated thereunder, which we expect will take place at our 2028 annual meeting of stockholders.

This proposal, commonly known as a "say-on-pay" proposal, is not intended to address any specific item of compensation,

but rather the overall compensation of our NEOs and our executive compensation philosophy, policies, and practices as

described in this Proxy Statement. Although the voting results are not binding, the Board and the Compensation and

Governance Committee will take into account the results of the vote when considering future executive compensation

arrangements.

We encourage our stockholders to read the Compensation Discussion and Analysis, which immediately follows this

proposal. The Compensation Discussion and Analysis describes in more detail our executive compensation program and

related policies and practices and explains the decisions the Compensation and Governance Committee has made under

this program and the factors considered in making those decisions. We also encourage our stockholders to review the 2025

Summary Compensation Table elsewhere in this Proxy Statement and other related compensation tables and narratives,

which provide detailed information on the compensation of our NEOs.

Therefore, in accordance with Section 14A of the Exchange Act and as a matter of good corporate governance, we are

asking stockholders to approve the following advisory resolution at the Annual Meeting:

RESOLVED, that the stockholders of the Company approve, on an advisory basis, the compensation of the

Company's named executive officers as disclosed in the Compensation Discussion and Analysis and the tabular

disclosure regarding each named executive officer's compensation (together with the accompanying narrative

disclosure) in this Proxy Statement, as disclosed pursuant to Item 402 of Regulation S-K, for the 2026 Annual

Meeting of Stockholders.

Vote Required

The affirmative vote of the majority of the voting power of capital stock present or represented by proxy at the virtual Annual

Meeting and entitled to vote thereon is required for approval of the advisory (non-binding) resolution. Votes to "Abstain" are

treated as cast "Against" this proposal and broker non-votes will have no effect on the vote for this proposal.

Holders of proxies solicited by this Proxy Statement will vote the proxies received by them as directed on the Proxy Card or,

if no direction is given, then FOR the advisory (non-binding) resolution to approve the compensation of the Company's

NEOs as described in this Proxy Statement pursuant to the compensation disclosure rules of the SEC.

---

| | |
|:---|:---|
| ![14.jpg](ryan-20260317_g22.jpg) | **The Board recommends a vote "FOR" the advisory (non-binding) resolution to approve the** <br>**compensation of the Company's NEOs, described in this Proxy Statement pursuant to the** <br>**compensation disclosure rules of the SEC.**<br>|

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **30** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **30** |

---

**EXECUTIVE COMPENSATION:** 

**COMPENSATION DISCUSSION AND ANALYSIS** 

This Compensation Discussion and Analysis ("CD&A") describes our compensation philosophy and provides an overview

analysis of (i) our 2025 compensation programs and policies for our NEOs; (ii) the material compensation decisions made by

the Compensation and Governance Committee of our Board under those programs and policies as reflected in the executive

compensation tables that appear following this CD&A; and (iii) the material factors that the Compensation and Governance

Committee considered and the process it utilized in making those decisions.

Our Named Executive Officers

Our 2025 Named Executive Officers ("NEOs"), as defined under applicable SEC rules, are:

• Patrick G. Ryan (Executive Chairman of the Board)

• Timothy W. Turner (Chief Executive Officer)

• Janice M. Hamilton (Chief Financial Officer)

• Stephen P. Keogh (Co-President and Chief Operating Officer)

• Benjamin M. Wuller (CEO, Ryan Specialty Underwriting Managers)

• Jeremiah R. Bickham (former President)

Summary of Our Executive Compensation Practices

We developed and maintain a comprehensive compensation and governance framework that we believe is aligned with

market practices and standards.

**What We Do:** 

---

| | |
|:---|:---|
| ✔ | Annual "say-on-pay" vote (as recommended by the Board and management).  |
| ✔ | Independent compensation consultant selected, engaged, and overseen by the Compensation and Governance <br>Committee. <br>|
| ✔ | A substantial majority of total compensation for executives tied to performance.  |
| ✔ | Clawback policy in place in case of an accounting restatement. |
| ✔ | Compensation and Governance Committee oversight of risks associated with compensation policies and practices.  |
| ✔ | Long-term incentive program with long-term vesting schedules. |
| ✔ | Stock ownership guidelines to align interests of executives with our stockholders. |
| ✔ | Majority of executive compensation delivered in the form of long-term incentives. |
| ✔ | Compensation and Governance Committee consists only of independent Board members. |

---

**What We Don't Do:** 

**x** No backdating of share options and no option repricing without stockholder approval. 

**x** No excise tax gross-ups. 

**x** No guaranteed annual incentive payouts without regard to performance.

**x** No pledging (absent Board approval) or hedging of Company stock by directors, executive officers, or employees. 

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **31** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **31** |

---

Compensation Philosophy

Our compensation philosophy is focused on the following objectives:

---

| | |
|:---|:---|
| **Objective** | **How we accomplish this objective** |
| **Alignment with Stockholders** | •Annual short-term cash incentive program tied to key business objectives, which <br>objectives lead to long-term stockholder value creation<br>•Long-term incentives vest over multiple years and reward sustained stockholder <br>value creation<br>•IPO awards are subject to lock-up provisions<br>|
| **Attract and Retain** | •Competitive compensation for executives is based upon job responsibilities, <br>experience, individual performance, and comparisons to the market<br>|
| **Pay for Performance** | •Majority of executive compensation is delivered in the form of variable, at-risk <br>compensation<br>•Annual incentive plan payouts are determined based on financial performance<br>•The Compensation and Governance Committee establishes rigorous targets for the <br>annual incentive plan<br>•Long-term incentives are delivered in the form of performance-based awards, stock <br>options or restricted equity grants, which reward participants for increasing the stock <br>price and directly align executives to the stockholder experience<br>|
| **Sound Risk Management** | •Conduct an annual risk assessment of our executive compensation programs<br>•Compensation and Governance Committee is made up of independent directors and <br>retains an independent compensation consultant<br>•Incorporate a variety of corporate governance and compensation best practices<br>|

---

Our Executive Compensation Program in Detail

*Our Pay Philosophy* 

**Base Salary** 

We strive to be the employer of choice for the top-talent in our industry and our goal is to always hire top-tier talent

throughout our Company, including our executive officers. As a result, our Compensation and Governance Committee sets

base salary for executives above the median of the compensation landscape. In line with the Compensation and

Governance Committee's compensation philosophy, exceptional performance by executive officers is generally rewarded

through short-term incentive ("STI") and/or long-term incentive ("LTI") awards and not through base salaries. Adjustments to

base salaries are made by the Compensation and Governance Committee to reflect changes in responsibilities or when

competitive market or internal conditions warrant.

The following table sets forth the base salary for each of our NEOs for 2025 as approved by the Compensation and

Governance Committee.

---

| | |
|:---|:---|
| **Named Executive Officer** | **2025**<br>**Base Salary**<br>|
| Patrick G. Ryan | $1200000 |
| Timothy W. Turner | 1500000 |
| Janice M. Hamilton | 600000 |
| Stephen P Keogh | 600000 |
| Benjamin M. Wuller | 850000 |
| Jeremiah R. Bickham | 850000 |

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **32** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **32** |

---

The Compensation and Governance Committee reviewed each NEO's base salary in January 2026. They considered the

new positions and responsibilities of certain of our NEOs and compared their current compensation with our peer group.

Based on our philosophy of targeting base salary at or above the 75<sup>th</sup> percentile when compared to the members of our peer

group, the Compensation and Governance Committee approved the following compensation changes to be effective in

March 2026: Ms. Hamilton - $750,000 and Mr. Keogh - $725,000. The base salaries for Messrs. Ryan, Turner, and Wuller

were not increased (or otherwise adjusted) from 2025 to 2026.

**Short-Term Incentive Compensation** 

STI awards are an integral component of our NEOs' total compensation and are based on our financial results and individual

performance. They are intended to deliver exceptional pay for exceptional performance and provide a well-timed link

between recent performance and individual compensation.

Each NEO is eligible to receive an annual STI award expressed as a percentage of their base salary. STI targets for the

Company's executive officers were established by the Compensation and Governance Committee in early 2025 following a

thorough evaluation of our executive officers' total compensation and market practices.

---

| | |
|:---|:---|
| **Named Executive Officer** | **2025**<br>**Bonus**<br>**Target %**<br>|
| Patrick G. Ryan | 200% |
| Timothy W. Turner | 200% |
| Janice M. Hamilton | 200% |
| Stephen P. Keogh | 150% |
| Benjamin M. Wuller | 200% |
| Jeremiah R. Bickham | 200% |

---

***The 2025 Executive Incentive Corporate Plan***

In early 2025, the Compensation and Governance Committee determined that the actual amount of the 2025 bonuses

payable to those NEOs on our Executive Incentive Corporate Plan, which include all of our NEOs other than Mr. Wuller,

would be determined based on the following criteria, which include both Company-based performance metrics and

individual, merit-based achievement:

---

| | |
|:---|:---|
| **Metric** | **Percent** <br>**of Bonus**<br>|
| Organic Revenue Growth Rate | 35% |
| Adjusted EBITDAC Margin | 35% |
| Individual Merit-Based Achievement | 30% |

---

For the Organic Revenue Growth Rate metric, payment was based on the following scale:

---

| | |
|:---|:---|
| **Organic Revenue Growth Rate** | **Target** <br>**Payout %**<br>|
| <10% | 0% |
| 13 - 15% | 100% |
| >18% | 150% |

---

Target payout percentage for Organic Revenue Growth Rate between the benchmarks set forth above was determined

based on a graduated basis.

Organic Revenue Growth Rate is calculated as the percentage change in Net commissions and fees, as compared to the

same period for the prior year, adjusted to eliminate revenue attributable to acquisitions for the first twelve months of

ownership, revenue attributable to sold businesses for the subsequent twelve months after a sale, and other items such as

contingent commissions and the impact of changes in foreign exchange rates. Please see "*Management's Discussion and* 

*Analysis of Financial Condition and Results of Operations - Non-GAAP Financial Measures and Key Performance Indicators* 

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **33** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **33** |

---

*- Organic Revenue Growth Rate*" in our Annual Report on Form 10-K for the year ended December 31, 2025, for additional

information about our method of calculation for Organic Revenue Growth Rate.

For the Adjusted EBITDAC Margin metric, payment was based on the following scale:

---

| | |
|:---|:---|
| **Adjusted EBITDAC Margin** | **Target**<br>**Payout%**<br>|
| <33.25% | 0% |
| 33.50 - 33.70% | 100% |
| >34.20% | 150% |

---

Target payout percentage for Adjusted EBITDAC Margin between the benchmarks set forth above was determined based on

a graduated basis. Adjusted EBITDAC Margin is calculated by taking our Adjusted EBITDAC as a percentage of our Total

revenue. Adjusted EBITDAC, for the purposes of Short-Term Incentive Compensation, is calculated by taking our Net

income before Interest expense, net, Income tax expense, Depreciation, Amortization, and Change in contingent

consideration, adjusted to reflect items such as (i) equity-based compensation, (ii) acquisition and restructuring related

expenses, (iii) exclusion of the results of unplanned M&A completed in 2025 as the targets were set prior to the M&A being

completed, (iv) exclusion of the impact of any higher (or lower) than target discretionary incentive accruals, and (v) other

exceptional or non-recurring items, as applicable. Please see "*Management's Discussion and Analysis of Financial* 

*Condition and Results of Operations - Non-GAAP Financial Measures and Key Performance Indicators - Adjusted EBITDAC* 

*Margin*" in our Annual Report on Form 10-K for the year ended December 31, 2025, for additional information about our

method of calculation for Adjusted EBITDAC Margin.

Individual Merit-Based achievement is linked to an individual's contribution towards (i) culture, (ii) results, (iii) client centricity,

(iv) teamwork, and (v) inclusion.

***The 2025 Executive Incentive Business Unit Plan***

In early 2025, the Compensation and Governance Committee determined that the actual amount of the 2025 bonus payable

to Mr. Wuller pursuant to the Executive Incentive Business Unit Plan would be determined based on the following criteria,

which include both Company based performance metrics, business unit based performance metrics, and individual merit-

based achievement:

---

| | |
|:---|:---|
| **Metric** | **Percent** <br>**of Bonus**<br>|
| Organic Revenue Growth Rate | 15% |
| Adjusted EBITDAC Margin | 15% |
| Business Unit Organic Revenue Growth Rate | 20% |
| Business Unit Adjusted Expense Margin | 20% |
| Individual Merit-Based Achievement | 30% |

---

The Organic Revenue Growth Rate and the Adjusted EBITDAC Margin metrics and applicable targets are the same as

described above for the Executive Incentive Corporate Plan.

For the Business Unit Organic Revenue Growth Rate metric, payment was based on the following scale:

---

| | |
|:---|:---|
| **Business Unit Revenue Growth Rate** | **Target** <br>**Payout %**<br>|
| <5% | 0% |
| 10 - 12% | 100% |
| >16% | 150% |

---

Target payout percentage for Business Unit Organic Revenue Growth Rate between the benchmarks set forth above was

determined based on a graduated basis. Business Unit Organic Revenue Growth Rate is an organic revenue growth

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **34** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **34** |

---

calculation undertaken on the same basis as Consolidated Organic Revenue Growth Rate but limited to the Net commission

and fees generated by a select number of operating MGUs and Programs.

For the Business Unit Adjusted Expense Margin metric, payment was based on the following scale:

---

| | |
|:---|:---|
| **Business Unit Adjusted Expense Margin** | **Target**<br>**Payout%**<br>|
| >51.89% | 0% |
| 50.07 - 50.57% | 100% |
| <49.07% | 150% |

---

Target payout percentage for Business Unit Adjusted Expense Margin between the benchmarks set forth above was

determined based on a graduated basis. Business Unit Adjusted Expense Margin is the operating expense of a select

number of operating MGUs and Programs divided by the revenue generated by those MGUs and Programs adjusted for the

same items outlined in the Adjusted EBITDAC Margin definition, as well as the exclusion of revenue and expense from

investments and acquisitions, allocated expense, and foreign exchange expense.

Individual Merit-Based Achievement is linked to an individual's contribution towards (i) culture, (ii) results, (iii) client centricity,

(iv) teamwork, and (v) inclusion.

***2025 Bonus Determination***

Organic Revenue Growth Rate for 2025 was 10.1%, resulting in an STI award of 3.3% of target for both plans. Adjusted

EBITDAC Margin, based on compensation amounts accrued throughout the year at target, was 30.97%, resulting in an STI

award of 0% of target for both plans. The Business Unit Organic Revenue Growth Rate for 2025 was 9.30%, resulting in an

STI award of 86.0% of target. The Business Unit Adjusted Expense Margin was 54.80%, resulting in an STI award of 0% of

target.

The Compensation and Governance Committee, in reviewing the Merit-Based Achievement component of each NEO's STI

award, relied on input from Messrs. Ryan and Turner for each NEO other than Messrs. Ryan and Turner. For each of the

NEOs other than Messrs. Ryan and Turner, the Compensation and Governance Committee determined that based on each

NEO's contribution to the Company's achievement, the Individual Merit-Based Achievement component of each such NEO's

STI award for 2025 would be 100% of target, with the primary contributing factor of such determination being the individual

contributions that each NEO provided to the Company's successes in 2025. As a result, the total STI award for each of our

NEOs on our Executive Incentive Corporate Plan for 2025 was approximately 31.2% of target and the total STI award for Mr.

Wuller, who is on the Executive Incentive Business Unit Plan, was approximately 47.7% of target.

The Compensation and Governance Committee, after due consideration and input from Messrs. Ryan and Turner that their

bonuses would be better used to provide additional funds to increase bonuses for the Company's bonus-eligible non-

executive employees who delivered exceptional performance, accepted Messrs. Ryan's and Turner's voluntary proposal to

forgo 2025 STI and, exercising its negative discretion, awarded each of Messrs. Ryan and Turner 0% of target.

The following table sets forth the STI award payments earned by each of our NEOs in 2025.

---

| | |
|:---|:---|
| **Named Executive Officer** | **2025**<br>**Bonus**<br>**Payment**<br>|
| Patrick G. Ryan | $— |
| Timothy W. Turner |  |
| Janice M. Hamilton | 374000 |
| Stephen P. Keogh<sup>(1)</sup> | 187000 |
| Benjamin M. Wuller | 810900 |
| Jeremiah R. Bickham<sup>(2)</sup> | 407899 |

---

<sup>(1)</sup> Stephen P. Keogh began his employment on May 1, 2025, and his bonus amount has been prorated for the year based on the number

of days employed.

<sup>(2)</sup> Jeremiah R. Bickham separated from the Company on October 8, 2025, and his bonus amount has been prorated for the year based on

the number of days employed.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **35** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **35** |

---

***2026 STI Compensation Plans and Bonus Target Percentages***

The target bonus percentages for all NEOs remain the same in 2026 as they were in 2025. For all NEOs, other than Mr.

Wuller, STI compensation for 2026 will be determined based on the Company achieving predetermined metrics for Organic

Revenue Growth Rate and Adjusted EBITDAC Margin, as well as the Individual Merit-Based Achievement component as

determined by the Compensation and Governance Committee. Mr. Wuller's STI compensation for 2026 will be determined

based on the Company achieving predetermined metrics for Organic Revenue Growth Rate, Adjusted EBITDAC Margin,

Business Unit Organic Revenue Growth Rate, and Business Unit Adjusted Expense Margin, as well as the Individual Merit-

Based Achievement component as determined by the Compensation and Governance Committee.

**Long-Term Incentive Compensation** 

All equity holdings in Ryan Specialty, LLC were converted to equity in a new holding company, New Ryan Specialty, LLC

("New LLC"), that was formed as a Delaware limited liability company on April 20, 2021, for the purpose of becoming an

intermediate holding company between Ryan Specialty Holdings, Inc., and Ryan Specialty, LLC. On September 30, 2021,

the equity interest holders of Ryan Specialty, LLC exchanged equity interests in Ryan Specialty, LLC for LLC Common Units

(as defined below) in New LLC. All new incentive equity relating to LLC Common Units granted after September 30, 2021,

will be issued in New LLC. As Ryan Specialty, LLC is substantively the same as New LLC, as previously noted, for the

purpose of this document we will refer to both New LLC and Ryan Specialty, LLC as the "LLC".

Our publicly traded stock differentiates Ryan Specialty from most of our competition by providing us with a unique currency

to attract and retain talent. We believe that our executive officers, including our NEOs, should have a significant equity stake

in the Company to incentivize performance, align their interest with one another and our stockholders, and facilitate

retention. Many of our executive officers held significant equity in the Company prior to our IPO. Due to the change in our

structure made in connection with the IPO, all vested and unvested incentive equity outstanding prior to the IPO was

exchanged for new units at the IPO as described herein. The equity received in exchange for existing equity was on

substantially the same terms and conditions (including vesting terms) as the pre-IPO equity. We further used the IPO as an

opportunity to provide significant new "staking grants" to some of our executive officers in order to bring them on par with

their similarly situated colleagues. The staking grants vest over five or ten year periods, depending on the nature of the grant

and the particular circumstances of each recipient. As the current equity grants vest over time, we will need to consider ad

hoc grants and an annual grant program for executive officers in order to maintain our objectives. The outstanding LTI

awards currently held by our NEOs consist of (i) LLC Common Units (as defined below), (ii) Class C Units (as defined

below), (iii) RLUs (as defined below), and (iv) PLUs and PSUs (each, as defined below).

***Common Units***

Prior to our IPO, some of our NEOs held awards of common units pursuant to the Limited Liability Company Agreement of

Ryan Specialty, LLC (the "Original Units"). The Original Units were profits interests that represented actual voting equity

interests meant to enable certain employees to share in our financial success after our preferred unitholders received a

certain level of return on their investment. The Original Units entitled unitholders to a percentage of future distributions, but

only after all preferred unitholders had received cumulative cash distributions of a certain multiple return and only to the

extent that distributions exceeded the return threshold associated with such Original Units.

The Original Units were subject to time-based vesting and generally vested in five equal annual installments beginning on

the first anniversary of the date of grant, subject to the NEO's continued employment with us through each vesting date.

In connection with the IPO, the Original Units were converted into non-voting common units in the LLC ("LLC Common

Units"), subject to the same vesting and forfeiture provisions as the Original Units. Vested LLC Common Units are

exchangeable into Class A common stock at the election of the holder, provided that the Company may elect (determined by

a majority of the Company's disinterested directors) to deliver cash in lieu of stock only to the extent that the Company has

received cash proceeds pursuant to a secondary offering. Each holder of LLC Common Units also holds one share of Class

B common stock for each LLC Common Unit they hold.

***Class C Common Incentive Units***

Certain of our NEOs hold Class C Common Incentive Units in the LLC ("Class C Units"), which are profits interests that

entitle the holder to a percentage of future distributions of the LLC, but only after a specified return threshold is met.

Certain of these Class C Units were granted in connection with the conversion of the Original Units into LLC Common Units

(such Class C Units, the "Reload Class C Units") and were intended to ameliorate the recipients' otherwise reduced

percentage of future value accretion following the conversion of their "appreciation only" Original Units into a smaller number

of "full value" LLC Common Units. The Reload Class C Units are subject to time-based vesting, and vest either 1/3 on each

of the third, fourth, and fifth anniversaries of the IPO or 100% on the third anniversary of the IPO, in each case subject to the

NEO's continued employment through each vesting date (other than for those exceptions provided in the award agreement).

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **36** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **36** |

---

Other Class C Units were granted as new awards to certain NEOs in connection with the IPO (the "Staking Class C Units")

and are intended to reward future performance. The Staking Class C Units are subject to time vesting and vest 10% on each

of the third through ninth anniversaries of the IPO, with the final 30% vesting on the tenth anniversary of the IPO, in each

case, subject to the NEO's continued employment through each vesting date (other than for those exceptions provided in

the award agreement). In 2023, we granted a new award to Mr. Wuller (the "2023 Class C Units") and such award is

intended to reward future performance. The 2023 Class C Units are subject to time vesting and vest 20% on April 1, 2026,

2027, 2028, 2029 and 2030 in each case, subject to continued employment through each vesting date (other than for those

exceptions provided in the award agreement).

Vested Class C Units (Reload Class C Units, Staking Class C Units and 2023 Class C Units) are exchangeable into a

number of shares of Class A common stock of equivalent economic value at the election of the holder, provided that the

Company may elect (as determined by a majority of the Company's disinterested directors) to deliver cash in lieu of stock

only to the extent that the Company has received cash proceeds pursuant to a secondary offering.

***Restricted LLC Units***

Awards of Restricted LLC Units ("RLUs") were granted as new awards to certain NEOs in connection with the IPO (the

"Staking RLUs") and are intended to reward future performance. The Staking RLUs are subject to time vesting and vest 10%

on each of the third through ninth anniversaries of the IPO, with the final 30% vesting on the tenth anniversary of the IPO, in

each case, subject to the NEO's continued employment through each vesting date (other than for those exceptions provided

in the award agreement). In 2022, each of the NEOs, other than Messrs. Ryan and Keogh, received a grant of RLUs (the

"2022 RLUs") in recognition of the exceptional performance achieved by the Company in 2021. Each 2022 RLU represents

the right to receive one LLC Common Unit upon vesting of the RLU. The 2022 RLUs vested in equal installments on April 1,

2023, 2024 and 2025, in each case subject to the NEO's continued employment through each vesting date (other than for

those exceptions provided in the award agreement).

***Performance LLC Units and Performance Stock Units***

In March 2024, each of the NEOs, other than Mr. Ryan, Ms. Hamilton, and Mr. Keogh, received a grant of long-term

performance-based awards which vest either into LLC Common Units ("PLUs") or shares of Class A common stock ("2024

PSUs"). Ms. Hamilton received a grant of 2024 PSUs on the same terms in November 2024, shortly after her promotion to

CFO. These awards are intended to align the recipients' compensation with Company performance and our key financial

metrics, promoting leadership goal continuity and retention, and driving shareholder value. Each PLU or 2024 PSU

represents the right to receive one LLC Common Unit or one share of Class A common stock upon vesting, respectively. The

PLUs and 2024 PSUs vest on April 1, 2029 (the "Certification Date") upon, and subject to, the attainment of certain

performance-based targets and subject to the NEO's continued employment through January 1, 2029 (other than for those

exceptions provided in the award agreement). The performance-based metrics that must be met are as follows: (i)

achievement of an Adjusted EBITDAC Margin Target by 2027 and maintained through 2028, (ii) achievement of a four-year

Organic Revenue Growth Compound Annual Growth Rate ("CAGR") target from 2024 through 2027, and (iii) stock price

CAGR targets measured from the closing stock price on February 29, 2024 of the Class A common stock to the average of

(a) the volume weighted average price ("VWAP") of the Class A common stock for the fourth quarter of 2027 and (b) the

VWAP of the Class A common stock for the first quarter of 2028. Both the Adjusted EBITDAC Margin and the Organic

Revenue Growth CAGR targets must be met for the awards to vest. The stock price CAGR targets will determine how many

LLC Common Units the PLUs vest into and how many shares of Class A common stock the 2024 PSUs vest into. If the

Adjusted EBITDAC Margin and the Organic Revenue Growth CAGR targets have been met, then at the threshold stock

price CAGR, the PLUs and 2024 PSUs will vest into 75% of the LLC Common Units or Class A common stock subject to the

award; at the target stock price CAGR the PLUs and 2024 PSUs will vest into 100% of the LLC Common Units or Class A

common stock subject to the award; and at the Maximum stock price CAGR, the PLUs and 2024 PSUs will vest into 150%

of the LLC Common Units or Class A common stock subject to the award. If the actual stock price CAGR is below the

threshold amount, the PLUs and 2024 PSUs will be forfeited. Payout percentage based on a stock price CAGR between the

benchmarks discussed above will be determined based on a graduated basis.

Mr. Keogh received a performance-based award in May 2025, shortly after he joined the Company ("2025 PSUs" and

together with the 2024 PSUs, the "PSUs"). Similar to the 2024 PSUs, the 2025 PSUs are intended to align the recipient's

compensation with Company performance and certain of our key financial metrics, promoting leadership goal continuity and

retention, and driving shareholder value. Each 2025 PSU represents the right to receive one share of Class A common stock

upon vesting. The 2025 PSUs vest on April 1, 2030 (the "Vesting Date") upon, and subject to, the attainment of certain

performance-based targets and subject to the NEO's continued employment through the Vesting Date (other than for those

exceptions provided in the award agreement). The performance-based metrics that must be met are as follows: (i)

achievement of a five-year Organic Revenue Growth CAGR target from 2025 through 2029 and (ii) stock price CAGR

targets measured from the closing stock price on March 4, 2025 of the Class A common stock to the VWAP of the Class A

common stock for the fourth quarter of 2029. The Organic Revenue Growth CAGR target must be met for the award to vest.

The stock price CAGR targets will determine how many shares of Class A common stock the 2025 PSUs vest into. If the

Organic Revenue Growth CAGR target has been met, then at the threshold stock price CAGR, the 2025 PSUs will vest into

75% of the Class A common stock subject to the award; at the target stock price CAGR, the 2025 PSUs will vest into 100%

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **37** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **37** |

---

of the Class A common stock subject to the award; and at the maximum stock price CAGR, the 2025 PSUs will vest into

150% of the Class A common stock subject to the award. If the actual stock price CAGR is below the threshold amount, the

2025 PSUs will be forfeited. Payout percentage based on a stock price CAGR between the benchmarks discussed above

will be determined based on a graduated basis.

***Treatment of Long-Term Incentive Awards Upon a Termination of Employment***

For LTI awards issued in conjunction with the IPO (LLC Common Units, Staking Class C Units, Reload Class C Units and

Staking RLUs), if an NEO's employment is terminated (i) by us without "Cause," (ii) due to the NEO's death or disability, or

(iii) the NEO retires in good standing (as determined by the Board) after reaching the age of 65 (a "Qualified Retirement"),

and, in each case, subject to the NEO's continued compliance with the restrictive covenants set forth in the applicable grant

agreement, the unvested LLC Common Units, Reload Class C Units, and Staking Class C Units held by the NEO will

continue to vest as if the NEO remained employed with us through each vesting date and the Staking RLUs will accelerate.

Upon any other termination of employment, any unvested LLC Common Units, Staking Class C Units, Reload Class C Units,

and Staking RLUs will be forfeited.

For the RLUs granted post-IPO, the award agreements provide that (i) in the event an NEO's employment with us is

terminated by us without "Cause," then the portion of RLUs eligible to vest on the next vesting date following the termination

will immediately vest and (ii) in the event of an NEO's death or disability, vesting of all unvested RLUs will fully accelerate.

The concept of a Qualified Retirement has been eliminated from the RLU grant agreements and upon any other termination

of employment, the RLUs will be forfeited.

For the 2023 Class C Units, the award agreements provide that (i) in the event the NEO's employment with us is terminated

by us without "Cause," then the portion of 2023 Class C Units eligible to vest on the next vesting date following the

termination will continue to vest as if the NEO remained employed with us through such next vesting date and (ii) in the

event of the NEO's death or disability, then all of the unvested 2023 Class C Units will continue to vest as if the NEO

remained employed with us through each vesting date. The concept of a Qualified Retirement has been eliminated from the

grant agreements for the 2023 Class C Units and upon any other termination of employment, any unvested 2023 Class C

Units will be forfeited.

For the PLUs or PSUs, the award agreements provide that (i) in the event an NEO's employment with us is terminated by us

without "Cause," then the PLUs or PSUs will remain outstanding and eligible to vest on the Certification Date or Vesting Date

in accordance with the performance-based metrics described above, but the number of PLUs or PSUs earned will be pro-

rated based on the applicable date of termination and (ii) in the event of an NEO's death or disability, a number of PLUs or

PSUs equal to the actual number of PLUs or PSUs earned as of the date of termination will vest in accordance with the

performance metrics described above generally based on actual performance (with the applicable performance period

deemed to have ended as of the date of termination, and for the PLUs and 2024 PSUs, the Adjusted EBITDAC Margin

Targets deemed achieved as of the date of termination).

Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to

the Release of Material Nonpublic Information

The Company grants awards of stock options and Class C Units, which are profits interests that entitle the holder to a

percentage of future distributions of the LLC, but only after a specified return threshold is met. Even though the Class C

Units do not require the payment of an exercise price, they are most similar economically to stock options and are generally

categorized as an instrument with an "option-like feature." While the Company does not have a written policy regarding its

equity grants, it is the Company's practice to make grants no more than once per quarter and for each quarterly grant of

equity to be effective on the third business day following the announcement of earnings for that quarter or as soon thereafter

as is reasonably practicable under the circumstances.

Neither the Board nor the Compensation and Governance Committee seeks to time equity grants to take advantage of

information, either positive or negative, about our Company that has not been publicly disclosed. During the year ended

December 31, 2025, we did not award any stock options or Class C Units to our NEOs.

Stock Ownership Guidelines

The Board adopted stock ownership guidelines that apply to all of our executive officers. The guidelines require our Chief

Executive Officer to accumulate Company stock with a value equivalent to six times their annual base salary and all other

executive officers are required to accumulate Company stock with a value equivalent to four times their annual base salary,

all within five years of the adoption of the requirement or within five years of being appointed as an executive officer of the

Company. If an executive officer becomes subject to a greater stock ownership requirement due to promotion, such person

is expected to meet the higher stock ownership requirement within 5 years after first becoming subject to the guidelines or

within 3 years after first becoming subject to the greater stock ownership requirement, whichever is longer. If an executive

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **38** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **38** |

---

officer does not hold sufficient shares of the Company's stock to meet the guideline requirements, they will then be required

to hold 100% of their current Company stock plus any future grants until they have met the requirement. Compliance with

the stock ownership requirements is measured annually and calculated on the last trading day of each calendar year, based

on the closing price of the Company's stock on such trading day.

For purposes of determining compliance with stock ownership requirements, the following forms of equity interests in the

Company, whether vested or unvested, are considered:

• Class A common stock owned directly or beneficially by the individual or his or her immediate family members;

• Restricted shares of Class A common stock, including shares granted but not vested;

• Class A common stock issuable upon the net after-tax settlement of RSUs;

• Class A common stock issuable upon the exercise of stock options;

• LLC Common Units on an as converted basis with the shares of Class A common stock issuable upon the

exchange of such LLC Common Units;

• Class C Units on an as converted basis with the shares of Class A common stock issuable upon the exchange of

such Class C Units; and

• LLC Common Units issuable upon the net after-tax settlement of any RLUs on an as converted basis with the

shares of Class A common stock issuable upon the exchange of such LLC Common Units.

The guidelines were adopted on June 7, 2022, such that each executive officer serving at that time has until June 7, 2027, to

meet the guidelines. For all other executive officers, the required compliance date is based on the date that such individual

became an executive officer of the Company or received a promotion as an existing executive officer.

Each of our executive officers' respective compliance date is set forth in the table below:

---

| | |
|:---|:---|
| **Executive Officer** | **Stock Ownership** <br>**Guidelines** <br>**Compliance Date**<br>|
| Patrick G. Ryan | June 7, 2027 |
| Timothy W. Turner | October 1, 2027 |
| Brendan M. Mulshine | June 7, 2027 |
| Stephen P. Keogh | May 1, 2030 |
| Janice M. Hamilton | October 1, 2029 |
| Michael L. Conklin | August 14, 2028 |
| Mark S. Katz | June 7, 2027 |
| Benjamin M. Wuller | October 30, 2029 |

---

Each of our executive officers has achieved holdings in excess of the applicable requirement as of December 31, 2025, or is

within the five-year compliance period.

Other Benefits for Named Executive Officers

*Employee Welfare Benefit Plans* 

Our NEOs are eligible to participate in the medical, life insurance, and other welfare benefits available to all other

colleagues. There are no special medical plans or other welfare plans for our NEOs.

*Retirement Benefits* 

We have not maintained, and do not currently maintain, a defined benefit pension plan. We currently make available a

retirement plan intended to provide benefits under Section 401(k) of the Internal Revenue Code, pursuant to which

employees (including our NEOs) may elect to defer a portion of their compensation on a pre-tax or post-tax basis and have it

contributed to the plan. Contributions are allocated to each participant's individual account and are then invested in selected

investment alternatives according to the participant's directions. We have historically matched 50% of elective deferrals up to

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **39** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **39** |

---

a maximum per participant per calendar year. All employee contributions to our 401(k) plan are 100% vested at all times.

Employer contributions vest over three years, such that all employer contributions to our 401(k) plan are fully vested for

employees who remain employed by us for at least three years. All contributions under our 401(k) plan are subject to certain

annual dollar limitations in accordance with applicable laws, which are periodically adjusted for changes in the cost of living.

Matching employer contributions are not guaranteed for any year.

We also sponsor the Ryan Specialty Nonqualified Deferred Compensation Plan (the "Nonqualified Deferred Compensation

Plan"), which allows certain highly compensated employees to defer a portion of their base salary and STI bonus to a later

date pursuant to an advance deferral election. As of December 31, 2025, none of our NEOs have participated in the

Nonqualified Deferred Compensation Plan.

Our LTI awards granted at the IPO provide for continued vesting on their original vesting schedule (or, in the case of RLUs

granted in connection with the IPO, accelerated vesting) in the case of a Qualified Retirement. See "*Long-Term Incentive* 

*Compensation — Treatment of Long-Term Incentive Upon a Termination of Employment*" above for more information.

Severance Plan

The Compensation and Governance Committee believes that severance benefits are a necessary component of a

competitive compensation program because they minimize distraction and ensure continuity during times of uncertainty or

transition, including during a change in control. In certain circumstances, such benefits are consideration for an executive's

agreement not to compete. Set forth below is a summary of the termination arrangements we have with our NEOs. All NEOs

are participants in the Executive Severance Plan (the "Severance Plan") as further described below.

Under the Severance Plan, the Company will provide different benefits depending on whether the severance to be provided

relates to a qualifying termination within six months prior to, or 18 months following, a "Change in Control" (as defined in the

Severance Plan) (a "Change-in-Control Termination") or a termination outside of such time period (a "Non-Change-in-Control

Termination"). For a qualifying termination, our NEOs will be entitled to the following benefits:

---

| | | |
|:---|:---|:---|
|  | **Non-Change-in Control Termination** | **Change-in-Control Termination** |
| Qualifying Termination | Termination without cause or by employee for <br>good reason<br>| Termination without cause or by employee <br>for good reason<br>|
| Cash Severance | Executive Chairman and CEO: 1.5 X Base <br>Salary and Target Bonus<br>All other NEOs: 1.0 X Base Salary and Target <br>Bonus<br>| All NEOs: 2.0 X Base Salary and Target <br>Bonus<br>|
| Pro-Rata Bonus in Year of <br>Termination<br>| Pro-rated and paid at the end of the period <br>based on actual performance<br>| Pro-rated and paid in a lump sum <br>following the qualifying termination based <br>on Target Bonus<br>|
| Equity Award Acceleration | The treatment of unvested equity incentive <br>awards is determined in accordance with the <br>terms of the applicable award agreement<br>| All unvested equity incentive awards that <br>vest solely based on continued <br>employment will accelerate and vest and <br>the treatment of unvested PLUs and <br>PSUs will be determined in accordance <br>with the terms of the applicable award <br>agreement<br>|
| Benefits | Health and welfare benefits will be provided for:<br>•18 Months for the Executive Chairman and <br>CEO<br>•12 Months for all other NEOs<br>| Health and welfare benefits will be <br>provided for:<br>•24 Months for all NEOs<br>|
| Restrictive Covenants | Post-employment non-compete and non-solicit <br>for:<br>•18 Months for the Executive Chairman and <br>CEO<br>•12 Months for all other NEOs<br>| Post-employment non-compete and non-<br>solicit for: <br>•24 Months for all NEOs<br>|

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **40** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **40** |

---

For additional details on payments that may be due to our NEOs in certain termination scenarios, see "*Compensation* 

*Tables — Potential Payments to Named Executive Officers Upon Termination and/or Change of Control.*"

Compensation Decision Process and Methodology

*Role of the Compensation and Governance Committee* 

The Compensation and Governance Committee is responsible for evaluating the compensation levels for each of our NEOs

and for administering the Company's executive compensation program. The Compensation and Governance Committee

reviews and approves all components of executive compensation for our NEOs, including our CEO. In addition, each year

the Compensation and Governance Committee reviews and approves the corporate goals and key objectives related to our

NEOs' compensation, evaluates their performance in light of those goals and objectives, and determines and approves their

compensation, including for our CEO. Each year the Compensation and Governance Committee also reviews, among other

things, proxy season trends and stockholder feedback and the compensation risk assessment. The Compensation and

Governance Committee also reviews talent, culture, and sustainable and responsible business practice initiatives; as well as

its charter and annual calendar.

*Compensation Risk Analysis* 

In reviewing the Company's pay programs, the Compensation and Governance Committee considers whether the programs

encourage unnecessary or excessive risk taking that might have an adverse impact on the Company. At the request of the

committee, the Company's independent compensation consultant, Frederic W. Cook & Co. ("FW Cook"), assisted the

committee in completing the annual compensation risk assessment of the Company's compensation programs. The risk

assessment included a review of the design and features of the Company's incentive compensation programs in place, as

well as an evaluation of program structure and philosophy, design characteristics, performance management, and

governance practices relative to compensation risk factors. The compensation risk assessment resulted in FW Cook and the

Compensation and Governance Committee agreeing that the Company's compensation programs do not create risks that

are reasonably likely to have a material adverse effect on the Company.

*Role of External Compensation and Governance Committee Consultant* 

The Compensation and Governance Committee has the independent authority to hire external consultants, as well as the

sole authority to retain and terminate the services of its consultants. As noted, in 2025 the committee engaged FW Cook as

its independent consultant.

During 2025, FW Cook worked directly under the guidance of the Compensation and Governance Committee, in

cooperation with management, to assist the committee with executing its executive compensation-related responsibilities. In

such role, the Compensation and Governance Committee's consultant served as an objective third-party advisor in

assessing the reasonableness of compensation levels and the appropriateness of the design of the evolving compensation

program structure in supporting the current and future business strategy and human resource objectives. FW Cook attended

three of the five formal meetings of the Compensation and Governance Committee during 2025.

During 2025, FW Cook supported the Compensation and Governance Committee by assisting with the design and

administration of the Company's executive compensation pay practices, including:

• reviewing and providing input on the peer group used to benchmark executive pay;

• assessing the market pay data used to inform 2025 pay decisions;

• providing input on the pay decisions for the Company's executive officers, including pay mix and levels;

• reviewing and providing input on the Company's STI and LTI plan designs;

• preparing the Company's compensation risk assessment;

• reviewing and providing input on the Company's compensation philosophy;

• providing a review and recommendation for non-employee director compensation; and

• keeping the Compensation and Governance Committee informed of changes in the regulatory or governance

environment for executive compensation issues.

The Compensation and Governance Committee was provided compensation market data and analysis from FW Cook. The

committee used that data and analysis to ensure that the compensation practices were consistent with the compensation

philosophy and objectives for both the amount and composition of executive compensation. Based on the data and analysis

provided by FW Cook, as well as information from management and outside counsel, the committee applied business

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **41** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **41** |

---

judgment in recommending and approving compensation awards, taking into account the dynamic nature of the businesses

and the adaptability and response required by senior leadership to manage change.

Other than serving as the consultant to the Compensation and Governance Committee, FW Cook provides no other services

to the Company. The committee determined that, based on the factors specified in the NYSE listing rules, FW Cook's

services produced no conflicts of interest, and it is an independent advisor to the Compensation and Governance

Committee.

*Role of our Executive Chairman, CEO, and Management* 

Our Executive Chairman and CEO do not participate in the Compensation and Governance Committee's determination of

their individual compensation. They do, however, make recommendations to the committee for each of the other NEOs. The

Executive Chairman and CEO base these recommendations on overall Company financial performance for the fiscal year as

described above along with their informed assessment of each NEO's individual performance and contributions. The

Compensation and Governance Committee reviews and considers the Executive Chairman's and CEO's recommendations,

makes adjustments, if any, as it determines appropriate, and approves compensation in its sole discretion.

*Use of Peer Company Data* 

In making its determinations for the year ended December 31, 2025, the Compensation and Governance Committee

considered publicly available information of a select group of peer companies, as well as survey data from the Company's

compensation surveys to inform the pay levels and structures for the Company's executive officers. All compensation data

used was supported by FW Cook as the Compensation and Governance Committee's independent compensation

consultant.

The peer group was selected by the Compensation and Governance Committee, in consultation with FW Cook and input

from management, on the comparability of the business operations of potential peer group companies, including reasonably

comparable size (based on revenue and market capitalization) and industry. Information about the peer group companies

was used to inform decisions regarding pay levels and mix and program design.

For conducting a competitive assessment of the compensation levels for the Company's executives for fiscal year 2025, the

Compensation and Governance Committee approved the below peer group of 15 companies. Argo Group International

Holdings, Ltd. was removed from the list used in 2024 due to merger and acquisition activity involving that company and

BRP Group, Inc. changed its name to Baldwin Insurance Group, Inc. Otherwise the list is unchanged from the prior year.

---

| | |
|:---|:---|
| •Aon PLC<br>•Arthur J. Gallagher & Co.<br>•AXIS Capital Holdings Limited<br>•Baldwin Insurance Group, Inc<br>•Brown & Brown, Inc.<br>•CBIZ, Inc.<br>•Crawford & Co.<br>•Erie Indemnity Company<br>| •Goosehead Insurance, Inc.<br>•Hanover Insurance Group, Inc.<br>•Marsh & McLennan Companies, Inc.<br>•Primerica, Inc.<br>•RLI Corp.<br>•Selective Insurance Group, Inc.<br>•Willis Towers Watson PLC<br>|

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **42** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **42** |

---

**COMPENSATION COMMITTEE REPORT** 

This report is submitted by the Compensation and Governance Committee to the stockholders of Ryan Specialty Holdings,

Inc. The Compensation and Governance Committee consists solely of non-employee directors who are independent, as

determined by the Board in accordance with the Company's guidelines and NYSE listing standards.

The Compensation and Governance Committee has reviewed, and discussed with management, the Compensation

Discussion and Analysis contained in this Proxy Statement, and based on this review and discussion, recommended to the

Board that it be included in this Proxy Statement.

Submitted by the Compensation and Governance Committee of the Board of Directors of Ryan Specialty Holdings, Inc.

Henry S. Bienen (Chair)

Michael G. Bungert

Anthony J. Kuczinski

John W. Rogers, Jr.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **43** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **43** |

---

**EXECUTIVE COMPENSATION:** 

**COMPENSATION TABLES AND DISCLOSURE** 

Summary Compensation Table

The following table sets forth the total compensation earned for services rendered in 2025 by Timothy W. Turner (CEO),

Janice M. Hamilton (CFO), the Company's three other most highly compensated executive officers, and Jeremiah R.

Bickham (former President), collectively our NEOs, for the year ended December 31, 2025.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name and**<br>**Principal Position**<br>| **Year** | **Salary**<br>**($)**<br>| **Bonus**<br>**($)**<br>| **Stock**<br>**Awards**<br>**($)**<sup>(1)</sup><br>| **Option**<br>**Awards**<br>**($)**<br>| **Non-Equity**<br>**Incentive**<br>**Plan**<br>**Compen-**<br>**sation**<br>**($)**<sup>(2)</sup><br>| **All Other**<br>**Compen-**<br>**sation**<br>**($)**<sup>(3)</sup><br>| **Total**<br>**($)**<br>|
| **Patrick G. Ryan** | 2025 | 1233654 |  |  |  |  | 13947 | 1247601 |
| Founder and Executive <br>Chairman of the Board | 2024 | 1375000 |  |  |  | 2597237 | 13014 | 3985251 |
| Founder and Executive <br>Chairman of the Board | 2023 | 1375000 |  |  |  | 2870450 | 11250 | 4256700 |
| **Timothy W. Turner** | 2025 | 1442308 |  |  |  |  | 11750 | 1454058 |
| Chief Executive Officer | 2024 | 1200000 |  | 2470256 |  | 2266679 | 11500 | 5948435 |
| Chief Executive Officer | 2023 | 1200000 | 194880 |  |  | 2505120 | 47529 | 3947529 |
| **Janice M. Hamilton** | 2025 | 600000 |  |  |  | 374000 | 11750 | 985750 |
| Chief Financial Officer | 2024 | 429845 | 850005 | 2756259 |  |  | 12940 | 4049049 |
| Chief Financial Officer |  |  |  |  |  |  |  |  |
| **Stephen P. Keogh** | 2025 | 385385 |  | 1999985 |  | 187000 | 11750 | 2584120 |
| Co-President and Chief <br>Operating Officer |  |  |  |  |  |  |  |  |
| Co-President and Chief <br>Operating Officer |  |  |  |  |  |  |  |  |
| **Benjamin M. Wuller** | 2025 | 830769 |  |  |  | 810900 | 11750 | 1653419 |
| CEO Ryan Specialty <br>Underwriting Managers | 2024 | 725962 |  | 2349097 |  | 1839399 | 12940 | 4927398 |
| CEO Ryan Specialty <br>Underwriting Managers |  |  |  |  |  |  |  |  |
| **Jeremiah R. Bickham** <sup>(4)</sup> | 2025 | 646346 |  |  |  | 407899 | 3852075 | 4906320 |
| Former President  | 2024 | 649045 |  | 2349097 |  | 1275007 | 12940 | 4286089 |
| Former President  | 2023 | 600019 | 85550 |  |  | 939450 | 11250 | 1636269 |

---

(1)The amounts reported in this column for 2025 represent the aggregate grant date fair value of the 2025 PSUs granted to Mr. Keogh

calculated in accordance with Financial Accounting Standards Board ASC Topic 718. The estimated fair value of the grant of PSUs is

established on the date of grant using a Monte Carlo simulation model in a manner that is consistent with generally accepted

valuation principles. The value ultimately realized by the executive upon the actual vesting of the award may or may not be equal to

the Financial Accounting Standards Board ("FASB") ASC Topic 718 determined value. The assumptions used in calculating the grant

date fair value reported for the 2025 PSUs in this column are set forth in Note 10 to the consolidated financial statements included in

our Annual Report on Form 10-K for the year ended December 31, 2025. The value of the 2025 PSUs on the grant date, assuming

achievement of the maximum performance level of 150%, would be $2,999,978 for the grant to Mr. Keogh.

(2)The amounts reported in this column for 2025 reflect the short-term incentive bonus for each NEO determined pursuant to the

performance metrics set by the Compensation and Governance Committee. See "*Compensation Discussion and Analysis — Our* 

*Executive Compensation Program in Detail — Our Pay Philosophy — Short-Term Incentive Compensation*" for additional information.

Bonuses were paid in early 2026.

(3)Amounts reported in this column for "All Other Compensation" in 2025 include, for (i) Mr. Ryan, Company contributions under our

401(k) plan of $11,750 and the incremental cost to the Company of personal travel expenses of $2,197, (ii) Mr. Turner, Company

contributions under our 401(k) plan of $11,750, (iii) Ms. Hamilton, Company contributions under our 401(k) plan of $11,750, (iv) Mr.

Keogh, Company contributions under our 401(k) plan of $11,750, (v) Mr. Wuller, Company contributions under our 401(k) plan of

$11,750, and (vi) Mr. Bickham*,* Company contributions under our 401(k) plan of $11,750, payment of severance benefits under our

Severance Plan of $3,825,000, which is equal to one and a half times his base salary and target bonus at the time of his separation,

and payment of COBRA benefits of $15,325.

(4)On October 8, 2025, Jeremiah R. Bickham transitioned from the position of President to serve as a non-employee strategic advisor to

the Company through January 1, 2026.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **44** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **44** |

---

Grants of Plan-Based Awards

The following table sets forth the grants of plan-based awards made to our NEOs during 2025.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **Estimated Future Payouts Under** <br>**Non-Equity**<br>**Incentive Plan Awards**<sup>(1)</sup> | **Estimated Future Payouts Under** <br>**Non-Equity**<br>**Incentive Plan Awards**<sup>(1)</sup> | **Estimated Future Payouts Under** <br>**Non-Equity**<br>**Incentive Plan Awards**<sup>(1)</sup> | **Estimated Future Payouts Under** <br>**Equity**<br>**Incentive Plan Awards**<sup>(2)</sup> | **Estimated Future Payouts Under** <br>**Equity**<br>**Incentive Plan Awards**<sup>(2)</sup> | **Estimated Future Payouts Under** <br>**Equity**<br>**Incentive Plan Awards**<sup>(2)</sup> | **All Other**<br>**Stock**<br>**Awards:**<br>**Number of**<br>**Shares of** <br>**Stock or** <br>**Units**<br>**(#)** | **Grant Date** <br>**Fair Value** <br>**of Stock** <br>**and Option** <br>**Awards**<br>**($)**<sup>(3)</sup> |
| **Name** | **Grant** <br>**Date**<br>| **Threshold**<br>**($)**<br>| **Target**<br>**($)**<br>| **Maximum**<br>**($)**<br>| **Threshold**<br>**(#)**<br>| **Target**<br>**(#)**<br>| **Maximum**<br>**(#)**<br>| **All Other**<br>**Stock**<br>**Awards:**<br>**Number of**<br>**Shares of** <br>**Stock or** <br>**Units**<br>**(#)** | **Grant Date** <br>**Fair Value** <br>**of Stock** <br>**and Option** <br>**Awards**<br>**($)**<sup>(3)</sup> |
| Patrick G. Ryan | 2/18/2025 |  | 2400000 | 3600000 |  |  |  |  |  |
| Timothy W. Turner | 2/18/2025 |  | 3000000 | 4500000 |  |  |  |  |  |
| Janice M. Hamilton | 2/18/2025 |  | 1200000 | 1800000 |  |  |  |  |  |
| Stephen P. Keogh | 2/18/2025 |  | 900000 | 1350000 |  |  |  |  |  |
|  | 5/6/2025 |  |  |  | 57055 | 76074 | 114111 |  | 1999985 |
| Benjamin M. Wuller | 2/18/2025 |  | 1700000 | 2550000 |  |  |  |  |  |
| Jeremiah R. Bickham | 2/18/2025 |  | 1700000 | 2550000 |  |  |  |  |  |

---

(1)Represents the short-term incentive bonus for 2025 for each NEO. There is no threshold value associated with these short-term

bonuses. See the column captioned "*Non-Equity Incentive Plan Compensation*" in the Summary Compensation Table for actual

payout amounts relating to the 2025 fiscal year.

(2)Amounts represent the grant of 2025 PSUs made in 2025 to Mr. Keogh. These awards cliff vest on April 1, 2030, if the performance

criteria are met. See "*Compensation Discussion and Analysis — Our Executive Compensation Program in Detail — Our Pay* 

*Philosophy — Long-Term Incentive Compensation"* for our discussion on the PSUs.

(3)Amounts in this column represent the aggregate grant date fair value of the 2025 PSUs calculated in accordance with FASB ASC

Topic 718. The assumptions used in calculating the grant date fair value reported for the 2025 PSUs in this column are set forth in

Note 10 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2025.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **45** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **45** |

---

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth the options and share-based awards held by our NEOs as of December 31, 2025.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** |
| **Name** | **Grant**<br>**Date**<br>| **Number of**<br>**Securities**<br>**Underlying**<br>**Unexercised**<br>**Options**<br>**(#)**<br>**Exercisable**<br>| **Number of**<br>**Securities**<br>**Underlying**<br>**Unexercised**<br>**Options**<br>**(#)**<br>**Unexercisable**<br>| **Option**<br>**Exercise**<br>**Price**<br>**($)**<sup>(1)</sup><br>| **Option**<br>**Expiration**<br>**Date**<br>| **Number of**<br>**Shares or**<br>**Units of**<br>**Stock** <br>**That**<br>**Have Not**<br>**Vested**<br>**(#)**<br>| **Market**<br>**Value of**<br>**Shares or**<br>**Units of**<br>**Stock** <br>**That**<br>**Have Not**<br>**Vested**<br>**($)**<sup>(2)</sup><br>| **Equity** <br>**Incentive** <br>**Plan** <br>**Awards:** <br>**Number** <br>**of** <br>**Shares,** <br>**Units or** <br>**Other** <br>**Rights** <br>**That Have** <br>**Not** <br>**Vested** <br>**(#)**<br>| **Equity** <br>**Incentive** <br>**Plan** <br>**Awards:** <br>**Market or** <br>**Payout** <br>**Value of** <br>**Unearned** <br>**Shares,** <br>**Units or** <br>**Other** <br>**Rights That** <br>**Have Not** <br>**Vested ($)**<br>|
| Patrick G. Ryan |  |  |  |  |  |  |  |  |  |
| Timothy W. Turner | 7/22/2021<sup>(3)</sup> | 165942 |  | 23.14 | n/a |  |  |  |  |
|  | 3/1/2024<sup>(4)</sup> |  |  |  |  |  |  | 151860 | 7840532 |
| Janice M. Hamilton | 7/23/2021<sup>(5)</sup> |  |  |  |  | 46568 | 2404306 |  |  |
|  | 7/22/2021<sup>(6)</sup> | 18878 | 9440 | 23.14 | n/a |  |  |  |  |
|  | 11/4/2024<sup>(4)</sup> |  |  |  |  |  |  | 94912 | 4900307 |
| Stephen P. Keogh | 5/6/25<sup>(7)</sup> |  |  |  |  |  |  | 114111 | 5891551 |
| Benjamin M. Wuller | 7/22/2021<sup>(3)</sup> | 64945 |  | 23.14 | n/a |  |  |  |  |
|  | 3/3/2023<sup>(8)</sup> |  | 65274 | 40.54 | n/a |  |  |  |  |
|  | 3/1/2024<sup>(4)</sup> |  |  |  |  |  |  | 142369 | 7350511 |
| Jeremiah R. Bickham | 7/22/2021<sup>(9)</sup> | 133332 | 533335 | 23.14 | n/a |  |  |  |  |
|  | 7/22/2021<sup>(6)</sup> | 16009 | 8005 | 23.14 | n/a |  |  |  |  |
|  | 3/1/2024<sup>(4)</sup> |  |  |  |  |  |  | 47268 | 2440447 |

---

(1)Represents the return threshold applicable to the Class C Units as of December 31, 2025. The Class C Units' return threshold is used

to determine the value of such units and, by extension, the number of shares of Class A common stock into which such units may be

converted. The current return threshold is based on the return threshold when issued, which, pursuant to the terms of the operating

agreement of the LLC, is reduced on a 1-for-1 basis for each distribution from the LLC with respect to its common units. As of

December 31, 2025, the LLC has made eight distributions for a total amount of $0.36 per unit with respect to its common units since

each of the applicable Class C Units were issued.

(2)Amounts in this column were calculated by multiplying the number of units that have not vested by the closing price of the Company's

Class A common stock of $51.63 as reported on the NYSE on December 31, 2025.

(3)Represents fully vested Reload Class C Units in the LLC granted in connection with the conversion of Original Units into LLC

Common Units.

(4)Represents the grant of 2024 PSUs or PLUs which vest on April 1, 2029, the date that the Compensation and Governance Committee

ratifies the satisfaction of the performance metrics for the performance periods ending December 31, 2027 and 2028, subject to

continued employment through January 1, 2029 (the "Time Vesting Date"). The number reflects the maximum number of 2024 PSUs

or PLUs that may vest if the maximum level of performance is achieved and the dollar value reflects such maximum number of 2024

PSUs or PLUs multiplied by the closing price of the Company's Class A common stock of $51.63 as reported on the NYSE on

December 31, 2025. The maximum number of 2024 PSUs eligible to vest for Mr. Bickham has been prorated pursuant to the award

agreement based on the number of days employed as a ratio to the number of days from the grant date to the Time Vesting Date

following his separation from the Company on October 8, 2025.

(5)Represents Staking RLUs in the LLC. 5,821 Staking RLUs vest on each July 22 from 2026 through 2030 and 17,463 Staking RLUs

vest on July 22, 2031, in each case, subject to continuous service through each vesting date other than for those exceptions provided

in the award agreement.

(6)Represents Reload Class C Units in the LLC granted in connection with the conversion of Original Units into LLC Common Units.

These Reload Class C Units vested or vest equally on each of July 22, 2024, 2025, and 2026, in each case, subject to continuous

service through each vesting date other than for those exceptions provided in the award agreement. Mr. Bickham's Reload Class C

Units will continue to vest in accordance with the terms of the award agreement following his separation from the Company on

October 8, 2025.

(7)Represents the grant of 2025 PSUs which vest on April 1, 2030, the date that the Compensation and Governance Committee ratifies

the satisfaction of the performance metrics for the performance periods ending December 31, 2029, subject to continued employment

through April 1, 2030. The number reflects the maximum number of 2025 PSUs that may vest if the maximum level of performance is

achieved and the dollar value reflects such maximum number of 2025 PSUs multiplied by the closing price of the Company's Class A

common stock of $51.63 as reported on the NYSE on December 31, 2025.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **46** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **46** |

---

(8)Represents Class C Units in the LLC granted on March 3, 2023. These 2023 Class C Units vest in equal annual installments on April

1, 2026 through April 1, 2030, in each case, subject to continuous service through each vesting date other than for those exceptions

provided in the award agreement.

(9)Represents Staking Class C Units in the LLC. These Staking Class C Units vest 10% on each July 22 from 2024 through 2030 and

30% on July 22, 2031, in each case, subject to continuous service through each vesting date other than for those exceptions provided

in the award agreement. Pursuant to the terms of the award agreement the Staking Class C Units will continue to vest in accordance

with the terms following Mr. Bickham's separation from the Company on October 8, 2025.

Option Exercises and Shares Vested

The following table sets forth the profits interests exercised by our NEOs and the vesting of RLUs held by our NEOs during

2025. ---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Option Awards** | **Option Awards** | **Share-Based Awards** | **Share-Based Awards** |
| **Name** | **Number of** <br>**Shares** <br>**Acquired on** <br>**Exercise**<br>**(#)**<br>| **Value** <br>**Realized on** <br>**Exercise**<br>**($)**<br>| **Number of**<br>**Shares**<br>**Acquired on**<br>**Vesting**<br>**(#)**<br>| **Value** <br>**Realized on** <br>**Vesting**<br>**($)**<br>|
| Patrick G. Ryan |  |  |  |  |
| Timothy W. Turner<sup>(1)(2)</sup> | 129964 | 6755529 | 6978 | 515465 |
| Janice M. Hamilton<sup>(3)</sup> |  |  | 6279 | 413769 |
| Stephen P. Keogh |  |  |  |  |
| Benjamin M. Wuller<sup>(2)</sup> |  |  | 2726 | 201370 |
| Jeremiah R. Bickham<sup>(2)</sup> |  |  | 1831 | 135256 |

---

(1)Number of Shares Acquired on Exercise is equal to the number of shares of Class A common stock issued upon conversion of

222,000 Reload Class C Units. The Reload Class C Units' return threshold is used to determine the value of such units and, by

extension, the number of shares of Class A common stock into which such units may be converted. The return threshold of such units

on the date of exercise was $23.14. The Value Realized on Exercise equals the closing price of the Company's Class A common

stock as reported on the NYSE on the trading day immediately prior to the exercise date, or $51.98 on December 10, 2025, multiplied

by the number of shares acquired on exercise.

(2)Number of Shares Acquired on Vesting represent the number of shares of the 2022 RLUs that vested on April 1, 2025. The Value

Realized on Vesting equals the closing price of the Company's Class A common stock as reported on the NYSE on the trading day

immediately prior to the vesting date, or $73.87 on March 31, 2025, multiplied by the number of RLUs vested.

(3)Number of Shares Acquired on Vesting represent (i) 458 shares of the 2022 RLUs that vested on April 1, 2025, and (ii) 5,821 shares

of the Staking RLUs that vested on July 22, 2025. The Value Realized on Vesting equals the closing price of the Company's Class A

common stock as reported on the NYSE on the trading day immediately prior to the vesting date, or (i) $73.87 on March 31, 2025,

and (ii) $65.27 on July 21, 2025, respectively, multiplied by the number of RLUs vested.

Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based

Awards Table

Named Executive Officer Employment Agreements

*Agreement with Timothy W. Turner* 

In January 2010, we entered into an employment agreement with Mr. Turner. The agreement provided for an initial five-year

term that automatically renews for successive five-year periods until terminated by either party at least 30 days prior to a

renewal date. The agreement provides Mr. Turner with an annual base salary of $800,000 or such higher amount as

determined by the Board, and eligibility to earn an annual target bonus of $700,000. Mr. Turner's employment agreement

also provides for a car allowance and condominium allowance, in each case, of $2,000 per month. In the third quarter of

2023, Mr. Turner voluntarily agreed to forfeit his entitlement to the car and housing allowances.

Under the terms of Mr. Turner's employment agreement, in the event that his employment with us is terminated by us

without "cause," he will be entitled to receive, subject to his execution and non-revocation of a release of claims in favor of

the Company, continued payment of his base salary through the end of the then-current five-year term. In addition, if Mr.

Turner's employment is terminated by us without "Cause" or due to his death or disability and the applicable performance

metrics are achieved, Mr. Turner will be entitled to receive a prorated portion of his annual bonus, with 50% of the estimated

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **47** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **47** |

---

amount of such prorated bonus to be paid on July 31 of the year it is earned and the remaining portion paid on January 31 of

the following year.

Under the Company's Severance Plan, Mr. Turner would be entitled to payments in excess of those set forth in his

employment agreement under certain circumstances. See "— *Termination Benefits*" below.

Termination Benefits

Each of our NEOs is entitled to certain payments and benefits upon a termination of employment under certain

circumstances. Under the Severance Plan, severance payments and benefits are payable upon a termination without

"Cause" or for "Good Reason," and such payments and benefits are enhanced if such termination occurs within six months

prior to, or 18 months following, a "Change in Control" (such period, the "Change in Control Period"). Under the terms of the

award agreements evidencing the NEOs' LTI awards issued prior to or in conjunction with our IPO, the NEOs are eligible (a)

for continued vesting of all of the Staking Class C Units and Reload Class C Units and (b) acceleration of all unvested units

for Staking RLUs in the event their employment with us is terminated (i) by us without "Cause," (ii) due to death or disability,

or (iii) upon a Qualified Retirement. Under the terms of the award agreements evidencing the NEOs' LTI awards issued after

our IPO (2023 Class C Units), the NEOs are eligible for continued vesting of (a) the next tranche of unvested 2023 Class C

Units in the event their employment is terminated by us without "Cause," or (b) all unvested 2023 Class C Units in the event

their employment with us is terminated due to death or disability. Under the terms of the award agreements evidencing the

NEOs' LTI awards issued after our IPO (PSUs and PLUs), the NEOs are eligible for (i) continued vesting of all of the

unvested shares or units in the event their employment with us is terminated by us without "Cause" with the number of

shares prorated based upon the date of termination or (ii) acceleration for all of the unvested shares or units in the event

their employment is terminated due to death or disability. See "*Long-Term Incentive Compensation — Treatment of Long-*

*Term Incentive Upon a Termination of Employment*" above for more information.

Under the Severance Plan, in the event of a termination without "Cause" or for "Good Reason" during the Change in Control

Period, all unvested equity incentive awards that vest solely based on the NEO's continued employment will fully accelerate

and vest as of the date of such termination. For further details regarding these payments and benefits, see "— *Potential* 

*Payments to Named Executive Officers Upon Termination and/or Change of Control*" below.

For purposes of the Severance Plan and the equity award agreements, "Cause" generally means, subject to notice and cure

periods, any of the following: (a) any act or omission which constitutes a breach by the NEO of the terms of their

employment agreement with the Company or any of its affiliates (the "Company Group") that adversely impacts the business

or reputation of the Company Group, (b) the NEO's conviction of a felony or commission of any act that would rise to the

level of a felony, (c) the NEO's conviction or commission of a lesser crime or offense that adversely impacts or potentially

could impact the business or reputation of the Company Group in a material way, (d) the NEO's failure to meet the expected

standard of performance as communicated by such NEO's supervisor, (e) the NEO's violation of specific lawful directives of

the Company, (f) the NEO's commission of a dishonest or wrongful act involving fraud, misrepresentation, or moral turpitude

causing damage or potential damage to any member of the Company Group, (g) the NEO's failure to perform a substantial

part of his or her duties, or (h) the NEO's breach of fiduciary duty.

For purposes of the Severance Plan and the equity award agreements, "Good Reason" generally means, subject to notice

and cure periods, any of the following: (a) a reduction by more than 10% in the NEO's base salary, other than a general

reduction in base salary that affects all similarly situated employees, or failure to pay the NEO's compensation payable

under their employment agreement, or a material reduction in benefits payable under their employment agreement or any

amounts otherwise vested and/or due under the Company's employee benefit plans or employee benefit programs, (b) a

reduction by more than 10% in the NEO's target bonus opportunity, (c) during the Change in Control Period, the reduction of

the NEO's duties or responsibilities that are inconsistent in a material and adverse respect with the NEO's position with the

Company, or (d) if the NEO is required to report regularly to an office or primary work location, the relocation of the NEO's

office or primary work location more than 50 miles from the current location.

For purposes of the Severance Plan and the equity award agreements, a "Change in Control" generally means the

occurrence of any of the following: (a) any "person" (as defined in the Exchange Act) becoming the "beneficial owner" (as

defined in the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the combined

voting power of the Company's then outstanding voting securities (other than pursuant to a transaction that would not be a

Change in Control pursuant to the following clause (b)), (b) a merger or consolidation of the Company or a subsidiary with

any other entity, other than (i) a merger or consolidation which would result in the voting securities of the Company

outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into

voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the

Company or such surviving entity or its ultimate parent company outstanding immediately after such merger or consolidation

in substantially the same proportions as prior to such merger or consolidation or (ii) a merger or consolidation effected to

implement a recapitalization of the Company (or similar transaction) in which no person acquires more than 50% of the

combined voting power of the Company's then outstanding securities, (c) at any time, incumbent directors cease to

constitute a majority of the Company's Board (with any member of the Board being considered an incumbent director if his

or her election or nomination for election to the Board is approved by a majority of the incumbent directors), or (d) a

complete liquidation or dissolution of the Company or the consummation of a sale or disposition by the Company of all or

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **48** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **48** |

---

substantially all of the Company's assets (in one or a series of related transactions), other than to a person or persons who

beneficially own, directly or indirectly, 50% or more of the combined voting power of the outstanding voting securities of the

Company at the time of the sale.

Effective October 8, 2025, Mr. Bickham separated from the Company under what was considered an involuntarily

termination without cause. In connection with his termination and following the execution and non-revocation of a release of

claims against the Company, in accordance with the terms and conditions of the Severance Plan, his separation agreement,

and applicable equity award documents Mr. Bickham received or will receive the following payments and benefits totaling

$4,248,224 (excluding any value for the continued vesting of equity awards): (i) cash payment of $3,825,000 (representing

one and a half times base salary and target bonus); (ii) eligibility to earn his annual cash incentive award of $407,899 under

the 2025 Executive Incentive Corporate Plan based on the Company's performance for the year ended December 31, 2025;

(iii) continued vesting of outstanding Staking Class C Units and Reload Class C Units; (iv) continued vesting of outstanding

2024 PSUs but with the target number of PSUs earned pro-rated based on the applicable date of termination; and (v) cash

payment of $15,325 representing the full COBRA cost for continuing medical benefits for 18 months following termination.

Potential Payments to Named Executive Officers Upon Termination and/or Change in

Control

The below table reflects the severance benefits that Messrs. Ryan, Turner, Keogh, and Wuller and Ms. Hamilton would have

received under the Severance Plan and LTI award agreements had they been terminated for one of the below reasons as of

December 31, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name** | **Involuntary**<br>**Termination**<sup>(5)</sup><br>| **Involuntary**<br>**Termination**<br>**—**<br>**Change in**<br>**Control**<sup>(6)</sup><br>| **Termination**<br>**due to Death,**<br>**Disability or**<br>**Qualified**<br>**Retirement**<sup>(7)</sup><br>| **Voluntary**<br>**Resignation**<br>|
| ***Patrick G. Ryan*** |  |  |  |  |
| Cash Severance<sup>(1)</sup> | $5400000 | $7200000 | $— | $— |
| Pro-Rata Bonus<sup>(2)</sup> |  | 2400000 |  |  |
| Benefits Continuation<sup>(3)</sup> |  |  |  |  |
| Equity Acceleration<sup>(4)</sup> |  |  |  |  |
| **Total:** | **5400000** | **9600000** | **—** | **—** |
| ***Timothy W. Turner*** |  |  |  |  |
| Cash Severance<sup>(1)</sup> | 6750000 | 9000000 |  |  |
| Pro-Rata Bonus<sup>(2)</sup> |  | 3000000 |  |  |
| Benefits Continuation<sup>(3)</sup> | 31495 | 41993 |  |  |
| Equity Acceleration<sup>(4)</sup> |  | 5227021 |  |  |
| **Total:** | **6781495** | **17269014** | **—** | **—** |
| ***Janice M. Hamilton*** |  |  |  |  |
| Cash Severance<sup>(1)</sup> | 1800000 | 3600000 |  |  |
| Pro-Rata Bonus<sup>(2)</sup> | 374000 | 1200000 |  |  |
| Benefits Continuation<sup>(3)</sup> | 10421 | 20842 |  |  |
| Equity Acceleration<sup>(4)</sup> | 2404306 | 5957320 | 2404306 |  |
| **Total:** | **4588727** | **10778162** | **2404306** | **—** |
| ***Stephen P. Keogh*** |  |  |  |  |
| Cash Severance<sup>(1)</sup> | 1500000 | 3000000 |  |  |
| Pro-Rata Bonus<sup>(2)</sup> | 187000 | 900000 |  |  |
| Benefits Continuation<sup>(3)</sup> | 22459 | 44919 |  |  |
| Equity Acceleration<sup>(4)</sup> |  | 3927701 |  |  |
| **Total:** | **1709459** | **7872620** | **—** | **—** |

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **49** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **49** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name** | **Involuntary**<br>**Termination**<sup>(5)</sup><br>| **Involuntary**<br>**Termination**<br>**—**<br>**Change in**<br>**Control**<sup>(6)</sup><br>| **Termination**<br>**due to Death,**<br>**Disability or**<br>**Qualified**<br>**Retirement**<sup>(7)</sup><br>| **Voluntary**<br>**Resignation**<br>|
| ***Benjamin M. Wuller*** |  |  |  |  |
| Cash Severance<sup>(1)</sup> | 2550000 | 5100000 |  |  |
| Pro-Rata Bonus<sup>(2)</sup> | 810900 | 1700000 |  |  |
| Benefits Continuation<sup>(3)</sup> | 25273 | 20842 |  |  |
| Equity Acceleration<sup>(4)</sup> |  | 5743046 |  |  |
| **Total:** | **3386173** | **12563888** | **—** | **—** |

---

(1)Represents cash severance payable under our Severance Plan. See "*Compensation Discussion and Analysis — Severance Plan*" for

more information.

(2)Represents the pro-rata bonus payment under the Severance Plan. Because the termination is assumed to have occurred on

December 31, 2025, for purposes of this disclosure, amounts are pro-rated at 100%. For a termination that occurs outside of the

Change in Control Period, the amount represents the annual bonus based on actual achievement. For a termination that occurs

during the Change in Control Period, the amount represents the annual bonus based on target performance. For Stephen P. Keogh,

who began his employment on May 1, 2025, his bonus amount has been prorated for the year based on the number of days

employed.

(3)Represents benefits continuation payments under the Severance Plan. Mr. Ryan does not receive benefits through any health, dental,

or vision plan of the Company.

(4)Represents the value of equity awards held by our NEOs as of December 31, 2025, that are subject to accelerated vesting pursuant

to the applicable award agreements or the Severance Plan, as applicable. The value of RLUs is based upon the closing price of the

Company's Class A common stock of $51.63 as reported on the NYSE on December 31, 2025. The value of the Class C Units is

based on an exchange value of $53.45, which is the volume weighted average trading price of the Class A common stock for the 20

trading days preceding December 31, 2025. The value of PSUs and PLUs is determined by calculating the number of shares or units

to be issued based on the achievement of the performance metrics through the assumed date of termination of December 31, 2025,

and then multiplied by the closing price of the Company's Class A common stock of $51.63 as reported on the NYSE on December

31, 2025. Pursuant to the applicable award agreements for LTI awards granted during or prior to 2025, (i) upon a termination without

"Cause," due to death or disability, or as a result of a Qualified Retirement (a) LLC Common Units and Reload Class C Units will

remain outstanding and continue to vest pursuant to their original vesting schedule and (b) the vesting of all unvested Staking RLUs

will accelerate, (ii) upon a termination without "Cause," (A) the next tranche of the 2023 Class C Units will continue to vest and the

remaining tranches will be forfeited, and (B) the PLUs or PSUs will remain outstanding and eligible to vest on the Certification Date in

accordance with the performance-based metrics, but the number of PLUs or PSUs earned will be pro-rated based on the applicable

date of termination, (iii) upon a termination due to death or disability, unvested PLUs and PSUs will accelerate and vest in full and

their value with be calculated based on the achievement of the performance-based metrics measured as of the date of death or

disability (for the PLUs and 2024 PSUs, the Adjusted EBITDAC Margin Targets are deemed achieved as of the date of death or

disability) and unvested 2023 Class C Units will continue to vest in full. For purposes of the Termination due to Death, Disability or

Qualified Retirement column shown above, actual performance results determined as of December 31, 2025, resulted in no PLUs and

PSUs being earned. Other than during the Change in Control Period, "Good Reason" does not apply to the LLC Common Units,

Class C Units, or RLUs. Pursuant to the Severance Plan, upon a termination without "Cause" or resignation by the Named Executive

Officer for "Good Reason" during the Change in Control Period, all outstanding equity awards will fully vest. For purposes of the

Involuntary Termination – Change in Control column shown above, the PLUs and PSUs are included at target, which is greater than

actual results determined as of December 31, 2025. Where equity awards would remain outstanding and continue to vest pursuant to

their original vesting schedule, no amounts are shown. See "*Compensation Discussion and Analysis — Our Executive Compensation* 

*Program in Detail — Our Pay Philosophy — Long Term Incentive Compensation*" for more information.

(5)Represents amounts payable upon a termination by us without "Cause" or, for purposes of cash severance and benefits continuation

under the Severance Plan only, upon a resignation by the NEO for "Good Reason," in each case, other than during the Change in

Control Period. Amounts in the "Equity Acceleration" row of this column represent amounts payable on a termination without "Cause"

only.

(6)Represents amounts and benefits payable pursuant to the Severance Plan upon a termination by us without "Cause" or upon a

resignation by the Named Executive Officer for "Good Reason," in each case, during the Change in Control Period.

(7)Represents amounts payable upon a termination due to death, disability, or a Qualified Retirement. As of December 31, 2025, only

Mr. Ryan and Mr. Turner were eligible for a Qualified Retirement.

CEO Pay Ratio

Under the SEC rules adopted pursuant to the Dodd-Frank Act of 2010, the Company is required to calculate and disclose

the total compensation paid to its median paid employee, as well as the ratio of the total compensation paid to the median

employee as compared to the total compensation paid to the Company's CEO, Mr. Turner, as of the date the median

employee was selected.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **50** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **50** |

---

We calculated our median employee's total compensation for the year ended December 31, 2025, in accordance with the

requirements of Item 402(c)(2)(x) of Regulation S-K, the same way we calculated the total compensation of our CEO as

disclosed in our Summary Compensation Table. Using this methodology, we determined that our median employee's 2025

total compensation was $92,847. Based on this information, we estimate that for 2025 our CEO's annual total compensation

was approximately 16 times that of the median employee's total compensation.

Although the calculation of the ratio should be considered an estimate, we believe the ratio is a reasonable estimate

calculated in a manner consistent with SEC rules (Item 402(u) of Regulation S-K). We caution stockholders and other

readers against comparing our ratio to those of other companies. The SEC has stated that it did not believe a purpose of the

pay ratio rule was to facilitate comparisons among companies and, in adopting the rule, the SEC stated its belief that

comparability of the ratio across registrants has significant limits due to the variety of factors that could influence the ratio.

The discussion below describes our methodology for how we determined our median employee for 2025.

*Determining Our Median Employee* 

We determined there were no changes in our employee population or employee compensation arrangements during the last

completed fiscal year that we believe would significantly impact the pay ratio disclosure for 2025. Accordingly, we used the

same median employee we identified in 2024 for purposes of calculating our pay ratio disclosure for 2025.

To identify the median employee in 2024, we used our global population of regular and temporary employees, as of

December 31, 2024, comprising approximately 5,250 employees. We did not exclude any employees.

We did not annualize or otherwise adjust compensation for temporary employees and did not make any full-time

adjustments for anyone. Additionally, we made no cost-of-living adjustments in our calculations. For our U.S. employee

population, we collected 2024 W-2 data from our payroll system, whether employed on a full-time, part-time, or temporary

basis. For our international employee population, we collected comparable paid income data from our payroll system in local

currency, whether employed on a full-time, part-time, or temporary basis and then converted such amounts to U.S. dollars

based upon the exchange rate published by Bloomberg for December 31, 2024. We then compiled both the U.S. and the

international payroll information and used this data as our consistently applied compensation measure.

We then determined the 10 median employees based on the W-2 and international data that we collected. From that group,

we removed anyone who was no longer currently employed by the Company and selected as our median employee a

reasonably representative colleague who had relatively consistent employment and total compensation history.

Pay Versus Performance

The following table sets forth information concerning the compensation of our Principal Executive Officers ("PEOs") and

other NEOs ("Non-PEO NEOs") for each of the years ended December 31, 2025, 2024, 2023, 2022 and 2021, and our

financial performance for each such fiscal year.

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  |  |  |  | **Value of Initial** <br>**Fixed $100**<br>**Investment** <br>**Based On:** | **Value of Initial** <br>**Fixed $100**<br>**Investment** <br>**Based On:** |  |  |
| **Year** | **Summary**<br>**Compen-**<br>**sation**<br>**Table** <br>**Total for**<br>**PEO** <br>**Ryan**<br>**($)**<sup>(1)</sup><br>| **Compen-**<br>**sation** <br>**Actually** <br>**Paid to** <br>**PEO** <br>**Ryan**<br>**($)**<sup>(2)</sup><br>| **Summary**<br>**Compen-**<br>**sation**<br>**Table** <br>**Total for**<br>**PEO** <br>**Turner**<br>**($)**<sup>(3)</sup><br>| **Compen-**<br>**sation** <br>**Actually** <br>**Paid to** <br>**PEO** <br>**Turner** <br>**($)**<sup>(4)</sup><br>| **Average**<br>**Summary**<br>**Compen-**<br>**sation** <br>**Table** <br>**Total** <br>**for Non-**<br>**PEO**<br>**NEOs** <br>**($)**<sup>(5)</sup><br>| **Average**<br> **Compen-**<br>**sation**<br>**Actually**<br>**Paid to** <br>**Non-**<br>**PEO** <br>**NEOs**<br>**($)**<sup>(6)</sup><br>| **Total**<br>**Stock-**<br>**holder** <br>**Return**<br>**($)**<sup>(7)</sup><br>| **Peer** <br>**Group**<br>**Total**<br>**Stock-**<br>**holder**<br>**Return** <br>**($)**<sup>(8)</sup><br>| **Net**<br>**Income** <br>**($,000)**<br>| **Organic**<br>**Revenue**<br>**Growth** <br>**Rate**<br>**(%)**<sup>(9)</sup> <br>|
| 2025 |  |  | 1454058 | (1287247) | 2275254 | (1279863) | 191 | 164 | 214157 | 10.1% |
| 2024 | 3985251 | 3985251 | 5948435 | 13961632 | 4099916 | 8944994 | 236 | 142 | 229913 | 12.8% |
| 2023 | 4256700 | 4256700 |  |  | 2613734 | 3088497 | 156 | 109 | 194480 | 15.4% |
| 2022 | 4478995 | 4478995 |  |  | 2530394 | 3369573 | 151 | 97 | 163257 | 16.8% |
| 2021 | 2456731 | 2456731 |  |  | 8972955 | 22246054 | 147 | 109 | 56632 | 22.9% |

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **51** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **51** |

---

(1)Patrick G. Ryan was our PEO in 2021, 2022, 2023, and for part of 2024. Prior to our IPO on July 21, 2021, Mr. Ryan did not receive

any salary for his role as our Chief Executive Officer.

(2)Since Mr. Ryan (our PEO through October 1, 2024) has never received incentive equity grants and the Company does not have a

pension plan, Compensation Actually Paid ("CAP") to Mr. Ryan is the same amount as reported as total compensation in our

Summary Compensation Table ("SCT") for each year.

(3)Timothy W. Turner became our PEO on October 1, 2024.

(4)The following table provides a reconciliation calculation of our PEO (Mr. Turner) CAP back to his SCT:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Year** | **SCT**<br>**Total**<br>| **SCT Grant**<br>**Date Fair**<br>**Value**<br>**Deduction**<br>| **Year End** <br>**Value of**<br>**Equity**<br>**Granted**<br>**During Year**<br>**and** <br>**Unvested**<br>**at End of** <br>**Year**<br>| **Fair Value**<br> **as of** <br>**Vesting** <br>**Date of** <br>**Equity** <br>**Granted** <br>**During Year** <br>**and Vested** <br>**During Year**<br>| **Change in**<br>**Fair Value of**<br>**Equity**<br>**Granted in**<br>**Prior Year** <br>**and** <br>**Unvested at** <br>**End of Year**<br>| **Change in** <br>**Fair Value** <br>**of Equity** <br>**Granted in**<br>**Prior Year** <br>**and Vested** <br>**During** <br>**Year** <br>| **CAP** |
| 2025 | $1454058 | $— | $— | $— | $(2809410) | $68105 | $(1287247) |
| 2024 | 5948435 | (2470256) | 3803587 |  | 146747 | 6533119 | 13961632 |

---

(5)Our NEOs (other than our PEO) for 2025 included Patrick G. Ryan, Janice M. Hamilton, Stephen P. Keogh, Benjamin M. Wuller, and

Jeremiah R. Bickham. Mr. Bickham was our President until his separation on October 8, 2025. Our NEOs (other than our PEOs) for

2024 included Jeremiah R. Bickham, Janice M. Hamilton, Michael L. Conklin, Brendan M. Mulshine, and Benjamin M. Wuller. Our

NEOs (other than our PEO) for 2023 and 2022 included Timothy W. Turner, Jeremiah R. Bickham, Mark S. Katz, and Brendan M.

Mulshine. Our NEOs (other than our PEO) for 2021 included Timothy W. Turner, Jeremiah R. Bickham, Mark S. Katz, Michael T.

VanAcker, and Diane M. Aigotti. Ms. Aigotti was our Chief Financial Officer until she resigned from the Company on March 1, 2021.

(6)The following table provides a reconciliation calculation of the average Non-PEO NEOs' CAP back to the average Non-PEO NEOs'

SCT total:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Year** | **Average**<br>**SCT**<br>**Total**<br>| **SCT Grant**<br>**Date Fair**<br>**Value**<br>**Deduction**<br>| **Year End** <br>**Value of**<br>**Equity**<br>**Granted**<br>**During** <br>**Year**<br>**and** <br>**Unvested**<br>**at End of** <br>**Year**<br>| **Fair Value**<br> **as of** <br>**Vesting** <br>**Date of** <br>**Equity** <br>**Granted** <br>**During** <br>**Year** <br>**and Vested** <br>**During** <br>**Year**<br>| **Change in**<br>**Fair Value** <br>**of**<br>**Equity**<br>**Granted in**<br>**Prior Year** <br>**and** <br>**Unvested at** <br>**End of Year**<br>| **Change in** <br>**Fair Value** <br>**of Equity** <br>**Granted** <br>**in**<br>**Prior Year** <br>**and** <br>**Vested** <br>**During** <br>**Year** <br>| **Change in** <br>**Fair Value** <br>**of Equity** <br>**Forfeited** <br>**During** <br>**Year**<br>| **Average** <br>**CAP**<br>|
| 2025 | $2275254 | $(399997) | $116850 | $— | $(2814707) | $23951 | $(481214) | $(1279863) |
| 2024 | 4099916 | (2201439) | 2888360 |  | 3686548 | 471609 |  | 8944994 |
| 2023 | 2613734 | (374999) | 392166 |  | 439155 | 18441 |  | 3088497 |
| 2022 | 2530394 | (308222) | 367125 |  | 928526 | (148250) |  | 3369573 |
| 2021 | 8972955 | (4324316) | 17418303 | 179112 |  |  |  | 22246054 |

---

(7)Total Stockholder Return ("TSR") is calculated based on a fixed investment of $100 at the applicable measurement point on the same

cumulative basis as is used in Item 201(e) of Regulation S-K. The TSR is calculated from July 22, 2021, the first trading date of our

Class A common stock after our IPO, through the end of the applicable year.

(8)Our Peer Group TSR for the relevant fiscal year represents the cumulative TSR of the S&P 500 Financials Sector Index, consistent

with the industry index used in our "Performance Graph" pursuant to Section 201(e) of regulation S-K as presented in Item 5 of our

Annual Report on Form 10-K. The Peer Group TSR is calculated from July 22, 2021, the first trading date of our Class A common

stock after our IPO, through the end of the applicable year.

(9)Ryan Specialty's most important financial performance measure used to link CAP to our NEOs to Company performance for the year

ended December 31, 2025, is Organic Revenue Growth Rate. In the first quarter of 2024, the Company modified the methodology

that it uses to calculate Organic Revenue Growth Rate. While our Organic Revenue Growth Rate STI targets in 2024 and prior years

were determined based on the original calculation methodology, in 2025, STI targets were determined based on the new calculation

methodology, therefore we have presented the new methodology in the table above and the graph below. For completeness, Organic

Revenue Growth Rate calculated based on the original calculation methodology was 9.6%,12.1%, 15.0%, 16.4% and 22.4% for the

years ended December 31, 2025, 2024, 2023, 2022, and 2021, respectively.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **52** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **52** |

---

*Pay Versus Performance Comparative Disclosure*

The below charts depict Compensation Actually Paid, calculated in accordance with Item 402(v) of Regulation S-K ("Item

402(v)"), for our PEOs and the average of our Non-PEO NEOs in relationship to various performance metrics for the same

period. As discussed above, and based on our compensation philosophy, a significant amount of equity was granted to our

executive officers as part of our IPO on July 21, 2021. In addition, each of our NEOs other than our former PEO, Mr. Ryan,

received a grant of performance-based awards to further align executive comp with company performance. See "*Executive* 

*Compensation: Compensation Discussion and Analysis — Our Executive Compensation Program in Detail — Our Pay* 

*Philosophy*" for further details. The considerable increase in value of the Company's shares of Class A common stock from

the IPO to December 31, 2021 and from January 1, 2024 to December 31, 2024 is reflected in the average Compensation

Actually Paid to PEO (Turner) in 2024 and our Non-PEO NEOs in 2021 and 2024. The decrease in value of the Company's

shares of Class A common stock from January 1, 2025 to December 31, 2025 is reflected in the average Compensation

Actually Paid to PEO (Turner) in 2025 and our Non-PEO NEOs in 2025.

**Compensation Actually Paid and Company Total Stockholder Return**

The below chart depicts CAP to our PEOs and the average of our Non-PEO NEOs in relationship to our TSR for the same

period. Our Non-PEO NEOs' long-term incentive compensation is directly tied to the increase in value of our common stock.

![31017](ryan-20260317_g23.gif)

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **53** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **53** |

---

**Compensation Actually Paid and Net Income**

The below chart depicts CAP to our PEOs and the average of our Non-PEO NEOs in relationship to our Net Income for the

same period. The Company does not use net income as a performance measure in its overall executive compensation

program.

![31301](ryan-20260317_g24.gif)

**Compensation Actually Paid and Organic Revenue Growth Rate**

The below chart depicts CAP to our PEOs and the average of our Non-PEO NEOs in relationship to our Organic Revenue

Growth Rate for the same period. The Company first directly aligned short-term incentive compensation with Organic

Revenue Growth Rate in 2022, where 35% of each NEO's short-term incentive compensation was tied to our Organic

Revenue Growth Rate performance and such alignment continued in 2023, 2024, and 2025. See "*Executive Compensation:* 

*Compensation Discussion and Analysis — Our Executive Compensation Program in Detail — Our Pay Philosophy — Short-*

*Term Incentive Compensation*" for further details. An Organic Revenue Growth CAGR also forms an achievement floor for

the PSUs and PLUs that were granted to each of our NEOs, other than Mr. Ryan, in 2024 and 2025.

![32156](ryan-20260317_g25.gif)

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **54** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **54** |

---

**Company TSR and Peer Group TSR**

As demonstrated by the following graph, the Company's TSR increased 91% over the presented period in the table, while

the Company's peer group TSR increased 64% over the same period. The Company's TSR generally outperformed the peer

group during the period presented in the table, representing the Company's superior financial performance as compared to

the S&P 500 Financials Sector Index.

![32581](ryan-20260317_g26.gif)

*Pay Versus Performance Tabular List*

For the year ended December 31, 2025, the most important financial performance measures used to link CAP to our NEOs

to Company performance were Organic Revenue Growth Rate, Adjusted EBITDAC Margin, and TSR. Our NEOs' total

compensation is heavily weighted towards short and long-term performance with performance goals aligned with our

stockholders' interests. Each NEO's short-term incentive compensation is primarily determined by Organic Revenue Growth

Rate and Adjusted EBITDAC Margin. See "*Executive Compensation: Compensation Discussion and Analysis — Our* 

*Executive Compensation Program in Detail — Our Pay Philosophy —Short-Term Incentive Compensation*" for further detail.

Most of our NEOs have significant long-term equity incentive grants that vest over 5 or 10 years and as a result their actual

compensation is directly tied to TSR. In addition, each of our NEOs, other than Mr. Ryan, received a grant of performance-

based awards (PLUs or PSUs) the value of which is tied to TSR after achieving a minimum Organic Revenue Growth CAGR

and, for the 2024 PSUs and PLUs, a minimum target Adjusted EBITDAC Margin. See "*Executive Compensation:* 

*Compensation Discussion and Analysis — Our Executive Compensation Program in Detail — Our Pay Philosophy —Long-*

*Term Incentive Compensation*" for further detail.

---

| |
|:---|
| **Most Important Financial Performance Measures** |
| Organic Revenue Growth Rate |
| Adjusted EBITDAC Margin |
| Total Stockholder Return |

---

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **55** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **55** |

---

Securities Authorized for Issuance Under Equity Compensation Plans

The following table provides information, as of December 31, 2025, about the securities authorized for issuance under the

Company's equity compensation plans, categorized according to whether the equity plan was previously approved by

stockholders.

---

| | | | |
|:---|:---|:---|:---|
| **Plan Category** | **Number of**<br>**Shares to be**<br>**Issued Upon**<br>**Exercise of**<br>**Outstanding**<br>**Options,**<br>**Warrants and**<br>**Rights**<sup>(1)</sup><br>| **Weighted**<br>**Average**<br>**Exercise**<br>**Price of**<br>**Outstanding**<br>**Options,**<br>**Warrants and**<br>**Rights**<sup>(2)</sup><br>| **Number of**<br>**Shares**<br>**Remaining**<br>**Available**<br>**for Future**<br>**Issuance**<sup>(3)</sup><br>|
| Equity Compensation Plans Approved by Security Holders | 31741516 | $24.59 | 24331837 |
| Equity Compensation Plans Not Approved by Security Holders |  |  |  |
| Total | 31741516 | 24.59 | 24331837 |

---

(1)These amounts include the number of securities to be issued upon exercise, conversion, or settlement of 3,731,240 outstanding

Options, 5,669,191 outstanding Class C Units, 16,380,588 outstanding LLC Common Units, 1,777,594 outstanding RLUs, 4,661,986

outstanding RSUs, 487,218 outstanding PLUs, and 1,612,920 outstanding PSUs. The 5,669,191 outstanding Class C Units could

have been exchanged for 3,089,970 shares of Class A common stock on December 31, 2025, based on an exchange value of

$53.45, which is the volume weighted average trading price of the Class A common stock for the 20 trading days preceding

December 31, 2025.

(2)The weighted average exercise price does not include outstanding LLC Common Units, RSUs, RLUs, PLUs, and PSUs which do not

have an associated exercise price. Calculated without regard to the shares that will be issued in connection with the settlement of

RSUs, RLUs, PLUs, or PSUs, or the conversion of LLC Common Units, the weighted-average exercise price is $24.59.

(3)Represents the number of shares of common stock remaining available under the Ryan Specialty Holdings, Inc. 2021 Omnibus

Incentive Plan (the "Omnibus Plan") as of December 31, 2025. Beginning January 1, 2022, and on each January 1 thereafter through

and including January 2031, the total number of shares available for issuance under the Omnibus Plan automatically increases by an

amount equal to the lesser of (i) 2% of the outstanding shares of Class A and Class B common stock on the last day of the

immediately preceding year or (ii) an amount determined by the Board.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **56** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **56** |

---

**SECURITY OWNERSHIP OF CERTAIN BENEFICIAL** 

**OWNERS AND MANAGEMENT** 

The following table sets forth information about the beneficial ownership of our Class A common stock and Class B common

stock as of March 2, 2026, for:

• each person or group known to us who beneficially owns more than 5% of our Class A common stock or Class B

common stock;

• each of our directors and each of our NEOs; and

• all of our directors and executive officers as a group.

The number of shares of Class A common stock and Class B common stock beneficially owned, and the percentages of

beneficial ownership, set forth below are based on 128,670,686 shares of Class A common stock issued and outstanding

and 134,508,885 shares of Class B common stock issued and outstanding on March 2, 2026. These numbers exclude

134,508,885 shares of Class A common stock issuable in exchange for the same number of LLC Common Units and for the

cancellation on a one-to-one ratio of the related shares of our Class B common stock. If all outstanding LLC Common Units

were exchanged and all outstanding shares of Class B common stock were canceled as of March 2, 2026, we would have

263,179,571 shares of Class A common stock outstanding.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name of Beneficial Owner**<sup>(1)</sup>  | **Shares of**<br>**Class A**<br>**Common**<br>**Stock**<sup>(2)</sup><br>| **% of**<br>**Class A**<br>**Common**<br>**Stock**<br>**Outstanding** <br>| **Shares of**<br>**Class B**<br>**Common**<br>**Stock**<br>| **% of**<br>**Class B**<br>**Common**<br>**Stock**<br>**Outstanding** <br>| **% of**<br>**Combined**<br>**Voting**<br>**Power**<sup>(3)</sup> <br>|
| **5% Stockholders:** |  |  |  |  |  |
| Patrick G. Ryan<sup>(4)</sup> | 15678471 | 12.2% | 112048184 | 83.3% | 77.1% |
| The Vanguard Group<sup>(5)</sup> | 9397569 | 7.3% |  | \* | \* |
| BlackRock, Inc.<sup>(6)</sup> | 9294486 | 7.2% |  | \* | \* |
| T. Rowe Price Investment Management, Inc.<sup>(7)</sup> | 7182749 | 5.6% |  | \* | \* |
| Capital World Investors<sup>(8)</sup> | 6588460 | 5.1% |  | \* | \* |
| **Named Executive Officers, Directors and** <br>**Director Nominees:**<br>|  |  |  |  |  |
| Patrick G. Ryan<sup>(4)</sup> | 15678471 | 12.2% | 112048184 | 83.3% | 77.1% |
| Timothy W. Turner<sup>(9)</sup> | 12553 | \* | 2156186 | 1.6% | 1.5% |
| Henry S. Bienen<sup>(10)</sup> | 53328 | \* |  | \* | \* |
| David P. Bolger<sup>(11)</sup> | 81290 | \* |  | \* | \* |
| Michael G. Bungert |  | \* |  | \* | \* |
| Michelle L. Collins<sup>(12)</sup> | 13462 | \* |  | \* | \* |
| Francesca Cornelli<sup>(13)</sup> | 4620 | \* |  | \* | \* |
| Nicholas D. Cortezi<sup>(14)</sup> | 5020 | \* | 4308271 | 3.2% | 2.9% |
| Anthony J. Kuczinski | 4315 | \* |  | \* | \* |
| Michael D. O'Halleran<sup>(15)</sup> | 815158 | \* |  | \* | \* |
| John W. Rogers, Jr.<sup>(16)</sup> | 104676 | \* |  | \* | \* |
| Patrick G. Ryan, Jr.<sup>(17)</sup> | 684854 | \* | 5574738 | 4.1% | 3.8% |
| Janice M. Hamilton<sup>(18)</sup> | 8274 | \* | 141826 | \* | \* |
| Stephen P. Keogh |  | \* |  | \* | \* |
| Benjamin M. Wuller<sup>(19)</sup> | 94095 | \* | 438480 | \* | \* |
| Jeremiah R. Bickham<sup>(20)</sup> | 2159 | \* | 179508 | \* | \* |
| All executive officers and directors as a group <br>(18 individuals)<sup>(21)</sup><br>| 16966276 | 13.2% | 119957807 | 89.2% | 82.5% |

---

\*Denotes less than 1%

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **57** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **57** |

---

(1)Unless otherwise noted below, the address for each beneficial owner listed on the table is 155 North Wacker Drive, Suite 4000,

Chicago, Illinois 60606. We have determined beneficial ownership in accordance with the rules of the SEC. Except as indicated by

the footnotes below, we believe, based on the information furnished to us, that the persons and entities named in the table above

have sole voting and investment power with respect to all Class A common stock and Class B common stock that they beneficially

own, subject to applicable community property laws.

(2)The reported amount does not reflect shares of Class A common stock issuable on account of vested Class C Units, which are

redeemable by the holder for either, at the option of the Company, cash or a number of Common Units (which are immediately

redeemed on a one-for-one basis for shares of Class A Common Stock), determined by reference to (i) the Class C Units' return

threshold and (ii) adjustments for certain prior distributions made with respect to such Class C Units.

(3)Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is currently entitled to 10

votes per share. Each share of Class B common stock then outstanding will be entitled to one vote per share on the earliest to occur

of (i) 12 months following the death or disability of Patrick G. Ryan, (ii) the first trading day on or after such date that the outstanding

shares of Class B common stock represent less than 10% of the then-outstanding Class A and Class B common stock, which, in each

instance, may be extended to 18 months upon affirmative approval of a majority of the Company's independent directors, or (iii)

September 30, 2029. The Class A common stock and Class B common stock will vote as a single class on all matters except as

required by law or the Certificate.

(4)Amounts include 13,697,859 shares of Class A common stock and 91,353,821 shares of Class B common stock beneficially owned

by Mr. Ryan and his spouse and 1,954,747 shares of Class A common stock and 20,694,363 shares of Class B common stock

beneficially owned and attributed to Mr. Ryan and his spouse pursuant to certain trusts, entities, and accounts managed by, or for, the

benefit of family members and others.

(5)Number of shares held are derived from the Schedule 13-G/A filed with the Securities and Exchange Commission on February 13,

2024, as reported by The Vanguard Group ("Vanguard"). The address for Vanguard is 100 Vanguard Blvd., Malvern, Pennsylvania

19355. Vanguard reports sole dispositive power with respect 9,237,983 of the shares of Class A common stock reported, shared

voting with respect to 54,534 of the shares of Class A common stock reported, and shared dispositive power with respect to 159,586

of the shares of Class A common stock reported.

(6)Number of shares held are derived from the Schedule 13-G filed with the Securities and Exchange Commission on November 8,

2024, as reported by BlackRock, Inc. ("BlackRock"). The address for BlackRock is 50 Hudson Yards, New York, New York 10001.

BlackRock reports sole dispositive power with respect to all 9,294,486 of the shares of Class A common stock reported, sole voting

power with respect to 9,081,054 of the shares of Class A common stock reported, and no shared dispositive or voting power with

respect of the shares of Class A common stock reported.

(7)Number of shares held are derived from the Schedule 13-G filed with the Securities and Exchange Commission on February 17,

2026, as reported by T. Rowe Price Investment Management, Inc. ("T. Rowe Price"). The address for T. Rowe Price is 1307 Point

Street, Baltimore, Maryland 21231.

(8)Number of shares held are derived from the Schedule 13-G filed with the Securities and Exchange Commission on November 13,

2024, as reported by Capital World Investors ("Capital World"). The address for Capital World is 333 South Hope Street, 55th Floor,

Los Angeles, California 90071.

(9)The shares of Class A common stock and Class B common stock are held by Mr. Turner individually.

(10)All shares of Class A common stock are held in trusts beneficially owned and attributed to Mr. Bienen and his spouse.

(11)Includes 14,823 RSUs that were fully vested upon grant for which the director has elected to defer settlement until his separation from

service on the Board. The remaining shares of Class A common stock are held in a trust beneficially owned and attributed to Mr.

Bolger.

(12)Includes 10,462 RSUs that were fully vested upon grant for which the director has elected to defer settlement until her separation

from service on the Board. The remaining shares of Class A common stock are held by Ms. Collins individually.

(13)Includes 4,620 RSUs that were fully vested upon grant for which the director has elected to defer settlement until her separation from

service on the Board.

(14)Includes 5,020 RSUs that were fully vested upon grant for which the director has elected to defer settlement until his separation from

service on the Board. The shares of Class B common stock are held in trusts beneficially owned and attributed to Mr. Cortezi.

(15)Includes 14,823 RSUs that were fully vested upon grant for which the director has elected to defer settlement until his separation from

service on the Board. The remaining shares of Class A common stock are held by Mr. O'Halleran individually and in a trust

beneficially owned and attributed to Mr. O'Halleran.

(16)Includes 9,513 RSUs that were fully vested upon grant for which the director has elected to defer settlement until his separation from

service on the Board. The remaining shares of Class A common stock are held by Mr. Rogers individually.

(17)Includes 256,194 shares of Class A common stock beneficially owned by Mr. Ryan, Jr., and his spouse, 402,795 shares of Class A

common stock and 5,574,738 shares of Class B common stock beneficially owned and attributed to Mr. Ryan, Jr., and his spouse

pursuant to trusts for the benefit of his family members. All shares and percentages reported for Mr. Ryan, Jr., are duplicative and

included in the share counts and percentages for Patrick G. Ryan, represented in the table above and footnote (4) thereto, who

exercises voting power over the equity held by Mr. Ryan, Jr.

(18)The shares of Class A common stock and the shares of Class B common stock are held by Ms. Hamilton individually.

(19)The shares of Class A common stock and the shares of Class B common stock are held by Mr. Wuller individually.

(20)The shares of Class A common stock and the shares of Class B common stock are held by Mr. Bickham individually. The number of

shares reported is as of October 8, 2025, the day Mr. Bickham separated from the Company.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **58** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **58** |

---

(21)Includes (a) 61,584 RSUs that were fully vested upon grant for which directors have elected to defer settlement until such time as the

individual director's separation from service on the Board and (b) 7,637 RSUs that vest into an equivalent number of shares of Class

A common stock within 60 days of March 2, 2026. The remaining shares of Class A common stock and Class B common stock are

held directly by the directors or officers other than as specified in the notes above. The shares of Class A common Stock and Class B

common stock held by Patrick G. Ryan, Jr., have been excluded from the total since they are duplicative and included in the share

counts and percentages for Patrick G. Ryan who exercises voting power over the equity held by Mr. Ryan, Jr.

DELINQUENT SECTION 16(a) REPORTS

Section 16(a) of the Exchange Act requires the Company's directors, executive officers, and persons who beneficially own

more than 10% of a registered class of the Company's equity securities to file with the SEC reports on Forms 3, 4, and 5

concerning their ownership of, and transactions in, the Class A common stock and other equity securities of the Company.

As a practical matter, the Company assists its directors and executive officers by monitoring transactions and completing

and filing reports on their behalf. Based solely on the Company's review of copies of such reports filed with the SEC and

written representations that no other reports are required, the Company believes that all of its executive officers, directors,

and those greater-than-10% stockholders that filed any reports for the year ended December 31, 2025, reported all

transactions on a timely basis, with the exception of (i) a Form 3 for Stephen P. Keogh which was late by one day due to

delays in receiving EDGAR filing credentials and (ii) a Form 4 and a Form 5 for Patrick G. Ryan, Jr., which were delayed

because, prior to the reporting person becoming subject to Section 16 of the Exchange Act, the reporting person's spouse

had made an automatic dividend reinvestment election with respect to shares held in a brokerage account. The

reinvestments resulted in the quarterly acquisition of de minimis amounts of shares of Class A common stock, which

originally qualified for deferred reporting pursuant to Rule 16a-6 of the Exchange Act.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **59** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **59** |

---

**CERTAIN RELATIONSHIPS AND RELATED PARTY** 

**TRANSACTIONS** 

Policy for Approval of Related Party Transactions

We have adopted a written policy with respect to the review, approval, and ratification of related party transactions. Under

the policy, our Audit Committee is responsible for reviewing and approving or ratifying related party transactions. In the

course of its review and disapproval, approval, or ratification of related party transactions, our Audit Committee considers the

relevant facts and circumstances and determines whether to approve or ratify such transactions. In particular, our policy

requires our Audit Committee to consider, among other factors it deems appropriate:

• the related person's relationship to us and interest in the transaction;

• the material facts of the proposed transaction, including the proposed aggregate value of the transaction;

• the impact on a director's independence in the event the related person is a director or an immediate family

member of a director;

• the benefits to us of the proposed transaction;

• if applicable, the availability of other sources of comparable products or services; and

• an assessment of whether the proposed transaction is on terms that are comparable to the terms available to an

unrelated third party or to employees generally.

The Audit Committee may only approve or ratify those transactions that are in, or are not inconsistent with, our best interests

and those of our stockholders, as the Audit Committee determines in good faith.

In addition, under our Code of Conduct, our employees and directors will have an affirmative responsibility to disclose any

transaction or relationship that reasonably could be expected to give rise to a conflict of interest.

2025 Related Party Transactions

We describe below transactions and series of similar transactions that occurred during our prior fiscal year or that were

ongoing during the year or that are currently proposed, to which we were a party or will be a party, in which:

• the amounts involved exceeded or will exceed $120,000; and

• any of our directors, executive officers, immediate family members of our directors or executive officers, or

beneficial holders of more than 5% of any class of our capital stock had or will have a direct or indirect material

interest.

Other than as described below, there have not been, nor are there any currently proposed, transactions or series of similar

transactions meeting these criteria to which we have been or will be a party other than compensation arrangements, which

are described where required under "Executive Compensation."

Ryan Investment Holdings, Geneva Re, and Ryan Re

*Ryan Investment Holdings* 

Ryan Investment Holdings, LLC ("RIH") is an investment holding company that aggregates the funds of the LLC and

Geneva-Ryan Holdings, LLC ("GRH") for investment in Geneva Re Partners, LLC ("GRP"). GRH is an investment holding

company that aggregates investment funds of Patrick G. Ryan and Patrick G. Ryan, Jr., and members of their family,

Michael O'Halleran, and other affiliated investors. The LLC holds a 47% interest in RIH and GRH holds a 53% interest in

RIH. RIH has a 50% non-controlling interest in GRP and the other 50% is owned by Nationwide Mutual Insurance Company

("Nationwide"). GRP wholly owns Geneva Re, Ltd., a Bermuda-regulated reinsurance company ("Geneva Re") and GR

Bermuda SAC Ltd. (the "Segregated Account Company"). The Segregated Account Company has one segregated account,

which is beneficially owned by a third-party insurance company (the "Third-party Insurer").

RIH has committed to contribute additional capital to GRP over the next several years. Patrick G. Ryan, through a trust of

which he is the beneficiary and co-trustee, has committed to personally fund any such additional capital contributions. In

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **60** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **60** |

---

exchange for any such capital contributions, Mr. Ryan will receive promissory notes from RIH that will not affect the relative

ownership of RIH's common equity.

*Geneva Re*

On January 1, 2021, the Company entered into a service agreement with Geneva Re to provide both administrative services

to, as well as disburse payments for costs directly incurred by, Geneva Re. These direct costs include compensation

expenses incurred by employees of Geneva Re. The Company had $0.3 million due from Geneva Re under this agreement

as of December 31, 2025.

*Ryan Re Preferred Equity*

Mr. Ryan and his wife held preferred equity in Ryan Re Underwriting Managers, LLC ("Ryan Re"), a wholly owned subsidiary

of the Company, which accrued a preferred return at the rate of 10% annually. In October 2025, the Board approved the

payment of all unreturned capital to retire the outstanding preferred equity. On December 29, 2025, the Company made a

payment of $3.7 million to Mr. Ryan and his wife to settle the outstanding preferred equity, of which $0.4 million related to

accrued interest through the date of payment.

*Ryan Re Services Agreement with Geneva Re* 

On June 13, 2019, Ryan Re entered into a services agreement with Geneva Re to provide, among other services, certain

underwriting and administrative services to Geneva Re. Ryan Re receives a service fee equal to 115% of the administrative

costs incurred by Ryan Re in providing these services to Geneva Re. Revenue earned from Geneva Re, net of applicable

constraints, was $1.6 million for the year ended December 31, 2025. Receivables due from Geneva Re on the service

agreement, net of applicable constraints, was $0.8 million as of December 31, 2025.

On April 2, 2023, Ryan Re entered into a services agreement with Geneva Re in accordance with which Ryan Re

subcontracted certain services to Geneva Re that Ryan Re is required to provide to the segregated account of the

Segregated Account Company on behalf of the Third-party Insurer. The Company incurred expense of $11.7 million during

the year ended December 31, 2025, and had prepaid expenses of $6.4 million as of December 31, 2025, related to this

services agreement.

Company Charter of Corporate Jets

In the ordinary course of its business, the Company charters executive jets for business purposes from a third-party service

provider, Executive Jet Management ("EJM"). Mr. Ryan indirectly owns aircraft that he leases for remuneration to EJM and

which EJM then charters to third parties. The Company pays market rates for chartering aircraft through EJM, unless the

particular aircraft chartered is one which Mr. Ryan indirectly owns, in which case the Company receives a discount from

market rates. Historically, the Company often has been able to charter Mr. Ryan's aircraft through EJM thereby benefiting

from this discount, as well as having confidence in the maintenance record of the aircraft and skill of the crew. The Company

recognized an expense related to business usage of the aircraft of $0.9 million for the year ended December 31, 2025 (of

which Mr. Ryan indirectly received $0.5 million in remuneration).

Personal Guarantee by Patrick G. Ryan

In April 2021, Mr. Ryan personally guaranteed up to $10.0 million of the financial obligations of the LLC under an agency

agreement with certain insurance companies that are affiliated with National Indemnity Company. The Company did not pay

Mr. Ryan any consideration for this guarantee. Mr. Ryan's guarantee may be replaced by the Company with a letter of credit

at any time, subject to the prior approval of the insurance companies. It is expected that Mr. Ryan will not personally

guarantee any additional financial obligations of the Company or any of its subsidiaries.

Registration Rights Agreement

In connection with the IPO, we entered into the Registration Rights Agreement with the Ryan Parties and Onex. The Ryan

Parties are entitled to request that we register their shares of capital stock on a long-form or short-form registration

statement on any number of occasions in the future, which registrations may be "shelf registrations." The Ryan Parties are

also entitled to participate in certain of our registered offerings, subject to the restrictions in the Registration Rights

Agreement. We will pay expenses in connection with the exercise of these rights. The registration rights described in this

paragraph apply to (i) shares of our Class A common stock (including shares issuable to the Ryan Parties upon exchange of

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **61** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **61** |

---

their LLC Common Units) held by the Ryan Parties and Onex and their affiliates and (ii) any of our capital stock (or that of

our subsidiaries) issued or issuable with respect to the Class A common stock described in clause (i) with respect to any

dividend, distribution, recapitalization, reorganization, or certain other corporate transactions ("Registrable Securities").

These registration rights are also for the benefit of any subsequent holder of Registrable Securities; provided that any

particular securities will cease to be Registrable Securities when they have been sold in a registered public offering, sold in

compliance with Rule 144 ("Rule 144") of the Securities Act of 1933 (the "Securities Act"), or repurchased by us or our

subsidiaries. In addition, with the consent of the Company and holders of a majority of Registrable Securities, certain

Registrable Securities will cease to be Registrable Securities if they can be sold without limitation under Rule 144. Onex sold

its remaining Registrable Securities in 2025 in compliance with Rule 144 and therefore no longer has any registration rights

under the agreement.

Tax Receivable Agreement

We entered into a Tax Receivable Agreement with current and certain former LLC Unitholders that will provide for the

payment by us to the current and certain former LLC Unitholders, collectively, of 85% of the amount of tax benefits, if any,

that we actually realize (or under some circumstances are deemed to realize) as a result of (i) certain increases in the tax

basis of assets of the LLC and its subsidiaries resulting from purchases or exchanges of LLC Common Units, (ii) certain tax

attributes of the LLC and its subsidiaries that existed prior to the IPO, (iii) certain favorable "remedial" partnership tax

allocations to which we become entitled (if any), and (iv) certain other tax benefits related to our entering into the Tax

Receivable Agreement, including tax benefits attributable to payments that we make under the Tax Receivable Agreement.

These payment obligations are obligations of Ryan Specialty Holdings, Inc. and not of the LLC.

Director Nomination Agreement

In connection with the IPO, the Company entered into a Director Nomination Agreement with the Ryan Parties and Onex.

The Director Nomination Agreement currently provides the Ryan Parties the right to nominate certain members of our Board

based on the number of shares of the Company's common stock held by the Ryan Parties. The Director Nomination

Agreement provides the Ryan Parties the right to designate (in each instance, rounded up to the nearest whole number if

necessary): (i) all of the nominees for election to our Board for so long as the Ryan Parties control, in the aggregate, 50% or

more of the total number of shares of our common stock beneficially owned by the Ryan Parties upon completion of the IPO,

as adjusted for any reorganization, recapitalization, stock dividend, stock split, reverse stock split, or similar changes in our

capitalization (the "Original Amount"); (ii) 50% of the nominees for election to our Board for so long as the Ryan Parties

control, in the aggregate, more than 40%, but less than 50% of the Original Amount; (iii) 40% of the nominees for election to

our Board for so long as the Ryan Parties control, in the aggregate, more than 30%, but less than 40% of the Original

Amount; (iv) 30% of the nominees for election to our Board for so long as the Ryan Parties control, in the aggregate, more

than 20%, but less than 30% of the Original Amount; and (v) 20% of the nominees for election to our Board for so long as

the Ryan Parties control, in the aggregate, more than 10%, but less than 20% of the Original Amount, which could result in

representation on our Board that is disproportionate to the Ryan Parties' beneficial ownership. Upon the death or disability of

Patrick G. Ryan, or at such time that he is no longer on the Board or actively involved in the operations of the Company, the

Ryan Parties will no longer hold the nomination rights specified in (i) through (v); however, the Ryan Parties will have the

right to designate one nominee for so long as the Ryan Parties control, in the aggregate, 10% or more of the Original

Amount. For so long as the Ryan Parties hold the nomination rights specified in clause (i) through (v) above, the Ryan

Parties have the right to nominate the chairperson of the Board. The Director Nomination Agreement also prohibits us from

increasing or decreasing the size of our Board without the prior written consent of the Ryan Parties.

Onex's right to designate one nominee for election to our Board fell away upon its sale of shares of our Class A common

stock in April 2023. After Robert M. Le Blanc retired from the Board on February 11, 2026, the Ryan Parties became eligible

to nominate all of the nominees for the Board.

In addition, at any time when the Ryan Parties have the right to designate at least one nominee for election to our Board, the

Ryan Parties will also have the right to have one of their nominated directors hold one seat on each Board committee,

subject to satisfying any applicable stock exchange rules or regulations regarding the independence of Board committee

members. The Listing Standards of the NYSE require that, subject to specified exceptions, each member of a listed

company's audit and compensation and governance committees be independent and that Audit Committee members also

satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act.

This agreement will terminate at such time as the Ryan Parties control, in the aggregate, less than 5% of the Original

Amount.

Indemnification of Officers and Directors

We have entered into indemnification agreements with each of our officers and directors. The indemnification agreements

provide the officers and directors with contractual rights to indemnification, expense advancement, and reimbursement, to

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **62** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **62** |

---

the fullest extent permitted under the Delaware General Corporation Law ("DGCL"). Additionally, we may enter into (i)

indemnification agreements with any new directors or officers that may be broader in scope than the specific indemnification

provisions contained in the DGCL and (ii) standard policies of insurance that provide coverage to (a) our directors and

officers against loss arising from claims made by reason of breach of duty or other wrongful act and (b) the Company with

respect to indemnification payments that we may make to such directors and officers. Insofar as indemnification for liabilities

arising under the Securities Act may be permitted to our officers and directors pursuant to the foregoing agreements, we

have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the

Securities Act and is therefore unenforceable.

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **63** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **63** |

---

**OTHER MATTERS** 

We are not aware of any matters other than those discussed in the foregoing materials contemplated for action at the Annual

Meeting. The persons named in the Proxy Card will vote in accordance with the recommendation of the Board on any other

matters incidental to the conduct of, or otherwise properly brought before, the Annual Meeting. The Proxy Card contains

discretionary authority for them to do so.

Incorporation by Reference

Neither the Audit Committee Report nor the Compensation Committee Report shall be deemed soliciting material or filed

with the SEC and shall not be deemed incorporated by reference into any prior or future filings made by us under the

Securities Act or the Exchange Act, except to the extent that we specifically incorporate such information by reference. In

addition, this document includes website addresses, which are intended to provide inactive, textual references only. The

information on these websites is not part of this document.

Proposals of Stockholders and Communications with our Board

Stockholder proposals pursuant to SEC Rule 14a-8 of the Exchange Act for inclusion in our Proxy Statement for our 2027

annual meeting of stockholders must be received by us at our principal executive offices at 155 North Wacker Drive, Suite

4000, Chicago, IL 60606, Attention: Corporate Secretary, no later than November 17, 2026, in order to be considered for

inclusion in our proxy statement and form of proxy/voting instruction related to that meeting. Such proposals will need to be

in writing and comply with SEC regulations regarding the inclusion of stockholder proposals in Company-sponsored proxy

materials.

Stockholders wishing to make a director nomination or bring a proposal before the annual meeting to be held in 2027 (other

than pursuant to SEC Rule 14a-8 of the Exchange Act) must provide written notice of such nomination or proposal to the

Corporate Secretary at our principal executive offices no later than the close of business on January 28, 2027, and not

earlier than December 29, 2026, assuming we do not change the date of the 2027 annual meeting of stockholders by more

than 30 days before or after the anniversary of this Annual Meeting. If so, we will release an updated timeframe for

stockholder proposals. Any director nominations or proposals must comply with the other provisions of our Bylaws and be

submitted in writing.

To comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees, other

than the Company's nominees, must also provide notice that sets forth the information required by Rule 14a-19 under the

Exchange Act no later than February 27, 2027, assuming we do not change the date of the 2027 annual meeting of

stockholders by more than 30 days before or after the anniversary of this Annual Meeting. If so, we will release an updated

timeframe for stockholder notices. Such notice must be postmarked or transmitted electronically to the Corporate Secretary

at our principal executive offices.

Stockholders and other interested parties may contact an individual director, the Board as a group, or a specified Board

committee or group, including the non-employee or independent directors as a group, by sending regular mail to: Ryan

Specialty Holdings, Inc., 155 North Wacker Drive, Suite 4000, Chicago, Illinois 60606, Attention: Corporate Secretary. The

Corporate Secretary will forward the communication to the applicable directors or the Board as a whole, provided that we

generally will not forward to the directors a communication that is primarily commercial in nature, relates to an improper or

irrelevant topic, or requests general information regarding the Company. Each communication should specify to which

director or directors the communication is addressed, as well as the general topic of the communication. We will receive the

communications and process them before forwarding them to the addressee. We may also refer communications to other

departments within the Company.

Availability of SEC Filings and Where to Find Additional Information

We are subject to the informational requirements of the Exchange Act and, in accordance therewith, we file annual, quarterly

and current reports and other information with the SEC. Copies of our reports on Forms 10-K, 10-Q, 8-K and all

amendments to those reports filed with the SEC, our proxy statements, and any reports of beneficial ownership of our

common stock filed by executive officers, directors, and beneficial owners of more than 10% of our outstanding common

stock are posted on, and may be obtained through, our investor relations website, ir.ryanspecialty.com, or may be requested

in print, at no cost, by email at ir@ryanspecialty.com or by mail at Ryan Specialty Holdings, Inc., 155 North Wacker Drive,

Suite 4000, Chicago, Illinois 60606, Attention: Investor Relations.

These documents will be provided upon request as soon as reasonably practicable after such material is electronically filed

with or furnished to the SEC. We are an electronic filer, and the SEC maintains an Internet site that contains the reports and

other information, so such information may also be accessed electronically by means of the SEC's home page on the

---

| | |
|:---|:---|
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **64** |
| ![RyanSpecialty_RGB.jpg](ryan-20260317_g3.jpg) | 2026 Proxy Statement **64** |

---

Internet at www.sec.gov. Please note that our website address is provided as an inactive textual reference only. The

information provided on or accessible through our website is not part of this Proxy Statement.

Cost of Proxy Solicitation

Ryan Specialty is paying the expenses of this solicitation. We will also make arrangements with brokerage houses and other

custodians, nominees, and fiduciaries to forward proxy materials to beneficial owners of our common stock held as of the

Record Date by such persons, and Ryan Specialty will reimburse such persons for their reasonable out-of-pocket expenses

in forwarding such proxy materials. In addition to solicitation by mail, directors, officers, and other employees of Ryan

Specialty may solicit proxies in person, by telephone, or by other means of communication, without additional remuneration.

![RyanSpecialty_Proxy-02192026-Back COver.jpg](ryan-20260317_g27.jpg)

![PC Proof_03.12.26_Page 1.jpg](ryan-20260317_g28.jpg)

![PC Proof_03.12.26_Page 2.jpg](ryan-20260317_g29.jpg)